Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRP,Agouti-related protein,42296,0.289343719771866,0.00494059649554803,0.279660150640592,0.29902728890314,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL27,C-C motif chemokine 27,42145,0.261158321461203,0.00629504974053948,0.248820023969746,0.273496618952661,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN1,CCN family member 1,42047,0.367997594276185,0.00698690307321967,0.354303264252675,0.381691924299696,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHR,Growth hormone receptor,39736,0.113072860074489,0.0028358559312492,0.107514582449241,0.118631137699737,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0887968449644593,0.00216685710431645,0.0845498050399991,0.0930438848889196,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLR,Low-density lipoprotein receptor,42170,0.419263320349459,0.00411173943643882,0.411204311054038,0.427322329644879,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFGE8,Lactadherin,42137,0.252476781829499,0.00434408869282915,0.243962367991554,0.260991195667444,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPY,Pro-neuropeptide Y,42262,0.362271863855614,0.00604951933722511,0.350414805954653,0.374128921756575,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.146736527151366,0.00320669070162548,0.14045141337618,0.153021640926552,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPL,Lipoprotein lipase,42145,-0.191769264515308,0.00487377094359001,-0.201321855564744,-0.182216673465871,1.11253692925411e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCG,Pro-glucagon,41843,0.478962067255315,0.012647366170191,0.454173229561741,0.503750904948889,4.52266720957266e-298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.124091649846699,0.00329246004083917,0.117638428166654,0.130544871526744,7.79395035473051e-296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F7,Coagulation factor VII,42194,0.118954875924573,0.00315935183272559,0.112762546332431,0.125147205516715,3.34992217054895e-295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES1,Liver carboxylesterase 1,42163,0.323638882008101,0.00865949565833764,0.306666270517759,0.340611493498443,4.57581378473306e-291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH,Parathyroid hormone,39649,0.314302759779629,0.00841213987244831,0.29781496562963,0.330790553929628,7.84676322207204e-288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF9,Protein turtle homolog A,39958,0.322896632440801,0.00870752527467711,0.305829882902433,0.339963381979168,3.11539430959975e-284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.288687348235372,0.00778906693500371,0.273420777042765,0.30395391942798,6.47196624200446e-284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42230,0.180939719085254,0.00493512634045184,0.171266871457968,0.19061256671254,9.45595265974635e-281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.160200724802244,0.00437159769790989,0.151632393314341,0.168769056290147,1.76396735558981e-280
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FURIN,Furin,42181,0.118967568066004,0.00338660173227679,0.112329828670742,0.125605307461267,7.77089086371666e-259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APCS,Serum amyloid P-component,39870,0.114716302570117,0.00331994372716558,0.108209212864873,0.121223392275362,9.01345792554924e-249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROC,Vitamin K-dependent protein C,42199,0.0898854195861705,0.00263660396592716,0.0847176758129532,0.0950531633593877,1.6612786193588e-244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.29190318826628,0.00863822706825828,0.274972263212493,0.308834113320066,3.49239490574248e-240
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,42100,0.100116500360804,0.00298706215380658,0.0942618585393427,0.105971142182264,1.19172555421249e-236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCHE,Cholinesterase,39806,0.0921724294842843,0.00274821151341343,0.086785934917994,0.0975589240505746,4.27626190242607e-235
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.280133531720915,0.00840524381711785,0.263659253839364,0.296607809602466,5.4574204723572e-234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.499550278341878,0.0150615629562606,0.470029614947608,0.529070941736149,7.47943172648029e-232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLTP,Phospholipid transfer protein,42267,-0.12911879353112,0.00389678598404588,-0.13675649405985,-0.12148109300239,1.20943066714196e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,39966,0.132671464597476,0.0039982704449516,0.124834854525371,0.140508074669582,1.55609873205173e-230
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL23,C-C motif chemokine 23,42185,0.142203332627868,0.00435643926125594,0.133664711675806,0.15074195357993,4.54626819221174e-225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.28625101667643,0.00880153765496574,0.269000002872697,0.303502030480163,1.96579957826914e-223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBC,Inhibin beta C chain,42137,0.133268547915191,0.00410050893349489,0.125231550405541,0.141305545424841,3.51667861300601e-223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9,Complement component C9,39990,-0.187658504117158,0.0059115809331036,-0.199245202746041,-0.176071805488275,5.54754360256577e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.260696674283927,0.00826363919214887,0.244499941467315,0.276893407100539,8.2289252895452e-211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADIPOQ,Adiponectin,39979,-0.222785270207107,0.00707949877617501,-0.23666108780841,-0.208909452605804,1.69002716567012e-208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,42119,0.171841507835443,0.00548655929045606,0.16108785162615,0.182595164044737,6.02033371139126e-208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.195411228883721,0.00625566733662707,-0.20767233686351,-0.183150120903932,5.57956916489711e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,39835,0.0961595824172588,0.0031032541748838,0.0900772042344866,0.102241960600031,2.29642867142154e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.106631571721414,0.00345962228456562,0.0998507120436651,0.113412431399162,9.94748652557781e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA4,Kallistatin,39802,0.0742611208972161,0.0024130688709726,0.0695315059101098,0.0789907358843224,1.0214073200731e-199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR37,Prosaposin receptor GPR37,41900,0.204901430116367,0.00675072110391002,0.191670016752704,0.218132843480031,1.01347422201535e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN3,Contactin-3,42137,0.0890784386417922,0.00293708688409515,0.0833217483489657,0.0948351289346187,1.53851337994786e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.398564072798861,0.0131479535453204,-0.424334061747689,-0.372794083850033,2.01805604749391e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP1,Neuropilin-1,42230,-0.0857031040295877,0.00283002995602489,-0.0912499627433965,-0.0801562453157789,5.06699220662308e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTR,Transthyretin,39862,0.0775577224790301,0.0025603390368978,0.0725394579667104,0.0825759869913498,7.65327727889592e-194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.332158755455883,0.0110671419775674,0.310467157179851,0.353850353731915,1.25353455422062e-191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFM,Afamin,39979,0.062071892338231,0.00208725951888757,0.0579808636812114,0.0661629209952507,3.17498381457864e-187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG2,Desmoglein-2,42137,-0.0825431044461857,0.00280950530264376,-0.0880497348393675,-0.0770364740530039,5.53199100624069e-184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0589229565303696,0.00201135031457389,0.0549807099138048,0.0628652031469344,6.03095761599024e-183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAT,Tissue-type plasminogen activator,42272,0.15512574702788,0.00531641789387981,0.144705567955876,0.165545926099885,1.25927283358723e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.20780675432545,0.00713047999982621,0.193831013525791,0.22178249512511,3.97576047759724e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,42152,0.0937045618859732,0.00323787677263549,0.0873583234116077,0.100050800360339,9.63655571967365e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIP2,Cysteine-rich protein 2,42016,0.109396515193101,0.00378346701037605,0.101980919852764,0.116812110533438,2.19635951657506e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCA,Alpha-synuclein,39736,0.351940174435329,0.0121919349860775,0.328043981862617,0.375836367008041,9.15497270179899e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0918586028046087,0.00318451689399215,-0.0981002559168333,-0.0856169496923841,1.62112091431877e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,42296,0.225516593527889,0.00784817483014334,0.210134170860808,0.24089901619497,2.26537846625211e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0607220609134093,0.00214430514589834,0.0565192228274486,0.0649248989993701,2.75955018827316e-171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.176242402438459,0.00623792343186179,0.16401607251201,0.188468732364908,1.40553266483347e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,39958,0.167492172471965,0.00593338256517323,0.155862742644225,0.179121602299704,1.69364098150489e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA3,Glutathione S-transferase A3,41843,0.225966235665938,0.00803075209724158,0.210225961555344,0.241706509776531,3.06711065361075e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFH,Complement factor H,39418,0.0680760205489684,0.00242828923473047,0.0633165736488967,0.0728354674490401,5.24322127626112e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUSB,Beta-glucuronidase,42211,0.176845260040328,0.0063566641132875,0.164386198378284,0.189304321702371,1.01549676618392e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0706954516012081,0.00254288976882453,0.065711387654312,0.0756795155481042,1.72378398270406e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.35662749657202,0.0129042806874363,0.331335106424645,0.381919886719395,1.36110446822666e-163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,42137,0.0756501693337011,0.00275587085518792,0.0702486624575328,0.0810516762098695,1.7334799069074e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFP,Properdin,39979,0.067218311167711,0.00245761926966368,0.0624013773991702,0.0720352449362518,1.41921278976786e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPM,Carboxypeptidase M,42195,0.0957593875675726,0.00354452948826154,0.0888121097705799,0.102706665364565,1.25833857041403e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH1,Somatotropin,42129,-0.497912543246543,0.018522760832457,-0.534217154478158,-0.461607932014927,4.17466152180515e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,41843,0.308601740941162,0.0116591371548775,0.285749832117602,0.331453649764722,1.76257595889871e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCS1,Neuronal calcium sensor 1,42262,0.0781126988653463,0.00295235756294221,0.0723260780419796,0.083899319688713,1.77863652068782e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELN,Elastin,39958,0.0951470232990995,0.00361175840443288,0.088067976826411,0.102226069771788,1.66013739081061e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA1,Glutathione S-transferase A1,42119,0.23137226182832,0.00883909839830043,0.214047628967651,0.248696894688988,2.27099687023045e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0912849616623333,0.00349952376026511,-0.0981440282324529,-0.0844258950922136,1.960673610726e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY1,Aminoacylase-1,42145,0.170396552515855,0.00656373649851196,0.157531628978771,0.183261476052938,4.7666968512577e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKB,Creatine kinase B-type,39966,-0.155492960999329,0.00597624001554544,-0.167206391429798,-0.14377953056886,5.11759040376503e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0884712768441608,0.00342732831262691,0.081753713351412,0.0951888403369095,1.87052978949422e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42185,-0.0791567784725493,0.00306802800463491,-0.0851701133616338,-0.0731434435834649,2.40961368981072e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS15,Enteropeptidase,42070,0.236573131846841,0.00918807997460609,0.218564495096613,0.254581768597069,9.40809278778296e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFI,Complement factor I,39979,0.0521868960935503,0.00202256068129847,0.0482226771582053,0.0561511150288953,1.01038274167412e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.196386921818011,0.00764732179327951,0.181398171103183,0.211375672532839,5.06724715971193e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROS1,Vitamin K-dependent protein S,39979,0.0678825666461298,0.00264554034569623,0.0626973075685651,0.0730678257236944,3.29916629717748e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,42249,0.153687550365184,0.00600972108825274,0.141908497032208,0.165466603698159,6.16015478015753e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO3,Beta-enolase,39638,0.167058027509667,0.00655212180478233,0.154215868772293,0.17990018624704,2.20527636315021e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.154742341492935,0.00609128245147009,-0.166681255097816,-0.142803427888054,4.31554886441736e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42016,0.0806626796369136,0.00317534640344187,0.0744390006861675,0.0868863585876597,4.43287324993359e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.138341162505208,0.00544896500588312,0.127661191093677,0.149021133916739,5.53397774662328e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORT1,Sortilin,42129,0.10090472120308,0.00398686940515791,0.0930904571689707,0.10871898523719,4.02683812010276e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42070,0.333749068727859,0.0132002662176238,0.307876546941317,0.359621590514402,7.7456915895547e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRN,"Attractin, Isoform 2",39979,0.0438512753437635,0.0017373264200025,0.0404461155605586,0.0472564351269684,7.98776034451022e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.190524306776449,0.00756865075083434,0.175689751304814,0.205358862248085,1.1628744162833e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYNU,Kynureninase,42296,0.119669034042474,0.00475685811614472,0.110345592134831,0.128992475950118,1.45336481323349e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL16,C-C motif chemokine 16,42310,0.13495423466838,0.00536924395632833,0.124430516513976,0.145477952822784,2.47930813775054e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",41839,0.133040075265644,0.00529670634935153,0.122658530820915,0.143421619710373,4.78150577695013e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUMB,Protein numb homolog,39657,0.219407519466083,0.00874415222440338,0.202268981106252,0.236546057825913,3.52893306547838e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRP,Gastrin-releasing peptide,39638,0.139214075775498,0.00557137341024766,0.128294183891412,0.150133967659583,4.27728454949688e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42181,0.0654386948132322,0.00262639743867966,0.0602909558334201,0.0705864337930444,5.01992147827088e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.185003313920813,0.00740960558989825,0.170480486964613,0.199526140877014,5.51597086806829e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0839702910515147,0.00337174276602462,0.0773616752301065,0.090578906872923,6.51087798255228e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHBG,Sex hormone-binding globulin,39990,-0.120743116382642,0.00488627748089039,-0.130320220245187,-0.111166012520097,2.28052564543901e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPB1,Beta-ureidopropionase,39958,0.233322827751358,0.00945701205971502,0.214787084114316,0.251858571388399,5.78171556290804e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0506173663003936,0.0020570633062552,0.0465855222201334,0.0546492103806538,7.38327132057312e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.176067006086729,0.00715508995500595,0.162043029774917,0.190090982398541,8.93505577486653e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0992560600128304,0.00404612444998137,-0.107186463934794,-0.0913256560908669,4.48507669279256e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS1,Protein MTSS 1,39930,0.285520325148791,0.0116388934447965,0.26270809399699,0.308332556300593,1.57145710399184e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,39815,0.0670760568347032,0.00274461716870693,0.0616966071840377,0.0724555064853688,1.45971152735173e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,39657,0.221071814401085,0.00905520255246475,0.203323617398254,0.238820011403916,2.92365140668214e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42140,0.100970308988011,0.00414635608253382,0.0928434510662444,0.109097166909777,3.13240029260541e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLKB1,Plasma kallikrein,39759,0.0621599252920149,0.00256162970545673,0.0571391310693197,0.0671807195147101,8.40122265434885e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F9,Coagulation factor IX,42199,0.0464549905923221,0.00192144943125009,0.0426889497070719,0.0502210314775722,1.77838151423886e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0558345026462915,0.00230454570125875,0.0513175930718243,0.0603514122207586,2.03919301145615e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPIND1,Heparin cofactor 2,39959,0.0735602308543443,0.00304896155069812,0.067584266214976,0.0795361954937126,1.83901268930996e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTYMK,Thymidylate kinase,39958,0.169456097943063,0.00702787120880942,0.155681470373796,0.183230725512329,2.55694302301994e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP5,Retinol-binding protein 5,42070,0.14124964257309,0.00590199173147868,0.129681738779392,0.152817546366788,5.34870945806184e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.103693018355364,0.00434130923778313,0.0951840522493087,0.112201984461419,1.58724716937899e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPC,C-type natriuretic peptide,42119,0.1315741081817,0.00552173754001746,0.120751502603265,0.142396713760134,5.71994178838309e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEG1,Protein HEG homolog 1,39736,0.0688245189327545,0.00288304926564082,0.0631737423720985,0.0744752954934105,7.06149467186567e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0649240518862728,0.00272665123929007,0.0595798154572643,0.0702682883152813,8.79707655356035e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR2,Cadherin-related family member 2,42070,0.164138213797463,0.00690593307885174,0.150602584962914,0.177673842632012,2.34007312266397e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOST,Sclerostin,42129,0.0963665208023267,0.00406108553365646,0.08840679315636,0.104326248448293,5.49568460495223e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,P4HB,Protein disulfide-isomerase,42073,0.0960888949099777,0.0040502338410928,0.0881504365814358,0.10402735323852,6.29944719118508e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EEF1D,Elongation factor 1-delta,39958,0.226588297936088,0.0095346762585951,0.207900332469241,0.245276263402934,7.10292073815394e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LG,CMRF35-like molecule 9,42137,-0.0926886042245256,0.00391683810288041,-0.100365606906171,-0.08501160154288,2.41620954267988e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.163500984282297,0.00690215602323262,0.149972758476761,0.177029210087833,3.99471204462523e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,42070,0.281411938637957,0.0119775575820448,0.257935925777149,0.304887951498764,1.15360037573198e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.345232812133693,0.0146722166211846,0.316475267556171,0.373990356711214,1.45249244465404e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH9,Myosin-9,39966,0.279350425056798,0.011885126649462,0.256055576823853,0.302645273289744,2.5240560965481e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF21,Fibroblast growth factor 21,42247,0.295029820205236,0.0126005759242086,0.270332691393788,0.319726949016685,6.69421902022075e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42181,0.224511598877362,0.00960798221258209,0.205679953740701,0.243343244014023,1.97057235737843e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOMO1,Nodal modulator 1,42137,0.0570960010398114,0.00244369478992006,0.0523063592515681,0.0618856428280547,2.12389795479375e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FN1,Fibronectin,39979,0.0664901613818138,0.00285286969854493,0.0608985367726658,0.0720817859909619,2.09213226408916e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F10,Coagulation factor X,39990,0.0706091611470996,0.00303216760899105,0.0646661126334772,0.076552209660722,3.22707563704204e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0774293744343597,0.00333510384023625,0.0708925709074967,0.0839661779612228,5.67581558232688e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLN,Promotilin,42119,0.216134615473873,0.00938637405081071,0.197737322334284,0.234531908613462,4.09942915648789e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.208968526320385,0.00906514024500249,0.19120085144018,0.22673620120059,6.1291274013177e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR3,Anterior gradient protein 3,41827,0.143111780774828,0.00622045549041198,0.130919688013621,0.155303873536036,7.09107693829174e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR5,Cadherin-related family member 5,42145,0.0934740489422263,0.00406423510569023,0.0855081481350734,0.101439949749379,7.43312217836298e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FYB1,FYN-binding protein 1,42115,0.223299965827388,0.00972293418871376,0.204243014817509,0.242356916837267,1.55651512915707e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,39736,0.183825436885977,0.0079903440223597,0.168164362602152,0.199486511169802,1.84796348889347e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYAP1,Synapse-associated protein 1,39736,0.140715461402336,0.00613525303793334,0.128690365447987,0.152740557356685,8.67739706062443e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42145,0.0743671722728792,0.00325736751584464,0.0679827319418237,0.0807516126039347,3.09496589012721e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,39934,0.139378528096192,0.00611001025051388,0.127402908005184,0.151354148187199,1.1860090285027e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0710859375400715,0.00311707421654271,0.0649764720756478,0.0771954030044952,1.34093550888558e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,39915,0.262762295311235,0.011523555708469,0.240176126122636,0.285348464499835,1.46754465229469e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,41913,0.204805159397873,0.00899986509202662,0.187165423817501,0.222444894978245,1.71025768639902e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.155373215957038,0.00685924621430544,0.141929093377,0.168817338537077,1.74131907235418e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,39649,0.291331531038431,0.0129117524831951,0.266024496171369,0.316638565905494,3.01080889264259e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.131745043618302,0.00585698051309752,0.120265361812631,0.143224725423973,5.32597137585899e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.16170588363404,0.0071748338366675,0.147643209314172,0.175768557953909,5.40393194493756e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42181,0.0529191673614521,0.00236514631160135,0.0482834805907135,0.0575548541321908,6.39981369191214e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,39786,0.0315494851080739,0.00140765107835154,0.0287904889945049,0.0343084812216429,7.20309221940176e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.186402389943745,0.00833268914294871,0.170070319223565,0.202734460663924,1.69826978973541e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEP,Leptin,42145,0.163119993299103,0.00731081022922682,0.148790805249818,0.177449181348387,2.4923535114674e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42070,0.157993044076497,0.00709414154200157,0.144088526654174,0.17189756149882,6.20954367047117e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.134431649171057,0.00602951382517552,0.122613802073713,0.146249496268401,9.54600656659548e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0931226436795183,0.00419042147017469,-0.101335869761061,-0.0849094175979759,1.71254046577565e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN2,Ficolin-2,42116,0.0945264927748854,0.0042612716813133,0.0861744002795113,0.102878585270259,4.07226786938934e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL16,Pro-interleukin-16,42296,0.0984505801903936,0.00444951260702158,0.0897295354806313,0.107171624900156,1.29319389045926e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPY30,Protein dpy-30 homolog,42216,0.139538823805873,0.00631992735674599,0.12715176618665,0.151925881425095,3.6180580101224e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,42162,0.0749058988686443,0.00339255358204894,0.0682564938478284,0.0815553038894602,3.65357178928851e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.113417653979447,0.00516226130562462,0.103299621820423,0.123535686138472,3.95635736770219e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HJV,Hemojuvelin,39934,0.096756913872216,0.00441677748701269,0.0881000299976712,0.105413797746761,3.20487829647519e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJAP1,Tight junction-associated protein 1,42181,0.190775568593691,0.00874634493653107,0.17363273251809,0.207918404669292,1.06459915713981e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLA,Alpha-galactosidase A,39713,0.0895303957419843,0.00411212849354025,0.0814706238946454,0.0975901675893232,5.91998273783077e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORD,Sorbitol dehydrogenase,42204,0.157069011814019,0.0072311303075781,0.142895996411166,0.171242027216872,7.17008795279302e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0681774598342726,0.00315320687198739,0.0619971743651773,0.0743577453033679,1.25362991373264e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPY,Pancreatic prohormone,42089,0.232952909391396,0.0108322592201601,0.211721681319882,0.25418413746291,6.78532496216281e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS2,Protein MTSS 2,39919,0.226999887366786,0.0105523844247082,0.206317213894358,0.247682560839214,1.23323766981182e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,42185,0.148802179272225,0.00693976715216758,0.135200235653977,0.162404122890474,2.47786848237071e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4R,Reticulon-4 receptor,42262,0.0760345550496368,0.00355075167320898,0.0690750817701472,0.0829940283291264,4.36842582567912e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.256694346770365,0.0119744193841783,0.233224484777375,0.280164208763354,6.17993908760938e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXT,Oxytocin-neurophysin 1,42249,0.325610766613528,0.015260337915875,0.295700504298413,0.355521028928643,2.14444562791794e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F13B,Coagulation factor XIII B chain,39925,0.0574319898328024,0.00269128450285777,0.0521570722072012,0.0627069074584037,4.2559501249591e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.223513152588129,0.0104767600977209,0.202978702796596,0.244047602379662,4.77887919143994e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHK,Ketohexokinase,39638,0.14127921431418,0.00662112650971863,0.128301806355132,0.154256622273229,5.00269879843952e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.23861294069471,0.0112066556781787,0.21664789556548,0.260577985823941,5.6277882802794e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.219009011908673,0.0102905030609379,0.198839625909234,0.239178397908111,6.92985248284759e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAB2,Stabilin-2,39966,0.0628927996786731,0.00295201080815728,0.0571068584946848,0.0686787408626614,8.58583824995055e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.201740839209988,0.00948512946397919,0.183149985460589,0.220331692959388,9.34496746688349e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0922564674045556,0.00433503330147199,0.0837598021336705,0.100753132675441,1.40934759153566e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11R,Junctional adhesion molecule A,42137,0.124427376379152,0.00587207522953049,0.112918108929272,0.135936643829032,4.61710613527789e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2AP,CD2-associated protein,42145,0.140666334256278,0.00664171854150314,0.127648565914932,0.153684102597624,5.71335442787828e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0820957072863755,0.00387629031760044,0.0744981782638787,0.0896932363088724,5.86058917632743e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,39575,0.13457819214044,0.00638307826416336,0.122067358742679,0.1470890255382,9.19174784858841e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.114666854334117,0.00546566440282205,0.103954152104585,0.125379556563648,3.42499148481706e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES3,Carboxylesterase 3,42070,0.156857490762181,0.00748607790150088,0.142184778075239,0.171530203449123,5.90950462559414e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.187105644021087,0.00891616813589941,0.169629954474724,0.20458133356745,6.61847665002435e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXLNA,Alpha-taxilin,42016,0.194219360214688,0.00928122053154282,0.176028167972864,0.212410552456512,1.04080105192377e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFC,Platelet-derived growth factor C,41843,0.0616173470733825,0.002945118981689,0.0558449138692721,0.067389780277493,1.18561954809884e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MME,Neprilysin,42070,0.171526039233154,0.00820390103765055,0.155446393199359,0.187605685266949,1.48535532210054e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLUL1,Clusterin-like protein 1,42123,-0.0980824586788313,0.00470645576650738,-0.107307111981186,-0.0888578053764769,5.80139502667156e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,41997,0.0506353216555989,0.00243155852607804,0.0458694669444859,0.0554011763667118,8.23492357305728e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0610914629001955,0.00293398087053414,0.0553408603939486,0.0668420654064424,8.34865326449601e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.21944464550729,0.010547273754169,0.198771988949119,0.240117302065461,1.158842915786e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.171731677945289,0.00824367625078016,0.15557407249376,0.187889283396818,1.31302422303665e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.178462937488006,0.00859026624290942,0.161626015651904,0.195299859324109,2.0861195062127e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42098,-0.14125605062303,0.00681994097934882,-0.154623134942554,-0.127888966303507,7.69081961821935e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP20,Centrosomal protein 20,41843,0.164129556889476,0.00792977313232003,0.148587201550129,0.179671912228824,1.09260999168442e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.133668326876967,0.00646511995667519,0.120996691761884,0.146339961992051,1.7214543868628e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.119302687665056,0.00577414446338304,0.107985364516825,0.130620010813287,2.30158398238348e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCXR,L-xylulose reductase,42181,0.117905225936506,0.00571933911596475,0.106695321269215,0.129115130603797,5.28942614888146e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCLY,Selenocysteine lyase,42224,0.105523427640799,0.00512941563297479,0.0954697730001687,0.11557708228143,1.23768270260665e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.158039737051161,0.00768741663899227,0.142972400438737,0.173107073663586,1.63663066092236e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC1,Stanniocalcin-1,42249,0.0993049178630691,0.00483120337247957,0.0898357592530091,0.108774076473129,1.73930814590309e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD63,CD63 antigen,41992,0.109163138818513,0.00532250691435683,0.0987310252663737,0.119595252370652,4.55158850375639e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.113690245453981,0.00554451592945608,0.102822994232247,0.124557496675715,4.97334494179817e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTD,Biotinidase,39979,0.0443239098637827,0.00215877192904892,0.0400927168828468,0.0485551028447185,5.12912806287646e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXIN1,Axin-1,42119,0.208550457424973,0.0101819665842822,0.18859380291978,0.228507111930166,7.62355171164013e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,41843,0.140676042499795,0.00686892731294203,0.127212944966429,0.154139140033162,8.51591097586446e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM1,Isthmin-1,42119,0.0852625373255781,0.00416631762486187,0.0770965547808489,0.0934285198703074,1.082454667567e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,39929,0.103919495502414,0.0050725393064156,0.0939773184618397,0.113861672542989,1.28042258939625e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.158077662888182,0.00772667570479216,0.14293337850679,0.173221947269575,1.3026109759688e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,39575,0.145352217109863,0.00710556529297681,0.131425309135628,0.159279125084097,2.64158729507224e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.142918685491384,0.00700910086557875,0.129180847794849,0.156656523187918,5.04754486358687e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL22,C-C motif chemokine 22,41991,0.110934519171221,0.00547084917629401,0.100211654785685,0.121657383556757,4.55842929267458e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZN,Kazrin,39930,0.223946082402187,0.0110359585373704,0.202315603668941,0.245576561135433,5.89745100705774e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BECN1,Beclin-1,39638,0.127047631955407,0.00625987181389432,0.114778283200174,0.13931698071064,6.09354944389358e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRN,Agrin,42185,0.0763578127994969,0.00378178142695969,0.0689455212026559,0.0837701043963378,2.39292606577882e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM20A,Pseudokinase FAM20A,39958,0.0598564372549217,0.0029638261750591,0.0540473379518058,0.0656655365580375,3.88767123600009e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHBP1,EH domain-binding protein 1,39958,0.159181895475426,0.00788694894813609,0.143723475537079,0.174640315413773,4.98388231030198e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOC1,Apolipoprotein C-I,39959,0.0819076327773165,0.00406077002789827,0.0739485235226359,0.0898667420319971,6.35740905333724e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.042320613694077,0.00210279826234977,0.0381991290998715,0.0464420982882826,8.80138916659113e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.056958163955113,0.00283190500553255,0.0514076301442692,0.0625086977659568,1.12084139593703e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANG,Angiogenin,42152,0.0694428469766531,0.00345828736058374,0.0626646037499089,0.0762210902033972,2.11571468591198e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42119,0.0907676686280532,0.00452137013479764,0.0819057831638498,0.0996295540922566,2.34346428574217e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0597122040102976,0.00297320859487464,0.0538847151643433,0.0655396928562519,3.49600036184034e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP10,Stromelysin-2,42124,-0.121873427700304,0.00607904159076338,-0.1337883492182,-0.109958506182408,3.97616338774107e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK1,Dickkopf-related protein 1,42249,0.124637524404523,0.00622004059894861,0.112446244830584,0.136828803978462,4.71399930272024e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.111606204182783,0.00556882152077273,0.100691314002069,0.122521094363498,4.8376448963929e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.229998767016271,0.0114643478961215,0.207528645139872,0.252468888892669,5.29339019396297e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARF6,ADP-ribosylation factor 6,39930,0.229335589769668,0.011441190484338,0.206910856420366,0.251760323118971,7.41225901107153e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0753892217908885,0.00376684655641046,-0.082772241041453,-0.068006202540324,7.7626640069671e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0940014969112488,0.00469037039402253,-0.103194622883533,-0.0848083709389646,7.90073610118189e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN1,Dynactin subunit 1,42262,0.134665570371869,0.00674221032273096,0.121450838139316,0.147880302604422,1.65368028498182e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A4,Protein S100-A4,42181,0.117998372627291,0.00591298414499933,0.106408923703092,0.12958782155149,2.37241185315819e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.174089929909051,0.00873591429693316,0.156967537887062,0.19121232193104,7.51216299655283e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,42296,0.0692363124464991,0.00348602260878529,0.06240370813328,0.0760689167597183,1.4539437886967e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,41839,0.165845416737946,0.0083513656489436,0.149476740066017,0.182214093409876,1.68229771089534e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3F,Semaphorin-3F,42145,0.0557894596105467,0.00281223043146761,0.0502774879648702,0.0613014312562232,2.33734274373823e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.104456048041794,0.00526165420914818,0.0941432057918637,0.114768890291725,3.23041667429998e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MVK,Mevalonate kinase,41913,0.172736326275756,0.00873230937310371,0.155620999904473,0.189851652647039,7.34637493725167e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,42296,0.0888843605720373,0.00449575528427206,0.0800726802148641,0.0976960409292105,8.33063165162828e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE4,Ribonuclease 4,39645,0.0577160841109489,0.00292025957670364,0.0519923753406098,0.0634397928812881,1.80551475701433e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42185,0.260960765358103,0.0132332546831961,0.235023586179039,0.286897944537167,2.25734890711931e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBIN,Erbin,42070,0.213293765173337,0.010815574679407,0.192095238801699,0.234492291544974,2.26987326332096e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42100,0.0416518913865351,0.00211344472591777,0.0375095397237362,0.0457942430493339,2.89215036983719e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,39919,0.117545430224223,0.00596098689224115,0.10586189591543,0.129228964533015,3.93421732872537e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0528313063467043,0.00269504485014349,0.0475490184404231,0.0581135942529855,2.07876677858292e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5E,5'-nucleotidase,42181,0.1109305250886,0.00567988674740842,0.0997979470636795,0.12206310311352,8.51029688308015e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42310,0.0832942008921068,0.00426918910214887,0.074926590251895,0.0916618115323185,1.21239427725901e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA2,Apolipoprotein A-II,39990,-0.101433054950253,0.0052020723399266,-0.111629116736509,-0.0912369931639965,2.5564030152349e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNA4,Plexin-A4,42119,0.165344319918831,0.00849995892222507,0.14868440043127,0.182004239406393,3.79649836751113e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH2,Neutral ceramidase,42016,0.109020514009929,0.00562142698829276,0.0980025171128748,0.120038510906982,1.1754003569249e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCR,Breakpoint cluster region protein,42119,0.188952647263045,0.00975650427208292,0.169829898889762,0.208075395636327,1.91710231946261e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB2,Carboxypeptidase B2,39959,0.045904254647324,0.00237003291826937,0.041258990127516,0.050549519167132,2.99012900542943e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0482166375631781,0.00250102691264956,0.0433146248143849,0.0531186503119712,9.95626289299e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R9B,Neurabin-2,42296,0.19275262244042,0.0100112158848762,0.173130639306062,0.212374605574777,1.56635963127249e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAB2,Disabled homolog 2,42262,0.225011697258565,0.0117108533933656,0.202058424607569,0.247964969909562,3.3223651032961e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOT,Angiomotin,39736,0.0776146791866316,0.00404126970939538,0.0696937905562167,0.0855355678170466,6.71622385902262e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.20999660144963,0.0109981520905199,0.188440223352211,0.231552979547049,3.22219108036594e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.150612674810246,0.00788137400222811,0.135165181765879,0.166060167854613,4.14316023824999e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0978453645149441,0.00512123455825605,0.0878077447807623,0.107882984249126,4.29720298746905e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD6,T-cell differentiation antigen CD6,42284,0.104994719873802,0.00550433311533239,0.0942062269677502,0.115783212779853,4.45197502001612e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.216589518118905,0.0113556863593845,0.194332372854511,0.238846663383299,7.41922230815598e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,42119,0.183676445713962,0.0096603443628762,0.164742170762725,0.202610720665199,1.43717756724327e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42249,0.191696649413591,0.0100919973533068,0.171916334601109,0.211476964226072,1.98248505615058e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0787573133109748,0.00414900974008554,-0.0868893724015424,-0.0706252542204071,2.55505932210348e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EZR,Ezrin,42249,0.0487489253530562,0.00256875364554932,0.0437141682077795,0.0537836824983328,2.73054132871274e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FETUB,Fetuin-B,42199,0.0644333097035192,0.00339797363251367,0.0577732813837924,0.071093338023246,3.66212888478351e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.106367920120295,0.00561388614501442,0.0953647032760668,0.117371136964523,7.67133877483645e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,39930,0.171979437453842,0.0090927820438718,0.154157584647853,0.189801290259831,1.41580985032776e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOE,Apolipoprotein E,39979,0.139256395170328,0.00736614122853982,0.12481875836239,0.153694031978267,1.6483454120496e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.178808028282849,0.00946588140277439,0.160254900733411,0.197361155832286,2.2052110678811e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,39929,0.17603420921806,0.00931970660157048,0.157767584278982,0.194300834157138,2.26071250645704e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.21937579564423,0.0116142699461486,0.196611826549779,0.242139764738682,2.26965594829295e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGF,Hepatocyte growth factor,42296,0.0687900929184963,0.00364821082659098,0.0616395996983779,0.0759405861386146,2.57506111097516e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.189162783392989,0.010034060857462,0.169496024112364,0.208829542673615,2.81355662349203e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42070,0.272880546585672,0.0144873862350973,0.244485269564881,0.301275823606462,3.87201689471709e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAXX,Protein PAXX,39736,0.0920200217781427,0.0048834626519725,0.0824484349802766,0.101591608576009,5.42573350629431e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUOM,Fucose mutarotase,39736,0.128012152048264,0.00680252155605144,0.114679209798403,0.141345094298124,8.55046937215153e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42070,0.168639953944198,0.00897490360565888,0.151049142877107,0.18623076501129,8.94756835497412e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEFTY2,Left-right determination factor 2,42247,0.102279132446491,0.00544715843137921,0.0916027019209873,0.112955562971994,1.11485314396556e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLA2,Src-like-adapter 2,39934,0.210824017850027,0.0112568874320082,0.188760518483291,0.232887517216763,4.20904649732874e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.222260226231687,0.0119558188244052,0.198826821335853,0.245693631127521,3.43156413073294e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,42101,0.22114927649974,0.0118970741013202,0.197831011261152,0.244467541738328,3.54211154459884e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,42181,0.108721695427268,0.00585716937885223,0.097241643444718,0.120201747409819,5.64873157689742e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42145,0.170231411870326,0.00917988808627129,0.152238831221234,0.188223992519418,7.90422701933533e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.039191558918483,0.00211570812831123,0.035044770986993,0.043338346849973,1.14399266323848e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMIP,C-Maf-inducing protein,39919,0.163902771992239,0.00885510782417701,0.146546760656852,0.181258783327626,2.23451164584239e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN1,Perilipin-1,41839,0.0663630668242621,0.0035894555020287,0.0593277340402859,0.0733983996082384,2.27175742130155e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.046917210580412,0.00254162017064646,0.041935635045945,0.0518987861148791,3.7610261615913e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.205438024892079,0.0111557362359197,0.183572781869676,0.227303267914481,8.17692511290687e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.109309006417533,0.00594241556008897,0.0976618719197591,0.120956140915308,1.1954870580233e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH2,Cadherin-2,42145,0.0685023180000551,0.00372923628309969,0.0611930148851797,0.0758116211149305,1.86140064755025e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.135155155143001,0.00737236333131596,0.120705323013622,0.14960498727238,5.30851286995758e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,42185,0.206833931073902,0.011301605564006,0.18468278416845,0.228985077979353,6.23585439456553e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.220740207123326,0.012050640315646,0.19712095210466,0.244359462141992,6.94826848157949e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELP,P-selectin,42217,0.107898246897218,0.00589849131941793,0.0963372039111592,0.119459289883277,7.26227778580927e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINK1,Misshapen-like kinase 1,39929,0.179949357201497,0.00983733422587728,0.160668182118778,0.199230532284217,1.08717087502913e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.140644141034438,0.00770135770369023,0.125549479935205,0.155738802133671,1.98304678121338e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.162322993668925,0.00890273317246424,0.144873636650895,0.179772350686955,3.1335779918875e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCTN3,Tectonic-3,39958,0.0584301535679075,0.00321052279038003,0.0521375288987626,0.0647227782370523,5.63761088215151e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL32,Interleukin-32,42119,-0.0854904749514831,0.00470434838257463,-0.0947109977813293,-0.0762699521216368,6.25899969074923e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.105198208146008,0.00578832168965477,0.0938530976342845,0.116543318657731,6.27489303134091e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,39911,0.110663406714337,0.0060889081973619,0.0987291466475072,0.122597666781166,8.86421646722367e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL5,C-C motif chemokine 5,42217,0.193542069964499,0.0106657771553959,0.172637146739923,0.214446993189075,9.8980432895346e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,41900,0.104714616390339,0.00577249144377218,0.0934005331605458,0.116028699620133,1.14911896813321e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0946835784089012,0.00522344768021796,0.084445620955674,0.104921535862128,1.47630579963488e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0743775252569078,0.00410859491437554,0.0663246792247318,0.0824303712890839,2.11000739778577e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0716542557624282,0.00395588764241713,0.0639007159832906,0.0794077955415657,2.71594830654671e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.135665827954946,0.00750248036714161,0.120960966435348,0.150370689474543,3.17792399860026e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPL,N-acetylneuraminate lyase,39958,0.0887420491938161,0.00490366686389645,0.0791308621405791,0.0983532362470532,3.4557825556372e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO1,Forkhead box protein O1,42119,0.165776938142149,0.0091717223555853,0.147800362325202,0.183753513959096,3.55451307620011e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPK2,SRSF protein kinase 2,42119,0.162229956374468,0.00901094223147111,0.144568509600785,0.179891403148151,1.24902630310388e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.130559524309974,0.00725238320338644,0.116344853231337,0.144774195388611,1.95545399831122e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BACH1,Transcription regulator protein BACH1,42119,0.142678082122976,0.00793893022815025,0.127117778875801,0.15823838537015,2.18389959021688e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.141008305525917,0.00784275216022135,0.125636511291883,0.15638009975995,2.91900683631062e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0771783194905367,0.00429547101415134,0.0687591963028,0.0855974426782733,3.39991920048932e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.184858697186581,0.0103460637805637,0.164580412176677,0.205136982196486,1.33386732408635e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINH1,Serpin H1,39757,0.243361316545486,0.0136048093579902,0.216695890203825,0.270026742887147,1.41201777512381e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUCB2,Nucleobindin-2,42231,0.0708438581307814,0.00396647018889308,0.063069576560551,0.0786181397010118,1.5171326535824e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBP,Protein AMBP,42239,0.0380668303828886,0.00213226927116506,0.0338875826114051,0.0422460781543721,1.74175964486868e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.208803365937191,0.0117028444339218,-0.231740941027678,-0.185865790846704,2.12420122282675e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPD52L2,Tumor protein D54,39736,0.2051811991676,0.0115059346109551,0.182629567330128,0.227732831005072,3.71160740752873e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYY,Peptide YY,39575,0.188174695032453,0.0105671489296778,0.167463083130285,0.208886306934622,5.93102542686717e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42310,0.124963369312867,0.00703182614969479,0.111180990059465,0.138745748566269,7.17679826694739e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOM,Apolipoprotein M,42199,0.0533327376916146,0.00300131257700969,0.0474501650406756,0.0592153103425536,7.44930856476756e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KITLG,Kit ligand,42145,-0.0716406176047256,0.00403881734568748,-0.0795566996022731,-0.0637245356071782,1.30459805278614e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.131279318424624,0.0074050846905824,0.116765352431082,0.145793284418165,1.59430300414893e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,42296,0.141783197107971,0.00802341913600095,0.126057295601409,0.157509098614533,4.08352133200185e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.20235482814049,0.0114402862589171,0.179931867073012,0.224777789207967,4.39203156963285e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.192188592812643,0.0108682896206116,0.170886745156244,0.213490440469042,5.01630988676787e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,39657,0.150204017093011,0.00849943654310222,0.133545121468531,0.166862912717491,6.06208348472993e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR,GMP reductase 1,42296,0.0887644363279426,0.0050406613976629,0.0788847399885233,0.0986441326673618,1.18335232179393e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.144422774358028,0.00821004744448632,0.128331081366835,0.160514467349221,1.68184667543983e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,39934,0.135775909192698,0.0077148148551544,0.120654872076595,0.1508969463088,2.01733534170615e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD5,Programmed cell death protein 5,42249,0.106504059037665,0.00606312724894811,0.0946203296297272,0.118387788445604,2.53516420829886e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN2,CCN family member 2,42146,0.104710864616526,0.00597759619000692,0.0929947760841127,0.11642695314894,5.93118536550396e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.118143818076876,0.00675150708394785,0.104910864192338,0.131376771961414,8.44758260197832e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSO,Cathepsin O,42296,0.0566751779880137,0.00323983710944663,0.0503250972534984,0.0630252587225291,8.79261021204065e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2B3,SH2B adapter protein 3,41843,0.182620268283876,0.0104407286915322,0.162156440048473,0.203084096519279,9.6469564964283e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42119,0.121573706290805,0.00696594428927178,0.107920455483832,0.135226957097777,1.80367599731919e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.122794662073422,0.00704139992764926,0.10899351821523,0.136595805931615,2.35935509277493e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK2,Docking protein 2,42145,0.226543470911983,0.0130024170656896,0.201058733463231,0.252028208360734,2.97325060265561e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.16904311360208,0.00970860794170158,0.150014242036345,0.188071985167815,3.73173650391288e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL17,C-C motif chemokine 17,42107,0.168569938488024,0.00968500438249279,0.149587329898338,0.18755254707771,4.05807387154187e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,39736,0.0737041854571545,0.00423150403195123,0.0654104375545301,0.0819979333597789,4.65002616958283e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THOP1,Thimet oligopeptidase,42081,0.0575758734606833,0.00331663387371775,0.0510752710681965,0.0640764758531701,8.84951376426836e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP43,Centrosomal protein 43,41797,0.129081745635667,0.00745094094938671,0.11447790137487,0.143685589896465,1.67746741178399e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.173933330106221,0.0100545171127884,0.154226476565156,0.193640183647286,2.50465257088579e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C19orf12,Protein C19orf12,41839,0.122258207575924,0.00707496984500984,0.108391266679704,0.136125148472143,3.51181543570046e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,42119,0.0740832379967269,0.00428958134167113,0.0656756585670515,0.0824908174264024,4.01323237009569e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEC31A,Protein transport protein Sec31A,39638,0.140933930221878,0.00819389788664335,0.124873890364057,0.156993970079699,1.89082855127397e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.152255747091226,0.00886547731253624,0.134879411558655,0.169632082623797,2.063628455791e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,41843,0.110742664114309,0.006457960596146,0.0980850613458625,0.123400266882755,3.27232759179609e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USO1,General vesicular transport factor p115,42070,0.161657869631313,0.00942944261756241,0.143176162100891,0.180139577161736,3.42424965473567e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.139854372692269,0.00815206789539567,0.123876319617294,0.155832425767245,3.76125407448768e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTBS,Di-N-acetylchitobiase,39860,0.0499581543075465,0.00291212176325606,0.0442503956515647,0.0556659129635284,3.85147180817029e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPHN1,Oligophrenin-1,39929,0.196791480469226,0.011472259589058,0.174305851674672,0.21927710926378,3.90889417225884e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXN,Paxillin,41839,0.0931015915481352,0.00543472924660109,0.0824495222247971,0.103753660871473,4.38586023711203e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,39930,0.139562800145031,0.00815193803462698,0.123585001597162,0.1555405986929,6.85011487447969e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0435122116990743,0.00254425755313067,0.0385254668949381,0.0484989565032104,6.86498523196662e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.185301067390537,0.0108578345443871,0.164019711683538,0.206582423097535,1.69205618452265e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.184809211407628,0.010848272907495,0.163546596508937,0.206071826306318,2.06922783506859e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.20182160652825,0.0118504809446541,0.178594663876728,0.225048549179772,2.31091306694327e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,39934,0.113879815661898,0.00668467740327897,0.100777847951471,0.126981783372325,2.79701501864583e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTBDN,Retbindin,42070,0.0540285317252212,0.00317508116850144,0.0478053726349584,0.060251690815484,2.90805251708299e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,39657,0.174664002796274,0.0102558488179263,0.154562539113139,0.19476546647941,3.19537330361408e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.171484069619643,0.0100828534278295,0.151721676901097,0.191246462338189,3.44237578204405e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSD,Cathepsin D,41225,0.074340491642488,0.00438282703667846,0.0657501506505982,0.0829308326343778,8.00680256740085e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42185,0.153441807486049,0.00907930982327134,0.135646360232437,0.171237254739661,1.99256887135933e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.113235804319133,0.00669956885086812,0.100104649371432,0.126366959266835,2.00899647201307e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.140500943483628,0.00832364351736223,-0.156815284777658,-0.124186602189598,2.80239300821272e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0954592999213438,0.00565557517028311,0.0843743725875889,0.106544227255099,2.95151435457584e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1A,Meprin A subunit alpha,39930,0.135844967713562,0.00804454715406103,0.120077655291603,0.151612280135522,3.33910900184588e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42119,0.155058548878459,0.00920005232893135,0.137026446313753,0.173090651443164,4.30900317665474e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,39575,0.0762258101289335,0.00452195031243623,0.0673627875165585,0.0850888327413085,5.77245415851773e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42070,0.151223786019157,0.00899197557811934,0.133599513886043,0.168848058152271,7.9189570137323e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.111225855267228,0.00662399599956019,0.0982428231080897,0.124208887426366,1.59826130999615e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSTN,Growth/differentiation factor 8,41900,0.0958698471708851,0.0057216702461194,0.0846553734884911,0.107084320853279,2.24597340309856e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,39958,0.128954644683124,0.00769785194915268,0.113866854862784,0.144042434503463,3.04885895384967e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGF,Placenta growth factor,42296,0.0463397831747091,0.00277545658168184,0.0408998882746127,0.0517796780748054,5.71186386976313e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0589596970227094,0.00353232373320099,0.0520363425056354,0.0658830515397833,6.29474739334258e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMN,Protein amnionless,41913,0.0835584655323227,0.00500811751836694,0.0737425551963235,0.0933743758683219,7.19926513627335e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,39736,0.136169147139957,0.00815573919326932,0.120183898321149,0.152154395958764,7.87677730323607e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0483797642706421,0.00290194243711201,0.0426919570939026,0.0540675714473817,8.72849437141445e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,39934,0.134844613566168,0.00810286488776082,0.118962998386157,0.150726228746179,1.86223075788695e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.183112872417248,0.0110214554884494,0.161510819659887,0.204714925174609,2.21536351821058e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.137525569956494,0.0082776192782827,0.12130143617106,0.153749703741928,2.91237948574274e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0948453963308407,0.00570865362288391,0.0836564352299883,0.106034357431693,2.98063082197632e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0521722053769177,0.00314540783605126,0.0460072060182572,0.0583372047355782,3.42437074597308e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL13,C-C motif chemokine 13,42275,0.11969763567062,0.00722054435110814,0.105545368742448,0.133849902598791,4.00677741511908e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLM2,Protein GOLM2,42249,0.0399546367365666,0.00241118080524534,0.0352287223582857,0.0446805511148474,4.4882854588916e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.107749066369512,0.00650266761419392,0.0950038378456921,0.120494294893332,4.59102052735697e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN2,Prorelaxin H2,39709,0.0904066788536165,0.00545237721281631,0.0797200195164966,0.101093338190736,5.14743751430341e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0897846606672329,0.00541588922953862,0.0791695177773372,0.100399803557129,5.50552215207725e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,41900,0.128013821311689,0.00773349590821469,0.112856169331588,0.14317147329179,6.17471581424244e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLK1,Protein delta homolog 1,42310,0.101477732339935,0.00613320593952581,0.0894566486984645,0.113498815981406,6.69801344638484e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0652555113254459,0.00394877168016602,0.0575159188323205,0.0729951038185713,9.40844926327911e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,42002,0.063639293416636,0.00385081341814308,0.0560916991170756,0.0711868877161964,9.47488608259122e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRAP,BRCA1-associated protein,39813,0.192629761193878,0.0116516609287796,0.16979250577347,0.215467016614286,1.11791597191703e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.141722369237265,0.00858003756628198,0.124905495607353,0.158539242867178,1.39401028890428e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,39934,0.0971640099145332,0.00588634039029562,0.0856267827495538,0.108701237079513,1.66545818593115e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0965864428346444,0.00585988411184627,0.0851010699754257,0.108071815693863,1.86625444495384e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEXIM1,Protein HEXIM1,42119,0.141025728293459,0.00856014309816203,0.124247847821061,0.157803608765856,2.16045368580611e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT2,Omega-amidase NIT2,39903,0.127243793935084,0.00772542783376497,0.112101955380905,0.142385632489264,2.98886610822898e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AAMDC,Mth938 domain-containing protein,39638,0.0922901857188082,0.00561116051062835,0.0812923111179766,0.10328806031964,4.51107162234479e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.11127670555402,0.00677600322190679,0.097995739239083,0.124557671868958,6.51955492641657e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNMBP,Dynamin-binding protein,42016,0.105499634511632,0.00643304242112742,0.0928908713662226,0.118108397657042,7.34621640499387e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.165131749403726,0.0100816582580581,0.145371699217932,0.18489179958952,1.02968331077216e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,39481,0.0560133401436928,0.00341927821961349,0.0493115548332503,0.0627151254541352,1.33388788145074e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP2,Methionine aminopeptidase 2,42247,0.0966431446586409,0.00591044465831137,0.0850586731283506,0.108227616188931,1.56736884472635e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GLB2,Endophilin-B2,39929,0.113762473106401,0.00696309785731149,0.10011480130607,0.127410144906731,2.52315931167811e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.147114596635674,0.00901094232715924,0.129453149674442,0.164776043596906,3.16774209083293e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.124748188091431,0.00764406215896218,0.109765826259866,0.139730549922997,3.38635464711755e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA5,Integrin alpha-5,42137,0.0429908431409489,0.00263792094786552,0.0378205180831324,0.0481611681987653,3.77199399109536e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNST,Consortin,42145,0.187703442984322,0.0115419688556035,0.165081184027339,0.210325701941305,6.55804750795753e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.18827064190985,0.0115884650521607,0.165557250407615,0.210984033412085,8.48174926793397e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.074042905617852,0.004571955542733,0.0650818727540953,0.0830039384816087,2.46960812206027e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,39958,0.156686641366516,0.00967773021509785,0.137718290144925,0.175654992588108,2.6427422253243e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0903789397608965,0.00558934481756712,0.079423823918465,0.101334055603328,2.90131474804336e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,39934,0.195697099086149,0.0120968336720617,0.171987305088908,0.21940689308339,3.25290654621753e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.180348186351192,0.0111668765743076,0.15846110826555,0.202235264436835,5.13081098029639e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.174188641399193,0.010798352904399,0.153023869706571,0.195353413091815,5.36657729035972e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0437474911145108,0.00271027175822599,0.0384353584683878,0.0490596237606337,6.00412434451804e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,42129,0.16303901998785,0.0101129376775985,0.143217662139757,0.182860377835943,6.20648803725447e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREG1,Protein CREG1,41960,0.0689569170924196,0.00428566245130424,0.0605570186878633,0.0773568154969759,1.04187063598984e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0649000745312582,0.00403391012684073,0.0569936106826503,0.072806538379866,1.0518359930386e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0970177752714829,0.00602877888207784,0.0852013686626104,0.108834181880355,1.30300468662087e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42185,0.217095382603595,0.0135484634550513,0.190540394231695,0.243650370975496,2.92395959889977e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.154241364603061,0.00961787807846018,0.135390323569279,0.173092405636843,3.11188856338804e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42166,0.08857598484149,0.00553636273942328,0.0777247138722204,0.0994272558107596,4.32210704049521e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42137,0.0903581100792478,0.00565005850716444,0.0792839954052055,0.10143222475329,4.80269353923063e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42123,-0.058806298504856,0.00368222991225611,-0.066023469132878,-0.0515891278768341,6.81270479829649e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,39934,0.131385668536657,0.0082261745855612,0.115262366348957,0.147508970724357,8.37427545753225e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0496565724647393,0.00311607428861786,0.0435490668590483,0.0557640780704303,1.20493843355638e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAMBP,STAM-binding protein,41997,0.106569130409711,0.00668796539466789,0.0934607182361624,0.119677542583261,1.20982666567891e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINC1,Antithrombin-III,39959,0.0244301169702348,0.00153342831228828,0.0214245974781498,0.0274356364623199,1.56114725343157e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.111622080444042,0.00700860944310324,0.0978852059355598,0.125358954952524,1.70060959002489e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PENK,Proenkephalin-A,39736,0.0522936847622839,0.00328623506685462,0.0458526640312489,0.058734705493319,2.15169637372932e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,39934,0.199954469695096,0.0125706987027226,0.17531590023776,0.224593039152433,2.32577384139893e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX15,Sorting nexin-15,39736,0.0909736394031909,0.00571881898421209,0.0797647541941352,0.102182524612247,2.33300957318949e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,42249,0.105677391911246,0.00666998449649649,0.0926042222981125,0.118750561524379,4.90260004675865e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELE,E-selectin,42310,0.0848378473701816,0.00535640347182297,0.0743392965654086,0.0953363981749546,5.28558282574808e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42070,0.0622006875076782,0.00392742635201781,0.0545029318577233,0.0698984431576331,5.48343240972595e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.131244915444706,0.0082897950732949,0.114996917101048,0.147492913788364,7.40268581678311e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTDH,Protein LYRIC,39657,0.159881186879614,0.010097586386307,0.140089917562452,0.179672456196776,7.4822576681705e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,39929,0.104122222299487,0.0065771507116925,0.0912310069045701,0.117013437694405,7.54722903047716e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM13A,Protein FAM13A,39930,0.113951694090349,0.00719902396555635,0.0998416071178584,0.128061781062839,7.80057222885945e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MITD1,MIT domain-containing protein 1,42016,0.161643768980573,0.0102576680914583,0.141538739521314,0.181748798439831,1.89030939629414e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0815807460537533,0.0051788976745958,0.0714301066115455,0.091731385495961,2.09934280411285e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC5,Glypican-5,42016,0.0941295562383304,0.00598069355914729,0.0824073968624017,0.105851715614259,2.55591888929546e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42189,0.0574006136149949,0.00365219939821374,0.050242302794496,0.0645589244354939,3.55387537544887e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1S,Complement C1s subcomponent,39979,0.0351302328101145,0.00223666388990085,0.0307463715859089,0.0395140940343202,5.15255041232792e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.150525397167249,0.00958588063825148,0.131737071116276,0.169313723218222,5.4869699208716e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBNL,Drebrin-like protein,42185,0.154042560617105,0.00983571891383708,0.134764551545984,0.173320569688225,8.34865210930805e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EREG,Proepiregulin,41997,0.133365613008389,0.00851896423086158,0.1166684431159,0.150062782900878,9.35794449506665e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAG1,Dystroglycan,42185,0.0787655346072896,0.00503659496199431,0.0688938084817808,0.0886372607327984,1.1888040459401e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0623685320635251,0.00399153295980191,0.0545451274623134,0.0701919366647369,1.47607270887853e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,41900,0.0806142892185926,0.00516404028445301,0.0704927702610647,0.0907358081761205,1.87141054782601e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D23,TBC1 domain family member 23,42070,0.149066011343263,0.00955828593781973,0.130331770905136,0.167800251781389,2.33294067019927e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0508317332961003,0.00325593653903729,0.0444500976795872,0.0572133689126134,2.33874920667927e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.127913275944324,0.00821173282718332,0.111818279603044,0.144008272285603,3.16210139164645e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42249,0.112397957964996,0.00722242422087501,0.0982420064920807,0.126553909437911,3.82640687261651e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0547292609368449,0.00351799959552699,0.047833981729612,0.0616245401440778,4.17147848576283e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.175465921948849,0.0112849217855761,0.15334747524912,0.197584368648578,5.84941607552089e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.142101589666566,0.00913912293100991,0.124188908721787,0.160014270611346,5.85861835398179e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT1,Deaminated glutathione amidase,39638,0.0731344549877921,0.00470931026391816,0.0639042068705126,0.0823647031050717,8.08092377098395e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,42119,0.0968551178515453,0.00624329422747155,0.084618261165701,0.10909197453739,8.17897975223172e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.145923643411381,0.0094075901429433,0.127484766731212,0.16436252009155,1.03648835756601e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK10,Kallikrein-10,42138,0.0672085016203643,0.00433796220054723,0.0587060957072917,0.0757109075334369,1.11506071624137e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.119381470715687,0.00771749779528824,0.104255175036922,0.134507766394452,1.6153565691397e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS8,Prostasin,42080,0.0685504762554675,0.00443192197298674,0.0598639091884135,0.0772370433225215,1.65768945913147e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,41900,0.126174642704267,0.00815986419480364,0.110181308882452,0.142167976526082,1.80356932048989e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.139752016713822,0.00904901736903575,0.122015942670512,0.157488090757132,2.4184614641557e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42070,0.097929358716817,0.0063454631726927,0.0854922508983393,0.110366466535295,2.80553396468596e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,39934,0.0981392335222691,0.00635766853535358,0.085678203192976,0.110600263851562,3.23904819947027e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.101122096235767,0.00655512582602134,0.088274049616765,0.113970142854769,3.76809678017721e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRL,Appetite-regulating hormone,42145,0.135804141197873,0.00881435067148912,0.118528013881754,0.153080268513991,4.13130649492333e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRKL,Crk-like protein,42143,0.172419619314978,0.0111921111404449,0.150483081479706,0.19435615715025,4.24034959731723e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,39958,0.134879601880423,0.00874874442775468,0.117732062802024,0.152027140958822,4.33190633867518e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IST1,IST1 homolog,39850,0.160499052530049,0.0104443650575266,0.140028097017297,0.180970008042802,9.33942398285284e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB3,Plexin-B3,42099,0.0781781289977039,0.0050986738643285,0.0681847282236201,0.0881715297717878,1.27635973744655e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COCH,Cochlin,39958,0.0745763134146056,0.00486881565530234,0.0650334347302131,0.0841191920989982,1.96099374924163e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,39736,0.135060800273438,0.00881748013936788,0.117778539200277,0.152343061346599,2.00030084071668e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RB,Interleukin-17 receptor B,41934,-0.0878080438216337,0.00574366489678741,-0.099065627019337,-0.0765504606239304,2.55950450058576e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.135730976944248,0.00888825881031843,0.118309989676024,0.153151964212472,3.95329492805922e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.189076791728783,0.0124040384385553,0.164764876389214,0.213388707068351,4.9648819515642e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0316390033449878,0.00207623301189351,-0.0357084200482991,-0.0275695866416765,5.31322488402985e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.133383510885794,0.00876090891229569,0.116212129417694,0.150554892353893,6.65057515116166e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS6,Growth arrest-specific protein 6,42236,-0.0407405112839103,0.00267869643434729,-0.045990756295231,-0.0354902662725896,8.18921902333194e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.117004146573824,0.00769896817683432,0.101914168947228,0.132094124200419,1.18405680159045e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCC,Tubulin-specific chaperone C,42016,0.129707736369867,0.00854177414415777,0.112965859047317,0.146449613692416,1.19224293048081e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42137,0.0804043862857408,0.00530211717333048,0.0700122366260131,0.0907965359454686,1.60746143596291e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,41900,0.0565982666373275,0.00373305060312707,0.0492814874551985,0.0639150458194566,1.71509087325808e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2,Prothrombin,39979,0.0239133863917658,0.00157745366104406,0.0208215772161194,0.0270051955674121,2.08133146851327e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0465318401190459,0.00306966387174952,0.0405152989304168,0.0525483813076749,2.16175424672406e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS8,Galectin-8,42249,0.0978021289676165,0.00646211453218032,0.0851363844845431,0.11046787345069,2.49417951128154e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST13,Hsc70-interacting protein,39736,0.087367241026801,0.00576787936637353,0.0760621974687089,0.0986722845848931,2.56258830557249e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",41900,0.149031235988594,0.0098548737307443,0.129715683476335,0.168346788500853,3.06364840822523e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.106594077380336,0.00706140644227157,0.0927537207534842,0.120434434007189,5.43762506155225e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QDPR,Dihydropteridine reductase,42081,0.0674607105694922,0.00447357594377893,0.0586925017196855,0.0762289194192989,5.72331087770104e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,39930,0.07646464852712,0.00506801615823407,0.0665313368569812,0.0863979601972588,6.09151715116962e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBPL,FK506-binding protein-like,39930,0.0948759251300974,0.00629488239980964,0.0825379556264705,0.107213894633724,7.69915308984711e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BID,BH3-interacting domain death agonist,42119,0.105947504726812,0.00703548269628352,0.0921579586420964,0.119737050811528,7.77881866158846e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,42119,0.110881134529827,0.00736974639208398,0.0964364316013427,0.125325837458312,9.5188298054906e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,39930,0.153876986518366,0.0102293403786175,0.133827479376275,0.173926493660456,1.18712585699539e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.19727945830044,0.0131420123255644,0.171521114142334,0.223037802458546,1.62316795521046e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0586955003773233,0.00390935869692891,0.0510331573313427,0.066357843423304,1.81308298659166e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTPBP2,GTP-binding protein 2,39649,0.130612370660653,0.00871480583967941,0.113531351214882,0.147693390106425,2.76500189596896e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0698675519115287,0.00467267863740714,0.0607091017822107,0.0790260020408467,3.83543160438078e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSB,Arylsulfatase B,42070,0.0881198068872067,0.00589710589795007,0.0765614793272246,0.0996781344471888,4.36349793349836e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0993315935956114,0.00664923468864914,0.0862990936058591,0.112364093585364,5.70054209608323e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0701943844283102,0.00470331246321131,0.0609758920004161,0.0794128768562044,5.72746171620246e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.134277116662949,0.00899931197212798,0.116638465197578,0.151915768128319,6.004261194591e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.119857202761546,0.00803306302380788,0.104112399234882,0.135602006288209,6.08228733317206e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,41839,0.134844535869087,0.00903696459545015,0.117132085262004,0.152556986476169,6.08353741336164e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.114214593543525,0.00765948246580836,0.099202007910541,0.12922717917651,8.37525275204253e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,39990,0.0422320820632248,0.00283431295391609,0.0366768286735493,0.0477873354529004,9.64091767664617e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2L,Ataxin-2-like protein,39934,0.0759150972606161,0.00510239369445544,0.0659144056194834,0.0859157889017487,1.33750036226731e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42105,0.100884224289145,0.0067897966495806,0.087576222855967,0.114192225722323,1.51473167137877e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGLN1,Egl nine homolog 1,42119,0.0882094814595414,0.00593873401947622,0.076569562781368,0.0998494001377148,1.62773613644459e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD207,C-type lectin domain family 4 member K,41832,0.0613867563508729,0.00414365380548671,0.0532651948921189,0.0695083178096268,2.92198614585652e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYDGF,Myeloid-derived growth factor,39958,0.15622124015217,0.0105586067041871,0.135526371011963,0.176916109292377,4.47121871556066e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0904851356244727,0.00612190549826074,0.0784862008478816,0.102484070401064,4.69114721306264e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDHD2,Phospholipase DDHD2,39934,0.103911538777441,0.00703765083337113,0.0901177431440333,0.117705334410848,6.99184915790824e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGFR,Opioid growth factor receptor,42070,0.0502800509734293,0.00340990889883943,0.043596629531704,0.0569634724151545,7.92359263556419e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.228586084903966,0.0154941290714395,0.198217591923944,0.258954577883987,8.32974298387044e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0958538830718509,0.00650439745210622,0.0831052640657227,0.108602502077979,8.93983676286805e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0590704973859076,0.00400953061509939,0.0512118173803128,0.0669291773915024,9.63966210463451e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.07005572528109,0.0047554548424346,0.0607350337899182,0.0793764167722618,9.80713777486722e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0764113735490338,0.00519079477156278,0.0662374157967708,0.0865853313012969,1.33731493751593e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL4,C-C motif chemokine 4,42148,0.097220762599436,0.00661070408644918,0.0842637825899956,0.110177742608876,1.38526493859697e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST3,Cystatin-C,42184,0.0447487143802001,0.00304461876195548,0.0387812616067674,0.0507161671536329,1.57364487683945e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0637909825149385,0.00434154942186941,0.0552815456480744,0.0723004193818025,1.70237241687006e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUS,RNA-binding protein FUS,41831,0.0617726776431874,0.00422031298286942,0.0535008641967633,0.0700444910896114,3.87841519263706e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,39638,0.14197761141533,0.00969375348118039,0.122977854592217,0.160977368238444,4.01877605621147e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0527674161780686,0.00361570070850571,0.0456806427893974,0.0598541895667398,7.06584670864812e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGA,Protein O-GlcNAcase,39930,0.110539003401173,0.00757813196338483,0.0956858647529391,0.125392142049408,9.25614589765667e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42310,0.0354379762291946,0.00243397853142911,0.0306673783075935,0.0402085741507956,1.14937111441505e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIAE,Sialate O-acetylesterase,42147,0.0718597898161273,0.00493840289611748,0.062180520139737,0.0815390594925176,1.31118375230037e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA11,Annexin A11,42087,0.102217574920977,0.00703853864322883,0.0884220391802488,0.116013110661706,1.98724951204342e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD1,COMM domain-containing protein 1,39638,0.0940164498760013,0.00647969067664912,0.081316256149769,0.106716643602234,2.87328657249322e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP5,Fatty acid-binding protein 5,42218,0.102284294725649,0.00707603964555892,0.0884152570203534,0.116153332430944,5.19201136671847e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPP,Lipoma-preferred partner,39575,0.101327374233716,0.00700948541885686,0.0875887828127568,0.115065965654676,6.21642283631121e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP2B1,AP-2 complex subunit beta,39649,0.0745283836517641,0.00516526744994481,0.0644044594498723,0.0846523078536559,9.07110703808257e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,39934,0.116923985728569,0.00810683266797365,0.101034593699341,0.132813377757797,9.62381134561436e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK1,Docking protein 1,39929,0.21008983209509,0.0145689717055332,0.181534647552245,0.238645016637936,9.9810934821458e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TWF2,Twinfilin-2,39966,0.130319539460536,0.0090426104701179,0.112596022939105,0.148043055981967,1.12525595006981e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,41839,0.058634495250812,0.00407147387661629,0.0506544064526441,0.0666145840489799,1.1434120692115e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN1,Pantetheinase,39990,0.111771507308303,0.00776544999495234,0.0965512253181969,0.12699178929841,1.45623389271309e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.107113296404837,0.00744376377513463,0.0925235194055734,0.121703073404101,1.58086400421671e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0692449161691775,0.00481853863304863,0.0598005804484022,0.0786892518899528,1.74773057303897e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,41843,0.138516273093494,0.00964032164687357,0.119621242665622,0.157411303521366,1.82486058285308e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,39657,0.119973780512984,0.00834464435166585,0.103618277583719,0.136329283442249,1.88175384687754e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0693204909645823,0.00482241617011214,0.0598685552711626,0.0787724266580021,1.91687395825348e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0899147513868339,0.00627592214879182,0.0776139439752019,0.102215558798466,3.29223827143898e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.064243754878654,0.00448743689353793,0.0554483785673196,0.0730391311899883,3.73295501151816e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0703690743889638,0.00492089625589674,0.0607241177274062,0.0800140310505214,4.73193897923745e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.158343519037088,0.0110863695043985,0.136614234808467,0.180072803265709,6.05293881673179e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOA,Elongin-A,42070,0.0816336568619884,0.00571604375706539,0.0704302110981402,0.0928371026258366,6.17572709363551e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.110621744186128,0.00774132797911786,0.0954487413470565,0.125794747025199,6.49601722553676e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6AP2,Renin receptor,41843,0.0597040352821028,0.00418441436257075,0.0515025831314641,0.0679054874327414,7.55072119817093e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAX,Protein max,41839,0.161028428391814,0.0112884952988902,0.138902977605989,0.183153879177639,7.92021446433614e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGLL,Monoglyceride lipase,42166,0.13213623230417,0.00927158560203215,0.113963924524187,0.150308540084153,9.35106424024649e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YJU2,Splicing factor YJU2,39919,0.0500445083047821,0.00351210644015845,0.0431607796820715,0.0569282369274926,1.12588583006906e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0998596597237783,0.00700765751602794,0.0861246509923635,0.113594668455193,1.12780762351246e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASC3,Protein CASC3,39649,0.0653168246505232,0.00458485788020414,0.056330503205323,0.0743031460957233,1.19939753753847e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.110037990057936,0.0077366800225945,0.0948740972136512,0.125201882902222,1.40791538239505e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,39657,0.0836672538715543,0.00587888848718899,0.0721446324366639,0.0951898753064447,1.46718283840396e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGL1,Fibrinogen-like protein 1,39990,-0.0977249660201696,0.00687838325253614,-0.11120659719514,-0.0842433348451988,2.00832851205365e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXJ3,Forkhead box protein J3,39657,0.0682612899482552,0.00480622113462141,0.0588410965243972,0.0776814833721132,2.20763000821088e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,39657,0.0671144118878181,0.00473437748664312,0.0578350320139976,0.0763937917616387,3.20950172047499e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLB,Beta-klotho,41839,-0.112604309593512,0.00794933843747563,-0.128185012930964,-0.0970236062560599,3.2154614875895e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY4,Protein canopy homolog 4,42070,0.113065019868861,0.00798726270465245,0.0974099849677424,0.12872005476998,3.63042860304337e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42119,0.0502944659448273,0.00355667100871712,0.0433233907677417,0.0572655411219128,4.45399804989066e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD36,Platelet glycoprotein 4,39657,0.0698495122089201,0.00494205452051989,0.0601630853487011,0.0795359390691391,5.79364339672372e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0416627992154098,0.00295171022463483,0.0358774471751256,0.0474481512556941,6.40663201652715e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.107789024752455,0.00763925414554935,0.0928160866271787,0.122761962877732,6.84869712925811e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42119,0.0897182559690986,0.0063637516579871,0.0772453027194439,0.102191209218753,8.07574292866832e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0733846579578358,0.00520117929107037,0.0631903465473379,0.0835789693683337,8.16066644304525e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0881999057639866,0.00626039395113707,0.075929533619758,0.100470277908215,9.2560245668084e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLG4,Disks large homolog 4,39929,0.107980204895222,0.00765999664903298,0.0929666114631175,0.122993798327327,9.50693878969094e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,39657,0.131478523996549,0.00934404021279906,0.113164205179462,0.149792842813635,1.38994367896286e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.128641771467544,0.00914844611811611,0.110710817076037,0.146572725859052,1.57344226405909e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADD1,Alpha-adducin,39736,0.10412624200364,0.00740893859299541,0.0896047223613692,0.118647761645911,1.7420085092612e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.113546134933223,0.00809662016971593,0.0976767594005797,0.129415510465866,2.31118641158662e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0419661278925781,0.00299335776720164,0.0360991466688629,0.0478331091162934,2.41841877731411e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.129747790346709,0.00925512073499135,0.111607753706126,0.147887826987292,2.44281665417347e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEXN,Nexilin,39990,0.10379864301454,0.00740503837409078,0.0892847678013216,0.118312518227757,2.84786151321934e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPART,Spartin,39736,0.115866863128355,0.00826546750890268,0.0996665468109053,0.132067179445804,2.86731413972273e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11,Coagulation factor XI,39822,0.0468121827321495,0.00334018113080946,0.0402654277157629,0.053358937748536,2.98267627446298e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,42262,0.183771148278864,0.0131390573003989,0.158018595970082,0.209523700587646,3.7910563851962e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GET3,ATPase GET3,39958,0.0803496539835609,0.00574091929690347,0.0690974521616301,0.0916018558054917,3.83545050468861e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.102283046084413,0.00731358111099185,0.087948427106869,0.116617665061957,3.86111950752074e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC13,Mucin-13,41839,0.0783266960912463,0.00560378460712814,0.0673432782612751,0.0893101139212174,4.40073437461076e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILPL2,RILP-like protein 2,39958,0.146775802051355,0.0104966823585145,0.126202304628667,0.167349299474044,4.58346042714117e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.117896091320268,0.00843784839703103,0.101357908462087,0.134434274178449,4.72774301109782e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASHC3,WASH complex subunit 3,39929,0.112710617744844,0.00806741958685128,0.0968984753546155,0.128522760135073,5.41955480084197e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM17,Splicing factor 45,39934,0.114044222528188,0.00816383140433573,0.0980431129756904,0.130045332080686,5.54146344164408e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0579191108624175,0.00415185498685761,0.0497814750881766,0.0660567466366584,6.30363139219332e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH9,Protocadherin-9,39930,0.0500750154366635,0.00359566457882683,0.0430275128621629,0.0571225180111641,1.00192495028667e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0770885000694634,0.00553562751854741,0.0662386701331104,0.0879383300058163,1.01124809551354e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0880327133629737,0.00632745268438875,0.0756309061015717,0.100434520624376,1.07060085771971e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN3,Ataxin-3,39929,0.0901024201324198,0.00648498555701885,0.0773918484406629,0.102812991824177,1.5662233646831e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD226,CD226 antigen,39657,0.062836199698596,0.00452227500677738,0.0539725406853123,0.0716998587118797,1.58003718570717e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDUA,Alpha-L-iduronidase,42262,0.0695331511257412,0.00501144146781047,0.0597107258488327,0.0793555764026497,1.77332538732263e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPSE,Heparanase,39866,0.140829188207919,0.0101426816272511,0.120949532218507,0.160708844197331,1.78503735064782e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53,Cellular tumor antigen p53,41843,0.0656425392332231,0.00473194041884535,0.0563679360122862,0.0749171424541599,1.87880790974411e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,39657,0.0745807269190742,0.00537507483350254,0.0640455802454092,0.0851158735927391,2.06543251820525e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0851381181453406,0.00614247993723142,0.073098857468367,0.0971773788223142,2.18625219680853e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0757447946293279,0.00546480535310064,0.0650337761372507,0.0864558131214052,2.48054676577222e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,42119,0.0535903145051109,0.00387162875641267,0.0460019221425421,0.0611787068676797,2.81315045922743e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNMT,Histamine N-methyltransferase,41961,0.0705031256889424,0.00509521753469278,0.0605164993209445,0.0804897520569402,3.02372573200991e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDC,Nuclear migration protein nudC,42296,0.0933869116420657,0.00675071874989617,0.0801555028922692,0.106618320391862,3.1197630146424e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,39934,0.0970352570955555,0.00701126980165395,0.0832931682843138,0.110777345906797,3.2867132846687e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN2,Centrin-2,41839,0.099996694812956,0.00724181344392679,0.0858027404628595,0.114190649163053,4.51900333121929e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.130096558230787,0.00941980823072671,0.111633734098563,0.148559382363011,4.87316447870056e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0949959148788727,0.00688496361266415,0.081501386198051,0.108490443559694,5.12447843971332e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREH,Trehalase,39966,0.11040792378115,0.00799801368255029,0.0947318169633518,0.126084030598949,5.32511816996977e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON2,Spondin-2,42070,-0.0510712847046655,0.003709714528364,-0.0583423251802589,-0.043800244229072,7.85794921693358e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,39979,0.0241980182802578,0.00175663809530148,0.0207550076134669,0.0276410289470487,7.92529688167532e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBKS,Ribokinase,41830,0.0724206744900094,0.00526847328021111,0.0620944668607956,0.0827468821192232,1.05686563599294e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0375350155488471,0.00273096630035751,0.0321823216001463,0.0428877094975478,1.06673517082574e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RWDD1,RWD domain-containing protein 1,42249,0.0909184858071656,0.00662251863914032,0.0779383492744506,0.103898622339881,1.31154606233807e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO3,Forkhead box protein O3,41843,0.140371450055595,0.01022362066705,0.120333153548177,0.160409746563013,1.31208038368719e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEPR,Leptin receptor,42145,-0.0458470074640565,0.00334140863783688,-0.0523961683942168,-0.0392978465338962,1.46615201314021e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42217,0.0673454645338347,0.00490843556707751,0.0577249308223628,0.0769659982453067,1.47130250659972e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,42239,0.0518509451194728,0.00378278434878882,0.0444366877958467,0.0592652024430989,1.76036949237514e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.119779034728786,0.00876815400511683,0.102593452878757,0.136964616578815,3.31842045470124e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHD3,EH domain-containing protein 3,39638,0.171527121590952,0.0125538258092936,0.146921623004736,0.196132620177167,3.70010911592637e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,42253,0.0821500081391467,0.00602348576041689,0.0703439760487296,0.0939560402295638,4.47167221853386e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.136715489846357,0.0100262113796671,0.117064115542209,0.156366864150504,5.25719420345292e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0685869573581066,0.00503020259642991,0.058727760269104,0.0784461544471093,5.31447485680278e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICA1,Islet cell autoantigen 1,41913,0.115829947318245,0.00850661362364488,0.0991569846159008,0.132502910020589,6.10262034254858e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,42145,0.186754538917087,0.0137219946632801,0.159859429377058,0.213649648457116,6.59765591692884e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRY2,Protein sprouty homolog 2,41913,0.134355129908974,0.00987897655460835,0.114992335861941,0.153717923956006,7.60920456421193e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0879794533381691,0.0064704369079816,0.0752973969985252,0.100661509677813,7.82048710487178e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2,Microtubule-associated protein 2,39929,0.0676928624744862,0.0049764333670533,0.0579390530750617,0.0774466718739106,8.21628083812508e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN3,Centrin-3,39930,0.113646810835523,0.00835856462211561,0.0972640241761764,0.13002959749487,8.93467989453583e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42217,-0.0462391539606709,0.00340463715171602,-0.0529122427780343,-0.0395660651433075,9.67561814529913e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0818093820008088,0.00602574245134472,0.0699989267961731,0.0936198372054444,1.04729199595655e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TADA3,Transcriptional adapter 3,39919,0.0582636858762154,0.00429965749965715,0.0498363571768874,0.0666910145755434,1.65107312221818e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,39736,0.181932009567351,0.0134264311513268,0.155616204510751,0.208247814623952,1.68209745194401e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42145,0.115736871714942,0.00856333687227865,0.0989527314452758,0.132521011984608,2.35156074047448e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMVK,Phosphomevalonate kinase,41832,0.156288885117068,0.0115650767698935,0.133621334648077,0.178956435586059,2.43521980238999e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0589530631370708,0.00436357171825766,0.0504004625692858,0.0675056637048559,2.87347727349586e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRAS,Ras-related protein R-Ras,39649,0.188839588001656,0.0139833649705594,0.16143219265936,0.216246983343953,3.1184951461512e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0507407818967109,0.00375998421489239,0.0433712128355218,0.0581103509579,3.48475958166863e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPACT,Protein IMPACT,39929,0.0777203392923002,0.00576163837295647,0.0664275280813055,0.0890131505032949,3.75628502019321e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0724488636885433,0.00537461334035453,0.0619146215414484,0.0829831058356382,3.78880567595337e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7,Interleukin-7,42119,0.0925947232685388,0.0068714738961065,0.07912663443217,0.106062812104908,4.03061290802127e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0458510682398844,0.00341142946463471,-0.0525374699905684,-0.0391646664892003,6.39160791922485e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42016,0.113433330309083,0.00844472723911718,0.0968816649204133,0.129984995697753,7.16851997345969e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RFC4,Replication factor C subunit 4,39919,0.0316267854380211,0.00235601401902641,0.0270089979607293,0.0362445729153129,8.98298482257232e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.136692837032616,0.0101909253193624,0.116718623406666,0.156667050658566,9.22146465356203e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF19,Fibroblast growth factor 19,42185,0.110637528431972,0.00826353118496258,0.0944410073094454,0.126834049554499,1.27435205057346e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR2,GMP reductase 2,39736,0.0946596272571694,0.00706561810255881,0.0808110157761542,0.108508238738185,1.29415095207602e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F12,Coagulation factor XII,39979,0.0586826418490492,0.00438617015114451,0.050085748352806,0.0672795353452925,1.62222366217988e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0816796790607456,0.00612035959683755,0.069683774250944,0.0936755838705472,2.56338233675626e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTF1,Cardiotrophin-1,41900,0.119832572557949,0.00899157829299933,0.10220907910367,0.137456066012227,2.91386569487018e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGF,Pro-epidermal growth factor,42081,0.147469809148207,0.0110662737056929,0.125779912685049,0.169159705611366,2.93493355055393e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0826594268436728,0.00620099612431696,0.0705054744400115,0.094813379247334,3.16308525099873e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0394667122253793,0.0029663139467141,0.0336527368898197,0.045280687560939,3.84335561473939e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.066041008657574,0.00496109649938967,0.0563172595187703,0.0757647577963778,4.02820920429982e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0759004201249414,0.00570798314823024,0.0647127731544102,0.0870880670954727,4.29699157142684e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBXN1,UBX domain-containing protein 1,39736,0.0973772408835017,0.00732206499973507,0.083025993484021,0.111728488282982,4.72762491372535e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0703603877957423,0.00529469940506939,0.0599827769618063,0.0807379986296783,5.40787458454426e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0795003524047595,0.00598323390779043,0.0677732139454902,0.0912274908640287,5.47189622252464e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,39736,0.159515666852614,0.0120094835010615,0.135977079190534,0.183054254514695,5.88734630894047e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0682489348919967,0.00514060700261948,0.0581733451668625,0.0783245246171309,6.28837799249549e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP6,Bone morphogenetic protein 6,41886,0.0564434938998118,0.00426107105888815,0.0480917946243911,0.0647951931752326,8.47101360703723e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.137844434054441,0.0104065319096918,0.117447631511445,0.158241236597437,8.52745096718758e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.098905475250247,0.0074745282372658,0.084255399905206,0.113555550595288,1.00610852538749e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0410819991245174,0.00310760045766085,0.0349911022275021,0.0471728960215327,1.32876290461373e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4D,Semaphorin-4D,42249,0.0422475596492764,0.0032008447879529,0.0359739038648887,0.0485212154336641,1.55515085666481e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TALDO1,Transaldolase,39948,0.061962375743768,0.00469886202611245,0.0527526061725875,0.0711721453149484,2.03992812074991e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM3,Dynamin-3,39934,0.0772291237759334,0.00585782357245619,0.0657477895739193,0.0887104579779475,2.11622276328411e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,39919,0.0776353526852242,0.00588994380227988,0.0660910628327557,0.0891796425376928,2.20060085459523e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0281388080823042,0.00213482435159411,0.0239545523531798,0.0323230638114287,2.20443033994715e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF2,Growth/differentiation factor 2,42145,0.0494644302844619,0.00375851725245441,0.0420977364696512,0.0568311240992725,2.57654923614613e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,41839,0.0870732318836209,0.00661889679054649,0.0741001941741497,0.100046269593092,2.79934643557907e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK13,Kallikrein-13,41839,0.0626273818082684,0.00477583707613513,0.0532667411390436,0.0719880224774933,4.83216658583538e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0928948650397409,0.00709201822859351,0.0789945093116976,0.106795220767784,6.500220424734e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42310,0.099762272697485,0.00764592476251598,0.0847762601629536,0.114748285232016,1.1120410878914e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0844290382320684,0.00647042205894122,0.0717470109965436,0.0971110654675931,1.1227920672862e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42107,0.151778557480682,0.0116491062577152,0.12894630921556,0.174610805745804,1.42559671438258e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0777298642190979,0.00597232397253867,0.0660241092329221,0.0894356192052737,1.70344947603496e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0441632617017188,0.00339374778847891,0.0375115160363001,0.0508150073671375,1.97482629282197e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP10,Caspase-10,41839,0.0987187504325159,0.00759157115863988,0.0838392709615817,0.11359822990345,2.00289313867337e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0644325375350317,0.00495903844202936,-0.0741522528814092,-0.0547128221886542,2.26525762361213e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,41843,0.0625375015900267,0.00481790190667989,0.0530944138529341,0.0719805893271192,2.71178811488769e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE2,Glia-derived nexin,39958,0.0895466097425688,0.00689757572780569,0.0760273613160697,0.103065858169068,2.88353936045327e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMNL1,Formin-like protein 1,41839,0.0871207306046827,0.00673069068856876,0.0739285768550879,0.100312884354277,4.3355167105993e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT1,Angiopoietin-1,42085,0.114938498277972,0.00889050404380331,0.0975131103521173,0.132363886203826,5.24535684606103e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID1,Nidogen-1,42189,0.0495333734856805,0.00383354586650466,0.0420196235873314,0.0570471233840297,5.73078167327625e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.108744111163957,0.00841486469237075,0.0922509763669102,0.125237245961004,6.30203136796584e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESYT2,Extended synaptotagmin-2,39929,0.114453346596021,0.00886682444076394,0.0970743706921235,0.131832322499918,7.49212991435844e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.10548213687995,0.00817806780868842,0.0894531239749204,0.121511149784979,7.69879277401181e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0778771571070855,0.00604469483285653,0.0660295552346866,0.0897247589794843,9.3077934734359e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIFBP,KIF-binding protein,42070,0.113123719632721,0.00878587064346134,0.0959034131715368,0.130344026093905,1.02998929440672e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD22,B-cell receptor CD22,42296,0.0584078506040631,0.00453885399596117,0.0495116967719792,0.067304004436147,1.12034698643027e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PF4,Platelet factor 4,39914,0.133606245705118,0.0103793605084339,0.113262699108587,0.153949792301648,1.18391732777978e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED8,Protein TMED8,39930,0.141398457164398,0.0109892132045138,0.119859599283551,0.162937315045245,1.26531198888652e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THPO,Thrombopoietin,41900,0.0533472872919957,0.00414856070937548,0.0452161083016198,0.0614784662823716,1.27875649079839e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,39736,0.0927650276180685,0.00721367892340109,0.0786262169282023,0.106903838307935,1.40553612817217e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG2,Secretogranin-2,42193,0.0451000266009227,0.00351200394370614,0.0382164988712587,0.0519835543305867,1.58248374828457e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.091904104428378,0.00715220135844023,0.0778857897658351,0.105922419090921,1.59320669562127e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.135185444502094,0.0105231387094463,0.114560092631579,0.155810796372608,1.64387759053266e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LARP1,La-related protein 1,39919,0.0850509389022608,0.00662319504719964,0.0720694766097495,0.0980324011947721,1.75552798788978e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1B,Meprin A subunit beta,42145,0.156509149832177,0.0121962369178662,0.13260452547316,0.180413774191195,1.78049093149475e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP7,Caspase-7,39929,0.115431944404237,0.0089900503948969,0.0978114456302391,0.133052443178235,1.7863841219494e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,39990,0.100001256383694,0.00779053846883091,0.0847318009847852,0.115270711782602,1.86710022120594e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18,Interleukin-18,42069,0.0604918042474522,0.00471657462998225,0.051247317972687,0.0697362905222174,1.95740843494664e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.152106270892186,0.0118781377013591,0.128825120997522,0.17538742078685,2.54080879300764e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRD2,Protein ZNRD2,39930,0.0946797816909255,0.00742159528115466,0.0801334549398623,0.109226108441989,5.09835763190057e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC4,Syndecan-4,42145,0.0641810156876928,0.00503752054693811,0.0543074754156941,0.0740545559596915,5.7316513758329e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF23,Fibroblast growth factor 23,42250,0.0684955606156246,0.00537923055527908,0.0579522687272776,0.0790388525039716,6.2600990021412e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0859674167335164,0.0067515315543912,0.0727344148869096,0.0992004185801231,6.93126652767468e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMT,Catechol O-methyltransferase,41740,0.112778514138692,0.00886351689534519,0.0954060210238155,0.130151007253569,7.18639054575318e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARC,SPARC,42181,0.0945372043167331,0.00744075128102586,0.0799533318059224,0.109121076827544,8.94259305532375e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,42249,0.041224219754185,0.00324860133169525,0.0348569611440623,0.0475914783643077,1.08490222566933e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL18,C-C motif chemokine 18,42020,0.0947722737090143,0.00747118691499089,0.0801287473556322,0.109415800062396,1.16197674584245e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCG,Gamma-synuclein,42016,0.0901912732939833,0.00711517071574744,0.0762455386911183,0.104137007896848,1.3038228814056e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL11,Eotaxin,42296,0.0503634840897536,0.00397797194131494,0.0425666590847763,0.0581603090947309,1.56594039399201e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.117184851415971,0.00925568149447089,0.099043715686808,0.135325987145134,1.73754421273689e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL1,Growth-regulated alpha protein,42117,0.125267296246887,0.00990097634753594,0.105861382605716,0.144673209888057,1.75530163335901e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0431958125360883,0.00341492612401936,-0.0498890677391663,-0.0365025573330104,1.80832345654085e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSNL1,Visinin-like protein 1,39929,0.0521580686314552,0.00412348575034694,0.0440760365607752,0.0602401007021352,1.99625271550808e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0882181219394255,0.00697618948221059,0.0745447905542928,0.101891453324558,2.12182881675069e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,39657,0.0435612739756364,0.00344579230401869,0.0368075210597598,0.050315026891513,2.21387284173929e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.076197214633966,0.00603190091150822,0.0643746888474099,0.0880197404205221,2.24595737191691e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0446335114937377,0.00353592527272239,0.0377030979592018,0.0515639250282736,2.52627324146419e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.11328662130493,0.00897604855181515,0.0956935661433725,0.130879676466488,2.61738444772385e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.114352960408611,0.00905937414074007,0.0965965870927604,0.132109333724461,2.77919751078847e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.106065472358719,0.00841048203192181,0.0895809275761521,0.122550017141286,2.94478122849549e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.132760294672447,0.0105283362355997,0.112124755650672,0.153395833694222,3.32012939217653e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIP,Gastric inhibitory polypeptide,39638,0.0678386129330213,0.00538724245893278,0.057279617713513,0.0783976081525295,4.11320618363771e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS2,Trypsin-2,42217,0.0765023731379605,0.00608201610032995,0.0645816215813138,0.0884231246946072,4.40217739028336e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WDR46,WD repeat-containing protein 46,39919,0.0489964311562066,0.00389586367087807,0.0413605383612856,0.0566323239511276,4.94851455410773e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0992659628891782,0.00789428265616892,0.0837931688830871,0.114738756895269,5.12145989057732e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.101263684197398,0.0080543710200629,0.0854771169980747,0.117050251396721,5.27579219638935e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL3,C-C motif chemokine 3,42119,0.0793306611751445,0.00631957030975677,0.0669443033680212,0.0917170189822678,6.05823162002874e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC3B,Tetranectin,39726,0.0280682029995383,0.00223579020787719,0.023686054192099,0.0324503518069776,6.61228504735161e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,39513,0.0708277058040508,0.00565203920550756,0.059749708961256,0.0819057026468456,8.86427914159408e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,39736,0.159702808699796,0.0127473507310367,0.134718001266964,0.184687616132627,9.10288892004613e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0869267615494418,0.00694842679025515,0.0733078450405417,0.100545678058342,1.04388357186489e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0456677665652015,0.00365245610954361,0.038508952590496,0.052826580539907,1.12835953094451e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0356748815896701,0.00285324075324939,0.0300825297133013,0.0412672334660389,1.22900232233069e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0650464117073722,0.00520506353141149,0.0548444871858057,0.0752483362289387,1.33420727315625e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX2,Heme oxygenase 2,41839,0.0635478405158363,0.00509141076430071,0.053568675417807,0.0735270056138657,1.49516857458873e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTF2,Transcription termination factor 2,39649,0.0660853029190693,0.00529847543555037,0.0557002910653906,0.076470314772748,1.82665774933362e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCB,Tubulin-folding cofactor B,42016,0.132782547402508,0.0106556426276597,0.111897487852295,0.153667606952721,1.90802190575725e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0975092220690368,0.00782608230677031,0.082170100747767,0.112848343390307,2.14636673388282e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,42125,0.101673079838768,0.0081681398765571,0.0856635256807161,0.11768263399682,2.25354741551038e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,42119,0.111537776189693,0.00896099181231394,0.0939742322375574,0.129101320141828,2.26756170055217e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPBP,Platelet basic protein,39908,0.113587699722185,0.00912350925891427,0.0957056215747127,0.131469777869657,2.38333801380351e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0887880824124048,0.00715706017555692,0.0747602444683133,0.102815920356496,3.8165462653417e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.060851740436589,0.00490364060412005,0.0512406048525137,0.0704628760206643,3.95978495185288e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.100477719212977,0.00810415925634483,0.0845935670705408,0.116361871355413,4.13598561191708e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD69,Early activation antigen CD69,42082,0.115528593940937,0.00932197552297384,0.0972575219159088,0.133799665965966,4.41893972105108e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB1,Heat shock protein beta-1,41949,0.0924405977906631,0.00746438481590426,0.0778104035514908,0.107070792029835,4.95422065961142e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0495721309885119,0.00400684246344275,0.0417187197601641,0.0574255422168597,5.77762910362892e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS1,Galectin-1,42145,0.0460170235888871,0.00372564510114705,0.0387147591906389,0.0533192879871354,7.37114014046598e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0804322809399056,0.00650822945666072,0.0676761512048506,0.0931884106749606,7.44383500106371e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIN2,Bridging integrator 2,42137,0.117227850081797,0.00950567740539886,0.0985967223672155,0.135858977796379,9.31355278014959e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0850275460260621,0.00689753073567387,0.0715083857841413,0.0985467062679829,9.88771502200833e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.056477833609364,0.00458293589525871,0.0474952792546569,0.0654603879640711,1.04279804108147e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.137349022630726,0.0111540371092098,0.115487109896675,0.159210935364777,1.28124226360853e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL8,C-C motif chemokine 8,42239,0.079353462095796,0.00645009893147526,0.0667112681901045,0.0919956560014875,1.33672644465041e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOF,Apolipoprotein F,39990,-0.0338535855046547,0.00275466323654689,-0.0392527254482866,-0.0284544455610228,1.70424023698121e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,39638,0.0748764308024237,0.00609882442412457,0.0629227349311395,0.0868301266737079,2.01338810213879e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLG,Plasminogen,39742,0.0285092259907264,0.00232665708445103,0.0239489781052024,0.0330694738762504,2.68066425525752e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2,Complement C2,42199,0.0294392177893382,0.00240530102049669,0.0247248277891647,0.0341536077895117,2.90244297164584e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRADD,Death domain-containing protein CRADD,41997,0.0972845777261501,0.00795525248986623,0.0816922828460123,0.112876872606288,3.31217458501873e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0681441010664954,0.00557921768065487,0.0572088344124118,0.0790793677205789,4.32699166510966e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C3,Complement C3,39445,0.0597512420193317,0.00489908203142123,0.0501490412377461,0.0693534428009173,5.4212157372096e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO9B,Unconventional myosin-IXb,41913,0.0855657959373967,0.00702398698764154,0.0717987814416193,0.0993328104331742,5.88085866561416e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0710975252367523,0.00583753898108936,0.0596559488338172,0.0825391016396875,6.06738117056221e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42296,0.0865811122403193,0.00711298203013349,0.0726396674612577,0.100522557019381,6.53698200351252e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0668302035174001,0.00548784295452293,0.0560740313265352,0.0775863757082651,6.72054323277884e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0859455389563982,0.00706611843546225,0.0720959468228922,0.0997951310899042,8.06846861258141e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,39934,0.100830320283939,0.00829778073077978,0.0845666700516103,0.117093970516267,9.13383968858577e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.034415089565826,0.00283293818603513,-0.0399676484104549,-0.0288625307211971,9.48530677725403e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,41843,0.0731078388643894,0.00602600360762247,0.0612968717934494,0.0849188059353295,1.0778987123805e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.063325901037113,0.00522296935617078,0.0530888810990183,0.0735629209752078,1.27982885818333e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,39958,0.0352450685847939,0.00290888605548146,0.0295436519160502,0.0409464852535376,1.39386073653929e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YWHAQ,14-3-3 protein theta,39736,0.095566381724794,0.00789635223730397,0.0800895313396782,0.11104323210991,1.66015114963602e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB9,Serpin B9,42016,0.042308546344225,0.00349849866259968,0.0354514889655296,0.0491656037229203,1.71044900908334e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATOX1,Copper transport protein ATOX1,42181,0.0914614637649425,0.00756878094112606,0.0766266531203354,0.10629627440955,1.90392997503414e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0727251144087119,0.00602006932555724,-0.0845244502868041,-0.0609257785306197,2.17564528750315e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0926689383367093,0.00768237158478335,0.0776114900305339,0.107726386642885,2.49059114426293e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0595034609912815,0.00493407073545551,0.0498326823497887,0.0691742396327743,2.54609634858245e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACYBP,Calcyclin-binding protein,39713,0.133211596449802,0.0110485402405086,0.111556457578406,0.154866735321199,2.87475983989621e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.117357807660073,0.0097578615483217,0.0982323990253624,0.136483216294784,3.78361926849313e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.127247490312562,0.010582866553147,0.106505071868394,0.14798990875673,3.92608580445567e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA12,Serpin A12,41751,0.138647398719488,0.0115381051490195,0.11603271262741,0.161262084811567,4.33823991144244e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,39952,0.0606784350955179,0.00505973952944691,0.050761345617802,0.0705955245732339,6.15651138276096e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM106A,Transmembrane protein 106A,39919,0.0914713411004252,0.00763089557187923,0.0765147857795419,0.106427896421308,6.57687036413602e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D5,TBC1 domain family member 5,42119,0.0995320270348843,0.00830940751596398,0.0832455883035949,0.115818465766174,6.77882538104726e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,39649,0.101284752381455,0.00845369626641539,0.0847155076992809,0.117853997063629,7.13051612041415e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD72,B-cell differentiation antigen CD72,39736,0.0553662844453673,0.00462460560867513,0.046302057452364,0.0644305114383705,7.90925566344616e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0324397973816142,0.0027098521959522,0.0271284870775479,0.0377511076856806,7.93722945213004e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSPN,Persephin,42119,0.110147238366139,0.00921134508434712,0.0920930020008185,0.128201474731459,8.6511982894999e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CERT,Ceramide transfer protein,41839,0.0782147139586463,0.00654210341020057,0.0653921912746532,0.0910372366426394,8.95097372247558e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.122124874284354,0.0102210550459376,0.102091606394316,0.142158142174392,9.66830608644982e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42119,0.062839806894125,0.00526592785192043,0.052518588304361,0.073161025483889,1.15799359431645e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILP,Rab-interacting lysosomal protein,42224,0.0744194715250078,0.00624128303658326,0.0621865567733046,0.086652386276711,1.29326300552077e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.118836112804035,0.00997472413795143,0.0992856534936503,0.13838657211442,1.46511103863442e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.059438913535952,0.00498781525279332,0.0496627956404771,0.0692150314314269,1.51297409290948e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,39934,0.0790651795833119,0.00663987392667291,0.066051026687033,0.0920793324795908,1.68700935225521e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1R,Complement C1r subcomponent,39979,0.0238297417345408,0.0020022860623411,0.0199052610523523,0.0277542224167294,1.8158836765559e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0420717256213788,0.00354281720020603,0.035127803908975,0.0490156473337826,2.29649646339267e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP2,Caspase-2,42119,0.086412416599957,0.00728166918974188,0.0721403449880629,0.100684488211851,2.53792383220855e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG4A,Cysteine protease ATG4A,41843,0.0735892684908315,0.00620221462330859,0.0614329278291467,0.0857456091525164,2.62224455261351e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,39736,0.0291235048998674,0.00246145035970227,0.0242990621948509,0.0339479476048838,4.159318795962e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD244,Natural killer cell receptor 2B4,42296,0.0346645504043018,0.00293200509380382,0.0289178204204463,0.0404112803881573,4.26182674608417e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MESD,LRP chaperone MESD,42137,0.153502968288627,0.012985819556422,0.12805076195804,0.178955174619214,4.38173534626916e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB6,Serpin B6,42216,0.0736396553945704,0.00623697082604184,0.0614151925755284,0.0858641182136124,5.14761252619696e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,39930,0.0728225963840479,0.00617285497467992,0.0607238006336752,0.0849213921344205,6.20085708471492e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0802561903211433,0.00680627699847338,0.0669158874041354,0.0935964932381511,6.68184033308083e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD2,Polycystin-2,39575,0.0734423594014211,0.00622921425871288,0.0612330994543439,0.0856516193484984,6.84442970320833e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THTPA,Thiamine-triphosphatase,39897,0.110058224173933,0.0093450027585236,0.0917420187672264,0.128374429580639,7.84995059668473e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.118746242488574,0.010082775587676,0.0989840023367289,0.138508482640419,7.85167962186824e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDT,D-dopachrome decarboxylase,39966,0.0508520619378905,0.00433172599054849,0.0423618789964154,0.0593422448793655,1.2182135188533e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.105007507736196,0.00894895809599333,0.0874675498680486,0.122547465604342,1.22554831485727e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0804578669144798,0.00685709211017766,0.0670179663785316,0.093897767450428,1.30714621790915e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0628671310525827,0.00536121698850246,0.0523591457551179,0.0733751163500476,1.32314932786857e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,39575,0.0830337026708854,0.00707766759704346,0.0691614741806802,0.0969059311610906,1.35204378022403e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42185,0.0310627552522731,0.00265014065133941,0.0258684795756479,0.0362570309288984,1.40902210704972e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAP,Prolyl endopeptidase FAP,42310,0.0343192045002451,0.00293251755499852,0.028571470092448,0.0400669389080422,1.73700113079031e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,39929,0.124201158745013,0.0106124191343489,0.103400817241689,0.145001500248337,1.85788030948358e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA11,Integrin alpha-11,42119,-0.0422118941935942,0.00360897698349865,-0.0492854890812516,-0.0351382993059369,1.88563747616976e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1,Allograft inflammatory factor 1,41843,0.0651090328659184,0.00557142988994236,0.0541890302816314,0.0760290354502054,2.13722695691229e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0860429917658696,0.00735949784725338,0.071618375985253,0.100467607546486,2.16388408597948e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0596005678679125,0.00509835318847746,0.0496077956184967,0.0695933401173284,2.16650963487541e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX1,Peroxiredoxin-1,41742,-0.114292060341298,0.00978883526602499,-0.133478177462707,-0.0951059432198892,2.42108838465625e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C4BPB,C4b-binding protein beta chain,42181,0.0474341233181436,0.004070492430893,0.0394559581535933,0.0554122884826939,3.11293580855837e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM3,Junctional adhesion molecule C,39736,0.063107063558699,0.00541839952678388,0.0524870004862026,0.0737271266311954,3.61028896725883e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGT1,Protein SGT1 homolog,41843,0.0990312733181817,0.00851484330000113,0.0823421804501795,0.115720366186184,4.08847332260015e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.11198511236136,0.00962505099732634,0.0931200124066005,0.13085021231612,4.1635065849969e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0830203315907174,0.00715190844491758,0.069002591038679,0.0970380721427559,5.2529308492299e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS9,Galectin-9,42129,0.0388366318669372,0.00334618240752645,0.0322781143481853,0.045395149385689,5.37102231285423e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42093,0.110720185808899,0.00954275678457709,0.0920163825111279,0.12942398910667,5.61195543637574e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.110670323364716,0.00953949039156185,0.0919729221972552,0.129367724532178,6.06489724323933e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFASC,Neurofascin,42296,0.0359991761466737,0.00310535542807738,0.029912679507642,0.0420856727857054,6.26356370461311e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0661162841086044,0.00570468547345691,0.0549351005806289,0.07729746763658,6.92988182145359e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIAPIN1,Anamorsin,42181,0.0756348754736397,0.00653170619869302,0.0628327313242014,0.0884370196230781,7.29597995427785e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,42070,0.105021876206568,0.00907097712216411,0.0872427610471262,0.122800991366009,7.47476604823344e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.07549041365916,0.00651942760988974,0.0627123355437761,0.0882684917745438,7.90278731092789e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,39915,0.108004119630697,0.00933624251875492,0.0897050842939373,0.126303154967457,8.88917229604135e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.132618477725289,0.0114933535108005,0.11009150484412,0.155145450606458,1.24865812067513e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0653598551325076,0.0056831145265232,0.0542209506605221,0.076498759604493,1.82537293814726e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA1,Carboxypeptidase A1,42310,0.0792719238440179,0.0068948592249317,0.0657579997631518,0.092785847924884,1.87801031601761e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0386511098839254,0.00336249675541729,0.0320606162433075,0.0452416035245433,1.9398978130633e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICALL2,MICAL-like protein 2,39649,0.0839381250728882,0.00729956601334475,0.0696309756867325,0.0982452744590439,1.98640022906536e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX6,Peroxiredoxin-6,42262,-0.0734936194247292,0.00639911669614492,-0.0860358881491732,-0.0609513507002851,2.16457100272324e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,42295,0.0285168534565344,0.0024852573246948,0.0236457491001326,0.0333879578129362,2.44093115006545e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.156186504708183,0.0136060657329107,0.129518615871678,0.182854393544688,2.46892822928649e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,41843,0.0531320166911898,0.00463473237674781,0.0440479412327641,0.0622160921496155,2.78331193453796e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.138788244751903,0.0121123633125882,0.11504801265923,0.162528476844576,2.93805806495559e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,39930,0.101861789204623,0.00888940220585195,0.0844385608811536,0.119285017528093,3.11692595802897e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB1,Carboxypeptidase B,42310,0.0756976632000779,0.00661215597540482,0.0627378374882845,0.0886574889118714,3.29077062249864e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0522023521768391,0.00456233429117085,0.0432601769661442,0.061144527387534,3.54105604057621e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.11076538262484,0.00967546759935523,0.0918014661301038,0.129729299119576,3.55803195479746e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MENT,Protein MENT,39736,-0.0289831892666309,0.00253311621481628,-0.0339480970476708,-0.024018281485591,3.81208898579542e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164,Sialomucin core protein 24,42137,0.0329229704308041,0.00287972991764781,0.0272786997922144,0.0385672410693938,3.94799082818353e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,42137,0.0299740725698457,0.00262192349241451,0.0248351025247132,0.0351130426149781,3.97358131163368e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.131871456110451,0.0115448157071253,0.109243617324485,0.154499294896416,4.79290421032551e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,41843,0.0693369440212418,0.0060866525553668,0.0574071050127228,0.0812667830297607,6.34273487947923e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XCL1,Lymphotactin,42262,0.0661922233199902,0.00581301879302143,0.0547987064856682,0.0775857401543122,6.62916220138863e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLB1,Beta-galactosidase,42016,0.0523154292115686,0.00459656150159835,0.0433061686684359,0.0613246897547014,7.09388742431056e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.081277271199755,0.00714239493972201,0.0672781771178998,0.0952763652816101,7.74866262633926e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42181,0.0448116367341656,0.0039406717903489,0.0370879200250817,0.0525353534432494,7.90358410753917e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.135515540162543,0.0119279294914429,0.112136798359314,0.158894281965771,8.94903047007592e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0703906702508201,0.00619722360235621,0.0582441119902019,0.0825372285114383,9.25903074470206e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA3,Annexin A3,42224,0.0839855561909863,0.00740473919333742,0.0694722673720449,0.0984988450099276,1.10237420715694e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMFG,Glia maturation factor gamma,39958,0.0869480626025493,0.00767065071406888,0.0719135872029743,0.101982538002124,1.26737266746689e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL2,Chordin-like protein 2,42145,0.0551596221306922,0.00486956243711354,0.0456152797539496,0.0647039645074347,1.30426524636752e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0742718970529153,0.00655609104080487,0.0614219586129377,0.0871218354928928,1.36350489977184e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APP,Amyloid-beta precursor protein,42112,0.0798571846741887,0.00705391782094801,0.0660315057451306,0.0936828636032468,1.40411361659668e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0667637837897293,0.00590243257200648,0.0551950159485966,0.078332551630862,1.67656620081289e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0973019204183365,0.00860730074224657,0.0804316109635333,0.11417222987314,1.80702015925997e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARK7,Parkinson disease protein 7,42137,0.0609577543838392,0.00539761124525079,0.0503784363431476,0.0715370724245307,1.91411726203585e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.112825052579465,0.00999491248517784,0.093235024108516,0.132415081050413,2.03317690436276e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.146206723741495,0.0129639567666915,0.12079736847878,0.171616079004211,2.28101538960844e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX8,Syntaxin-8,42119,0.057496574495483,0.00510066858008953,0.0474992640785075,0.0674938849124585,2.42886912498874e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.144562943572224,0.0128322879653302,0.119411659160176,0.169714227984271,2.61811237062681e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0616570926462276,0.00547692021549532,0.0509223290238568,0.0723918562685984,3.03306280918618e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB1,Beta-crystallin B1,39958,0.0792531593009695,0.00704646775398024,0.0654420825031682,0.0930642360987708,3.4092465513315e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0634324830858904,0.00564278800579306,0.052372618594536,0.0744923475772448,3.64467508588777e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIF,Macrophage migration inhibitory factor,42105,0.0801367397216226,0.00713907107479553,0.0661441604150234,0.0941293190282218,4.13130454909407e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0769030858355355,0.0068669766404149,0.0634438116203223,0.0903623600507487,5.56723265041718e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOL1,Apolipoprotein L1,39990,0.0636746718429389,0.0056862912968655,0.0525295409010825,0.0748198027847953,5.91153884054903e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0997047410944682,0.00891770792530268,0.082226033560875,0.117183448628061,6.78990885389504e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,39966,0.0730065713449191,0.00652937834722231,0.0602089897843634,0.0858041529054749,7.12582461822664e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG2,Bone marrow proteoglycan,39966,-0.061040484211657,0.00546176001933457,-0.0717455338495527,-0.0503354345737612,7.55689868523152e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMA,Granzyme A,42296,0.040360389586955,0.0036159996272908,0.033273030317465,0.0474477488564449,8.36559181195808e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0825009256896825,0.00739178928211314,0.0680130186967407,0.0969888326826243,9.02140114718312e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0440787440439981,0.00395867335222415,0.0363197442736388,0.0518377438143574,1.1972466469578e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42185,0.104612803097052,0.00940233852480745,0.0861842195884295,0.123041386605675,1.24288735000922e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSNAX,Translin-associated protein X,39575,0.0465377897706081,0.00418740342929372,0.0383304790491924,0.0547451004920238,1.52678633513766e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,42145,0.0779825664517838,0.00702144493075722,0.0642205343874997,0.091744598516068,1.55172386769845e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,42247,0.0337476889059801,0.00304268477591548,0.0277840267451858,0.0397113510667744,1.82708935357909e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0703774057766866,0.00634718340262162,0.0579369263075482,0.0828178852458249,2.02079145257419e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0351857718238957,0.00317630385532222,0.0289602162674642,0.0414113273803273,2.13226460890193e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0436498980356989,0.00394447530409379,0.0359187264396751,0.0513810696317227,2.42344933498703e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP2,Retinol-binding protein 2,42070,-0.0917680394017915,0.00830745664984238,-0.108050654435483,-0.0754854243681005,3.01447876938794e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0464739477272233,0.00420883674479977,0.0382246277074158,0.0547232677470309,3.15955614363557e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPH,Hephaestin,39958,0.0328422729681924,0.00297341180686422,0.0270143858267386,0.0386701601096463,3.21441770533952e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN4,Cerebellin-4,42262,0.0373541005956668,0.00338354561826264,0.030722351183872,0.0439858500074616,3.22736578953583e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0656438253010751,0.00594780050470894,0.0539861363118455,0.0773015142903046,3.35441910114872e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0940180336691909,0.00852232343134021,-0.110721787594618,-0.0773142797437641,3.53159233877734e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP7,Matrilysin,41881,0.0609484138690211,0.00552760863252156,0.0501143009492788,0.0717825267887633,3.78485306256585e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN2,Matrilin-2,42144,0.0348023294713421,0.0031591779638248,0.0286103406622455,0.0409943182804387,4.19887756914307e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0332519738949924,0.00301870481946935,0.0273353124488325,0.0391686353411523,4.23434738083921e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.102724212324711,0.00932302856168448,0.0844510763438094,0.120997348305613,4.35379751302605e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFP,Alpha-fetoprotein,41976,0.0765266157035556,0.00695319935854437,0.0628983449608086,0.0901548864463026,4.71899566719799e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,41948,0.0327242118888696,0.0029748582457813,0.0268934897271382,0.0385549340506009,5.02694452952818e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0583783185548582,0.00530747006143179,0.0479756772344518,0.0687809598752645,5.09318934048149e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTD,Deoxycytidylate deaminase,39736,0.112350830949391,0.0102124963015629,0.0923343381983279,0.132367323700454,5.24847782639429e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,39930,0.102603644582057,0.00936721595375829,0.0842439013126905,0.120963387851423,8.81113425792584e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA1,Apolipoprotein A-I,39979,-0.0320118169681618,0.00292379300818082,-0.0377424512641962,-0.0262811826721274,9.26822570403542e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP3,Caspase-3,42310,0.102649978563181,0.0093851083088004,0.084255166277932,0.12104479084843,9.92556311850475e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,39990,0.0556164254409048,0.00509426300893432,0.0456316699433935,0.065601180938416,1.30313562398945e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0456159147924025,0.00417898908241898,0.0374250961908613,0.0538067333939437,1.33220553732922e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCA,Calcitonin,41997,0.0808460191281302,0.00741093546699039,0.066320585612829,0.0953714526434313,1.36341983096391e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0499101971545724,0.00457313389108683,0.0409468547280423,0.0588735395811026,1.36609501606652e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP3,Stromelysin-1,42137,-0.0577751968851385,0.00530046156029334,-0.0681641015433135,-0.0473862922269636,1.49957516345331e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0670657311763182,0.0061572721397643,0.0549974777823801,0.0791339845702562,1.63841062979442e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0549459685460216,0.00504959884065312,0.0450487548183414,0.0648431822737017,1.84917032595592e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBN1,Drebrin,39657,0.0591364056810605,0.00543663023489091,0.0484806104206743,0.0697922009414467,2.03337607333058e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.118158495041798,0.0108635832097673,0.0968658719506539,0.139451118132942,2.05296731208061e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN4,CCN family member 4,42262,0.0453332152421097,0.00417035267143994,0.0371593240060874,0.053507106478132,2.06616595184705e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,39929,0.0789643186673599,0.00726240348896245,0.0647300078289935,0.0931986295057263,2.11600213442102e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.120382874036972,0.0110835885060234,0.0986590405651667,0.142106707508778,2.40130299023173e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX4,Syntaxin-4,42070,0.0682347216996451,0.00628955834942815,0.0559071873347659,0.0805622560645243,2.61790228680039e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0741981004465423,0.00684014699827287,0.0607914123299275,0.0876047885631571,2.79211905413634e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0282300519674364,0.00260377427691882,0.0231266543846755,0.0333334495501972,2.82010932637015e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RP2,Protein XRP2,42070,0.0491731496915888,0.00454108300411062,0.040272627003532,0.0580736723796456,3.26484404434611e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0955362655118756,0.0088267292541509,0.0782358761737398,0.112836654850011,3.44277040025635e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG6,Large proline-rich protein BAG6,41900,0.0425554819775725,0.00393618852971879,0.0348405524593237,0.0502704114958213,3.94377325256476e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0458288653459118,0.00424027980982405,0.0375179169186567,0.054139813773167,4.05821638574954e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.11346101931457,0.0105000294552079,0.0928809615823624,0.134041077046777,4.37643647987989e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFB,Complement factor B,39794,0.0377502779756521,0.00349371630430715,0.03090259401921,0.0445979619320941,4.42376100715144e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0668392458833131,0.00618887593523299,0.0547090490502565,0.0789694427163698,4.46752670644904e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,39930,0.0568973313707382,0.00526635643935339,0.0465752727496056,0.0672193899918709,4.4681418390214e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLMH,Bleomycin hydrolase,42310,0.0354455250544884,0.00329554246893528,0.0289862618153752,0.0419047882936015,7.13873385471125e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12A_IL12B,Interleukin-12,42070,0.0882587120041285,0.00820875070961413,0.0721695606132848,0.104347863394972,7.47009091978018e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,41992,0.0465419533538897,0.00432977057175118,0.0380556030332574,0.055028303674522,7.68430978020655e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0868203993511697,0.00807642330483695,0.0709906096736893,0.10265018902865,7.99364398059726e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRIB,Protein scribble homolog,39638,0.100373742793432,0.00933937785230789,0.0820685622029085,0.118678923383955,8.27435557305654e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0831147266484712,0.00774153800531943,0.0679413121580451,0.0982881411388973,9.24761098124998e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0380078455608974,0.00354560729595551,0.0310584552608246,0.0449572358609702,1.0527368766279e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0658368239647241,0.00614819682405897,0.0537863581895685,0.0778872897398797,1.19596673971534e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FEN1,Flap endonuclease 1,41843,0.0734698321538503,0.00686196121174394,0.0600203881788322,0.0869192761288684,1.21516272402883e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL2,C-C motif chemokine 2,41992,0.0591716369735022,0.00553434807720328,0.0483243147421838,0.0700189592048206,1.42456242838798e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRGN,Neurogranin,39990,0.105235929160342,0.00984380739490797,0.0859420666663223,0.124529791654362,1.50545256525267e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRB1,Chymotrypsinogen B,42137,0.0665154410519492,0.00623120904195971,0.0543022713297082,0.0787286107741903,1.70646669979236e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0461588219311157,0.00432485971125838,0.0376820968970493,0.0546355469651821,1.73311412533243e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSZ,Cathepsin Z,42168,0.036665611458256,0.00343786167328777,0.029927402578612,0.0434038203379001,1.88402830257331e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.113787210160818,0.0106648040980422,0.0928841941286548,0.13469022619298,1.88920648694425e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,39934,0.0982895673315294,0.00921463852901445,0.0802288758146611,0.116350258848398,1.94511509423589e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.041557965082459,0.00390624657934005,0.0339017217869525,0.0492142083779655,2.50248960123888e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.071139764825524,0.00668767453597102,0.0580319227350208,0.0842476069160272,2.53435863934865e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0494664588269257,0.00465232568464278,0.0403479004850259,0.0585850171688255,2.81432240006227e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN9,Septin-9,42070,0.032574819561516,0.00306694434303202,0.0265636086491733,0.0385860304738588,3.01416848108328e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42016,0.0524477102490674,0.00494355287732032,0.0427583466095196,0.0621370738886152,3.42513751546593e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0422338797722685,0.00398033552442299,0.0344324221443995,0.0500353374001376,3.54582483486012e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOD,Apolipoprotein D,39468,-0.0480379247661514,0.0045270716700819,-0.0569109852395119,-0.0391648642927909,3.54733817256642e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGLAP,Osteocalcin,39966,0.0952162078140973,0.00897558534975832,0.0776240605285709,0.112808355099624,3.61146869055781e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBN,Nibrin,41913,0.0614659360063604,0.00579761259078239,0.0501026153284269,0.0728292566842939,3.71073071095895e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACYP1,Acylphosphatase-1,39701,0.0734899499549703,0.00693801416627827,0.0598914421890649,0.0870884577208757,4.30647412390705e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0453553178797099,0.00428346060319329,0.0369597350974511,0.0537509006619688,4.4583493889759e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,41900,0.0580551959732472,0.00548562077198638,0.0473033792601539,0.0688070126863405,4.52880178784097e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0521875450201834,0.00493558758795454,0.0425137933477925,0.0618612966925743,5.00936384286341e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0851224426137658,0.00804977462742668,0.0693448843440095,0.100900000883522,5.17093448746788e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLTA,Clathrin light chain A,41900,0.0527374601167569,0.00498969648730553,0.0429576550016381,0.0625172652318757,5.24555324975883e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0228956644685302,0.00217323001848184,-0.0271551953047546,-0.0186361336323058,7.47054376483329e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLNK,B-cell linker protein,39657,0.0469792494319916,0.00445884813787582,0.038239907081755,0.0557185917822282,7.79865646830684e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,39575,0.0789850916373105,0.0074966854559336,0.0642915881436806,0.0936785951309404,7.83007036732339e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0342415018711536,0.00325249697566568,0.0278666077988489,0.0406163959434584,8.08367489183982e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0737023585598507,0.00700698107330849,0.059968675656166,0.0874360414635353,9.33692204895802e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0332680043755601,0.00316683547298677,0.0270610068485061,0.0394750019026142,1.03019380722523e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,39927,0.0685087921690919,0.00653314007845596,0.0557038376153182,0.0813137467228656,1.30745017724786e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TST,Thiosulfate sulfurtransferase,41809,0.0842937307100039,0.00805664938852306,0.0685026979084987,0.100084763511509,1.61357186433062e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL7,C-C motif chemokine 7,42119,0.0627076342383421,0.00599439213889482,0.0509586256461083,0.074456642830576,1.63190005458944e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0473017671430432,0.00452092536388203,0.0384407534298345,0.056162780856252,1.68371789678965e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,41843,0.043224072331818,0.00413856514158776,0.035112484654306,0.05133566000933,1.95515549475343e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,39757,0.0818814500812914,0.00784619668197535,0.0665029045846197,0.0972599955779631,2.22640495911839e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0586580345278096,0.00562793352160247,0.0476272848254688,0.0696887842301504,2.56087586571884e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0363936946881615,0.00349636774738832,0.0295408139032804,0.0432465754730426,2.8128359015255e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,39586,0.0533324567014815,0.00513190886008656,0.0432739153357118,0.0633909980672511,3.51519592276624e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0674851789836148,0.00650778979226325,0.0547299109907789,0.0802404469764508,4.22070982229327e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.068667625233778,0.00663520230170029,0.0556626287224455,0.0816726217451106,5.23175878863037e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSS,Cathepsin S,39358,0.0268045429352104,0.00259188070748053,0.0217244567485485,0.0318846291218722,5.97008066468299e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCOF1,Treacle protein,39958,0.0357691752774116,0.00346004450106351,0.0289874880553271,0.0425508624994961,6.13206693943716e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.10667544944202,0.0103379857256776,0.0864129974196918,0.126937901464348,7.51537544367244e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0937133316995328,0.00909587853537167,0.0758854097702043,0.111541253628861,8.85431352228777e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP1,Guanylate-binding protein 1,39911,0.0709283264137167,0.00689230396628561,0.0574194106397969,0.0844372421876364,9.94980401105679e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0338492965311774,0.00329193645839882,0.0273971010727157,0.0403014919896391,1.08498993731136e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN6,Dynactin subunit 6,41839,0.0792285106447852,0.0077083700496392,0.0641201053474923,0.094336915942078,1.09352364391201e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POMC,Pro-opiomelanocortin,39638,0.0803437715716154,0.00783234943181913,0.0649923666852499,0.0956951764579809,1.4051755958682e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPLAH,5-oxoprolinase,39638,0.0759089485994656,0.00740656358392905,0.0613920839749646,0.0904258132239665,1.54201138044659e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL24,C-C motif chemokine 24,42166,0.0899350169338911,0.00878368349297958,0.0727189972876511,0.107151036580131,1.63037333970657e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPB,Natriuretic peptides B,41900,-0.152924582531989,0.0149614807877144,-0.182249084875909,-0.123600080188068,1.96159024563829e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0441213117626853,0.00431755063715203,0.0356589125138673,0.0525837110115033,2.0050191154389e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2R,Proteinase-activated receptor 1,42166,0.06243740101457,0.00611188262021216,0.0504581110789542,0.0744166909501859,2.06636633591112e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC79,Protein unc-79 homolog,39560,0.06079265317094,0.0059484615927178,0.0491336684492131,0.0724516378926669,2.07803031344876e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0405899197347485,0.0039756048450896,0.0327977342383728,0.0483821052311241,2.28607564650357e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMTN,Smoothelin,39897,0.100840646363897,0.00987982330197968,0.0814761926920168,0.120205100035777,2.35956035935194e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,39930,0.1076045337907,0.0105477040276138,0.0869310338965767,0.128278033684823,2.48195206060179e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ING1,Inhibitor of growth protein 1,41820,0.0518846067554149,0.0050877255112648,0.0419126647533359,0.0618565487574939,2.4904622104424e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0388879729630371,0.00381335291896762,0.0314138012418605,0.0463621446842136,2.5924562638266e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBI,Acyl-CoA-binding protein,42085,0.084608990646424,0.00830860851824295,0.0683241179506678,0.10089386334218,2.8820941279019e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0413088234310838,0.00405926058121852,0.0333526726918955,0.0492649741702721,3.10203790859142e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,39979,0.0338616653981507,0.0033307344030809,0.0273334259681121,0.0403899048281892,3.55155255616647e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0305226192723799,0.00300271524266625,0.0246372973967541,0.0364079411480057,3.63467303471451e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.130118989052293,0.0128117922342035,0.105007876273254,0.155230101831332,3.79674892637547e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0474707043111937,0.00467773881888666,0.0383023362261758,0.0566390723962115,4.2788152414781e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA2,Annexin A2,39492,0.0763462697480488,0.00752497649369785,0.061597315820401,0.0910952236756966,4.42955751303687e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGR1,Prostaglandin reductase 1,39958,0.0901779345050301,0.00891981186193284,0.0726951032556417,0.107660765754418,6.30731856563468e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.121532748874074,0.0120314722930194,-0.145114434568392,-0.0979510631797561,6.64144638007466e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES2,Cocaine esterase,42070,0.059916572854954,0.00593846451710797,0.0482771824014224,0.0715559633084856,7.46728965957035e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POSTN,Periostin,39966,-0.0407143502038688,0.00403528762193825,-0.0486235139428678,-0.0328051864648698,7.73989660075708e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.128482160202158,0.0127399098678379,0.103511936861196,0.15345238354312,7.80882011263056e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMB1,Laminin subunit beta-1,39638,0.0337632806729467,0.0033487600204509,0.0271997110328629,0.0403268503130305,8.38477324984205e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIT2,Slit homolog 2 protein,41839,0.0553857464618048,0.0055153298886871,0.0445756998799781,0.0661957930436315,1.20888037423188e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0376653720779094,0.00375105770385943,0.0303132989783449,0.0450174451774738,1.21428799996212e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0621463878951332,0.00618938319857269,0.0500151968259308,0.0742775789643357,1.2221751432378e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVR,Poliovirus receptor,42249,0.0399972225344058,0.00398967395399788,0.0321774615845699,0.0478169834842416,1.42538315044912e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DXO,Decapping and exoribonuclease protein,39929,0.0484185365691701,0.0048331873107364,0.0389454894401268,0.0578915836982134,1.59270992422262e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0360765474053344,0.00360221630207674,0.0290162034532639,0.0431368913574048,1.63860280817869e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLF4,Krueppel-like factor 4,39586,0.0433340150769709,0.00432724867186489,0.0348526076801157,0.0518154224738261,1.66468283230879e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42070,0.0250003088268892,0.00249879776621385,0.0201026652051101,0.0298979524486684,1.7510356262218e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0756854643077071,0.00757545935840667,0.0608375639652301,0.0905333646501842,2.08717659817136e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0337058267660839,0.00337512888806023,0.0270905741454859,0.040321079386682,2.11236542406616e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0248602789938245,0.00249106621573277,0.0199777892109883,0.0297427687766607,2.24558224150994e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,39638,0.0822554992106228,0.00824433527400139,0.0660966020735801,0.0984143963476656,2.4078052226965e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0885634114506284,0.00890765472855266,0.0711044081826651,0.106022414718592,3.3875158671658e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.029023672913664,0.00292089439977869,0.0232987198900978,0.0347486259372303,3.60854081855786e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0806746331913364,0.00812598095702187,0.0647477105155735,0.0966015558670992,3.9073242881499e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCA,Tubulin-specific chaperone A,39736,0.0884407768785626,0.00896777237179953,0.0708639430298355,0.10601761072729,7.53994986400476e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPPK1,Epiplakin,39638,0.0778587656928983,0.00790305223859428,0.0623687833052535,0.0933487480805431,8.36542815597105e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROK1,Prokineticin-1,42119,0.0521005571890254,0.00530697252483791,0.0416988910403431,0.0625022233377077,1.12845931863652e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0484064912395032,0.00493290032071479,0.0387380066109023,0.0580749758681042,1.22463338416112e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,39966,0.0878765666341182,0.00895673651990515,0.0703213630551041,0.105431770213132,1.2388785075968e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADM,Pro-adrenomedullin,42262,0.0273748036894459,0.00279198243019566,0.0219025181262624,0.0328470892526293,1.27496310901889e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB10,Ras-related protein Rab-10,39958,0.0557929524759368,0.00570217854782432,0.0446166825222011,0.0669692224296724,1.61073234696923e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0774655045316831,0.0079250328242034,0.0619324401962444,0.0929985688671217,1.7210487929476e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPAG1,Sperm-associated antigen 1,39934,0.060822008343435,0.00623055767346285,0.0486101153034478,0.0730339013834222,2.01070712661026e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARD3,Partitioning defective 3 homolog,39757,0.0771704135291845,0.00791240034089569,0.061662108861029,0.0926787181973401,2.19815568267908e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH7,Protocadherin-7,39930,0.0362957738523664,0.00372164722907297,0.0290013452833834,0.0435902024213494,2.20176422048382e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,39934,0.0377614807892815,0.00387314643567587,0.0301701137753568,0.0453528478032062,2.26815464963259e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0432014653014603,0.00443665108352346,0.0345056291777543,0.0518973014251663,2.56974361044391e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,41968,0.0446579168010645,0.0045937195557815,0.0356542264717328,0.0536616071303963,2.89286792269402e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0410156725225717,0.00421952468689399,-0.049285940908884,-0.0327454041362595,2.91762469770045e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNF,Tumor necrosis factor,41880,0.0376489251982638,0.00388137095988146,0.0300414381168962,0.0452564122796315,3.57483683288851e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0551494379055957,0.00569141488208765,0.043994264736704,0.0663046110744875,4.07538346398452e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL19,C-C motif chemokine 19,42249,0.116638944282018,0.012050938301498,0.0930191052110822,0.140258783352954,4.36800351426938e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SWAP70,Switch-associated protein 70,39930,0.0378446432794065,0.00391027239649396,0.0301805093822784,0.0455087771765347,4.54052561387941e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA13,Carbonic anhydrase 13,41967,0.108585500313415,0.011227755755561,0.0865790990325151,0.130591901594314,4.72138040835776e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42262,0.0378936311943855,0.00392214843426054,0.0302062202632348,0.0455810421255361,5.1697129447051e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42032,0.0295703167096717,0.00307261142564631,0.023547998315405,0.0355926351039385,7.45980455148823e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGRN,Neugrin,39929,0.02301999561773,0.00239158113249943,0.0183324965980312,0.0277074946374289,7.56971860972659e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0404536458914062,0.00420349578548804,0.0322147941518496,0.0486924976309627,7.68889880196197e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0309810064789645,0.00322183866142406,0.0246662027025734,0.0372958102553557,8.04093369334757e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39281,-0.113634773780699,0.0118365523864317,-0.136834416458105,-0.090435131103293,9.75263310903086e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,39958,0.0286304166267227,0.00298467777584347,0.0227804481860695,0.0344803850673759,1.03937133190203e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0303974695635086,0.00316975401927601,0.0241847516857276,0.0366101874412895,1.06582232736941e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,39919,0.0637666730877372,0.00665088339769723,0.0507309416282506,0.0768024045472238,1.08880086816511e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0543750291478767,0.00567660876841618,0.043248875961781,0.0655011823339724,1.15103573694013e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",39929,0.109446827486608,0.0114262333705427,0.0870514100803442,0.131842244892872,1.18856755403734e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0309005313549207,0.00322735903955865,0.0245749076373857,0.0372261550724556,1.1978825491781e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARFIP1,Arfaptin-1,39934,0.0706976962734868,0.00738486075142411,0.0562233692006956,0.085172023346278,1.24965099441419e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0462170050056632,0.0048441598036599,0.0367224517904898,0.0557115582208366,1.65803095397985e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP5,Platelet glycoprotein V,39736,0.037254565329251,0.00390497958025881,0.0296008053519437,0.0449083253065583,1.72099070603181e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX16,Syntaxin-16,41843,0.0580812888358718,0.00609446456504486,0.0461361382883839,0.0700264393833598,1.83978331633209e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.062950629153378,0.00660492029407206,0.0500049853769968,0.0758962729297593,1.88599100207989e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX9,Sorting nexin-9,42145,0.069046020555403,0.00724943205844283,0.054837133720855,0.0832549073899509,1.9385796853651e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TF,Serotransferrin,39979,0.0217690126929131,0.00228741811009988,0.0172856731971173,0.0262523521887089,2.14403229781145e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS27,Serine protease 27,42107,0.0407668867328435,0.00428661891309992,0.0323651136631676,0.0491686598025193,2.21850332774777e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0316520596604321,0.00333376777525601,-0.0381862444999339,-0.0251178748209303,2.63454347064431e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLO1,Lactoylglutathione lyase,41900,0.0571965369891838,0.00602830042578551,0.0453810681546442,0.0690120058237234,2.74985132317854e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",39638,0.0888632537521089,0.0093699044895117,0.070498240952666,0.107228266551552,2.9510378300966e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN1,Ficolin-1,39978,0.056308311397035,0.00594528733307882,0.0446555482242006,0.0679610745698695,3.31503610866637e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0347908596752466,0.00367489058050583,0.0275880741374551,0.041993645213038,3.34599303858572e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OCLN,Occludin,39934,0.04468953043095,0.00471986983829075,0.0354385855479001,0.0539404753139998,3.40355223660852e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0679062523286218,0.00717271850899467,0.0538477240509922,0.0819647806062514,3.45903745284806e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAP3,Cytosol aminopeptidase,41913,0.0484624403833478,0.00512553836613539,0.0384163851857225,0.0585084955809732,3.75995209735495e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF6,SLAM family member 6,41843,0.0390294029138173,0.00412877283047138,0.0309370081660934,0.0471217976615412,3.83748193462207e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0230715024315585,0.00244095153432395,0.0182872374242835,0.0278557674388334,3.86690840728116e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP6,Platelet glycoprotein VI,42115,0.0887059444689898,0.00940673647893539,0.0702687409702764,0.107143147967703,4.75730072322927e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FST,Follistatin,42166,0.0488568387729228,0.00519995122244822,0.0386649343769242,0.0590487431689213,6.58290423785887e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42181,0.0247770654265627,0.00264076492242957,0.0196011661786008,0.0299529646745247,7.44751309677788e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,42310,0.0425402885945889,0.00453469280300939,0.0336522907006905,0.0514282864884873,7.54040907394835e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL26,C-C motif chemokine 26,42119,0.0898773594990986,0.00958747965599142,0.0710858993733555,0.108668819624842,8.04211303910196e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40LG,CD40 ligand,42296,0.0792639708915219,0.00845757267745142,0.0626871284437171,0.0958408133393267,8.21818014150276e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,42119,-0.0497474896560812,0.00530933816429712,-0.0601537924581036,-0.0393411868540589,8.4013296273472e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0701291198140604,0.0074889530713489,0.0554507717942166,0.0848074678339042,9.09719601456427e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,39882,0.0487572318258322,0.00521141001542667,0.038542868195596,0.0589715954560685,9.85574405578191e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRG,Histidine-rich glycoprotein,39925,0.0310576305248825,0.00332108389008475,0.0245483061003164,0.0375669549494487,1.02459930519139e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0372370786436115,0.00398605414876045,0.029424412512041,0.045049744775182,1.12804367912937e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.026677636414728,0.00286202864878226,0.0210680602631147,0.0322872125663412,1.36845351477573e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0463231019732949,0.00497483392540752,0.0365724274794962,0.0560737764670937,1.45658088714888e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42016,0.0401348317493742,0.00431194145019249,0.031683426506997,0.0485862369917515,1.5044323614254e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL15,C-C motif chemokine 15,42310,0.0432417732202883,0.00464728627567223,0.0341330921199707,0.0523504543206058,1.54393831321008e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.064582900584441,0.00695147417298853,0.0509580112053835,0.0782077899634985,1.77031896258064e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML2,Trem-like transcript 2 protein,42137,0.0341952810378801,0.00368088826716878,0.0269807400342293,0.0414098220415309,1.77574780581633e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0355548147090616,0.00382736005795668,-0.0430564404226567,-0.0280531889954665,1.82990132173206e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,41843,0.0521172218393087,0.00561278794495487,0.0411161574671972,0.0631182862114202,1.85783868062716e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,41933,0.0336711706434755,0.00362674408359235,0.0265627522396345,0.0407795890473165,1.87889447087865e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASS1,Argininosuccinate synthase,39575,0.0765864778978291,0.00825208559426135,0.0604123901330769,0.0927605656625813,1.99663602443495e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0490774416302017,0.00529413965712479,0.0387009279022371,0.0594539553581663,2.21185109626217e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12B,Interleukin-12 subunit beta,42296,0.0541117805104186,0.00584983668192043,0.0426461006138545,0.0655774604069826,2.56919197961517e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,41973,0.0243373011997524,0.00263736454461261,0.0191680666923117,0.0295065357071931,3.16913034523439e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0814164185515948,0.00883004263621464,0.0641095349846141,0.0987233021185755,3.39226686291946e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42199,-0.027278887633071,0.00295950716116675,-0.0330795216689579,-0.0214782535971842,3.48553043699923e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABHD14B,Protein ABHD14B,41976,0.0550036243908355,0.00597163353001163,0.0432992226720127,0.0667080261096583,3.7121145441271e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.031115240560013,0.00337836107743459,0.0244936528482412,0.0377368282717848,3.73077928511641e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX,Glutaredoxin-1,42057,0.054567548129543,0.00592811671186389,0.0429484393742897,0.0661866568847962,3.91892619378735e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0474558999528175,0.00516315490231309,0.0373361163442838,0.0575756835613511,4.55882688334293e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPT,Dermatopontin,42310,0.0248973968820154,0.00271084525152853,0.0195841401890195,0.0302106535750113,4.72495154691864e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0646075232416177,0.00704883374531843,0.0507918091007936,0.0784232373824418,5.61338240835351e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0844064004160769,0.0092258933681854,0.0663236494144335,0.10248915141772,6.56836562628836e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR5,Complement factor H-related protein 5,39864,0.0406806730939305,0.00444870006949626,0.0319612209577178,0.0494001252301431,7.02355114570326e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0846100216968641,0.00927064520315818,0.0664395570986741,0.102780486295054,8.25726289247769e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0482276750406717,0.00530816372911976,0.037823674131597,0.0586316759497464,1.17260832314602e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,42016,0.0512363675526027,0.00563967725968939,0.0401826001236115,0.0622901349815939,1.18052412138975e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMSB10,Thymosin beta-10,42137,0.0736424765096794,0.00811631709401031,0.0577344950054192,0.0895504580139396,1.31087454414993e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,39934,0.0575630347136309,0.00635141767957924,0.0451142560616556,0.0700118133656062,1.47670071442923e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0428476165098928,0.00473031731027145,0.0335761945817608,0.0521190384380248,1.54466979934466e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0347619433407591,0.00384090474504444,0.027233770040472,0.0422901166410462,1.6636957939002e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM2,Paralemmin-2,39929,0.0374312275369291,0.00413701874916448,0.0293226707885667,0.0455397842852915,1.69498444306415e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0696847452970478,0.00770569810356979,0.054581577014051,0.0847879135800446,1.72831398631648e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,42181,0.0664023879306146,0.0073436951950874,0.0520087453482433,0.0807960305129859,1.74257041283522e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF2,Fibroblast growth factor 2,42119,0.0667087783075254,0.00737924772850917,0.0522454527596474,0.0811721038554034,1.7762741017078e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0855219170826305,0.00945754114538623,0.0669851364376735,0.104058697727588,1.78279218245236e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO2,Roundabout homolog 2,42249,0.0218409446079865,0.00241673457253594,0.017104144845816,0.0265777443701569,1.81779949345343e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN5,CCN family member 5,42137,0.0366190450852775,0.00405475800739992,0.0286717193907736,0.0445663707797813,1.92598900537601e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VGF,Neurosecretory protein VGF,39934,0.029046550932601,0.00321989725435707,0.0227355523140611,0.0353575495511408,2.16399206763292e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0850757398444797,0.00943284915785576,0.0665873554950824,0.103564124193877,2.20096111370435e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK7,Kallikrein-7,39475,0.038031934951747,0.00422769642249807,0.0297456499636508,0.0463182199398432,2.73176030474075e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFR,Epidermal growth factor receptor,42310,0.0153078977162417,0.00170480040913382,0.0119664889143394,0.018649306518144,3.07569862031188e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPL14,60S ribosomal protein L14,39638,0.0374172408213091,0.00417110389322181,0.0292418771905944,0.0455926044520239,3.42529123981401e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM3,Myomesin-3,39736,-0.0925034926701827,0.0103578708281535,-0.112804919493364,-0.0722020658470018,4.89514996551185e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,42016,0.0321546836391581,0.00360573280267058,0.0250874473459238,0.0392219199323925,5.37157240703998e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0416633683412268,0.00467139023708459,0.032507443476541,0.0508192932059126,5.43348301202062e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.046643687147991,0.00523222659594872,0.0363885230199315,0.0568988512760505,5.6391668156479e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDK2,Protein sidekick-2,39736,0.0374392423108545,0.00420191597387835,0.0292034870020529,0.0456749976196561,5.89359188874479e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0329590132598853,0.00370077136938177,0.025705501375897,0.0402125251438736,5.95215547141105e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FADD,FAS-associated death domain protein,42145,0.0724632872254621,0.0081428989144742,0.0565032053530927,0.0884233690978315,6.34483834283391e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,42249,0.0741725162894836,0.00833573905547104,0.0578344677407604,0.0905105648382069,6.38595284047103e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.023117470559079,0.0026016635567076,0.0180182099879321,0.0282167311302259,7.1518473971132e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTC,Probetacellulin,41843,0.0694160648482213,0.00783782905496399,0.0540539199004919,0.0847782097959508,9.29297369902786e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42119,-0.0496307000783219,0.00561045267325248,-0.0606271873178968,-0.0386342128387471,1.01733136756441e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHPS,Deoxyhypusine synthase,39919,0.0380498197629362,0.00430116214038335,0.0296195419677848,0.0464800975580875,1.03766619369248e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM1,Dynamin-1,39930,0.109236496700608,0.012350014595302,0.0850304680938161,0.1334425253074,1.05010236746573e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C5,Complement C5,39979,0.0141491564035231,0.0016044854876191,0.0110043648477896,0.0172939479592565,1.32855374817994e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSA,Arylsulfatase A,42137,0.0424368949951885,0.00481936870529069,0.0329909323328188,0.0518828576575583,1.45935058484089e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAL,Integrin alpha-L,39657,0.041068591560866,0.00466553541706743,0.0319241421434138,0.0502130409783182,1.53628004514611e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTN,Pleiotrophin,41900,0.0467744756549854,0.00531663989967302,0.0363538614516263,0.0571950898583445,1.56605859723849e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0418221979943123,0.00475427610197354,0.0325038168344442,0.0511405791541805,1.61707047675598e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL3,Insulin-like 3,39929,0.0845358516124948,0.00961136500989603,0.0656975761930986,0.103374127031891,1.6310828788391e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDCP1,CUB domain-containing protein 1,42016,0.0526077761108709,0.00598345558925402,0.040880203155933,0.0643353490658088,1.64324165292804e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0364351145655563,0.00414430508580428,0.0283122765973799,0.0445579525337327,1.64811380633802e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",39949,0.0215024599303878,0.00244817761046632,0.0167040318138738,0.0263008880469018,1.81893821575735e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1F,Protein phosphatase 1F,39958,0.0500064439493213,0.00569521696796833,0.0388438186921034,0.0611690692065392,1.86131204581314e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42145,0.0718992258450332,0.0081916941255,0.0558435053590532,0.0879549463310132,1.87631803617417e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0681531884407249,0.00777084587278402,0.0529223305300683,0.0833840463513816,1.99320475794261e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.034133201416641,0.00389106600151278,0.0265067120536759,0.041759690779606,2.00880860696229e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.058719278494684,0.00669417750406099,0.0455986905867245,0.0718398664026435,2.01822777010662e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,41843,0.0451513088131254,0.00515574605759995,0.0350460465402295,0.0552565710860213,2.23670685508031e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,42217,-0.0547979486999003,0.00625760668565739,-0.0670628578037888,-0.0425330395960118,2.23882569581232e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0338121642221233,0.00386244344409631,0.0262417750716946,0.0413825533725521,2.35692514489076e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0425619822111003,0.0048687928596743,0.0330191482061386,0.0521048162160619,2.56616746198583e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,39958,0.0183885152445073,0.00210591600763909,0.0142609198695347,0.0225161106194799,2.85558469000505e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0552975132453284,0.00634067376428848,0.042869792667323,0.0677252338233338,3.13931194303465e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,39757,0.0318599956724782,0.00366638442043416,0.0246738822084272,0.0390461091365291,4.13860625819994e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0300278428122464,0.0034571658508716,0.023251797744538,0.0368038878799547,4.27890543442864e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0398115719391771,0.0045906888774323,-0.0488093221389444,-0.0308138217394098,4.71160722835491e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,41843,0.0662628453800122,0.0076439318842215,0.0512807388869381,0.0812449518730863,4.87483447323519e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEK,Angiopoietin-1 receptor,42181,0.0204695775008024,0.00236428571069989,0.0158355775078306,0.0251035774937742,5.34495128984993e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPP1,Osteopontin,42286,-0.0406739259075783,0.0046989474899129,-0.0498838629878075,-0.031463988827349,5.4280778128988e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFC1,Cryptic protein,41843,0.0442295014097028,0.00511373214068959,0.0342065864139512,0.0542524164054544,5.7798088928664e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA6,Carbonic anhydrase 6,42103,-0.0577370465288399,0.00668929073268783,-0.070848056364908,-0.0446260366927717,6.7401918814435e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0799910505759406,0.00929586190616583,0.0617711612398556,0.0982109399120256,8.65175061568052e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NADK,NAD kinase,42145,0.0500873198843278,0.00583508440300526,0.0386505544544375,0.0615240853142182,1.01682287042771e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA9,Serpin A9,42025,0.0661904889306266,0.00772079280414215,0.051057735034508,0.0813232428267452,1.11738517436116e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,42137,-0.0259334257905532,0.0030297659270629,-0.0318717670075965,-0.0199950845735099,1.25411192953482e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0277887944897234,0.00324838718254545,-0.0341556333675125,-0.0214219556119343,1.30858445684201e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,41839,0.0536678986022,0.00627366448912363,0.0413715162035177,0.0659642810008823,1.3131851444736e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,39966,0.0316546791773103,0.00370380704680938,0.0243952173655639,0.0389141409890566,1.43028026193411e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0810681159256631,0.00949904233643937,0.062449992946242,0.0996862389050843,1.56096560286243e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0622266324096187,0.00729704325419671,0.0479244276313932,0.0765288371878442,1.65424521617758e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO1A,Coronin-1A,41883,0.0807887795857034,0.0094746687107334,0.0622184289126659,0.0993591302587409,1.6655514450094e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0629440236924608,0.007393167749427,0.0484534149035839,0.0774346324813377,1.85980248678649e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB2,Plexin-B2,42255,0.0222279750083497,0.0026133097252437,0.017105887946872,0.0273500620698273,1.99146261878453e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42249,0.042952787234168,0.00505101554874396,0.0330527967586298,0.0528527777097062,2.02403458130576e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42310,-0.0212516552522868,0.00250802362983929,-0.0261673815667718,-0.0163359289378018,2.62267333783133e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO2,Gamma-enolase,42249,0.0589226285528156,0.00695375075957026,0.0452932770640579,0.0725519800415733,2.62298732279054e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0222523720265504,0.00262634823190376,0.017104729492019,0.0274000145610817,2.69262315102691e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0507182677063793,0.00598922916478801,0.0389793785433948,0.0624571568693638,2.80158392051381e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PER3,Period circadian protein homolog 3,39657,0.111030889174581,0.0131194277771009,0.0853168107314637,0.136744967617699,2.93202827466833e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0209662114098072,0.00247749753583825,0.0161103162395642,0.0258221065800502,2.93341603981948e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0431484267078564,0.00510247807195943,0.0331475696868159,0.0531492837288969,3.09608411056522e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0550361282901492,0.00653038905413361,0.0422365657440473,0.067835690836251,3.88027986086622e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42126,0.0261779622188775,0.00310899578319114,0.0200843304838229,0.0322715939539322,4.13830460227028e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA2,Integrin alpha-2,39736,0.0311039484088894,0.0036980182033023,0.0238558327304169,0.0383520640873619,4.5617496853491e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42114,0.030552083425729,0.0036442562888128,0.0234093410996559,0.0376948257518021,5.63598963305137e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSL,Cathepsin L1,42145,0.0218901461133158,0.00261263181074691,0.0167693877642519,0.0270109044623798,5.88033660000818e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0875180387205383,0.0104655382123853,0.0670055838242631,0.108030493616813,6.73677534123897e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRN1,Secernin-1,42119,0.0493736930644534,0.00591425976170782,0.0377817439315061,0.0609656421974007,7.59660943914597e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMMT,MICOS complex subunit MIC60,39919,0.0396701132210593,0.00476120524005334,0.0303381509505548,0.0490020754915638,8.86853238898067e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0865711377069276,0.0103946707481276,0.0661975830405976,0.106944692373258,8.98301169626856e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD84,SLAM family member 5,42119,0.0283470368627239,0.00340467583998967,0.0216738722163442,0.0350202015091037,9.16623211275028e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0821803522590199,0.00988929832609903,0.0627973275398658,0.101563376978174,1.06567536698196e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH1,Acid ceramidase,39876,0.0419533602455169,0.00504851668427385,0.0320582675443402,0.0518484529466937,1.06618957455902e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0621308635579052,0.00748348521063303,0.0474632325450645,0.076798494570746,1.1381532246852e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAM,Integrin alpha-M,42137,-0.0279799149741912,0.00337492631186313,-0.0345947705454429,-0.0213650594029395,1.23300920600286e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID2,Nidogen-2,42137,0.0645630692396332,0.0077907862346511,0.0492931282197171,0.0798330102595494,1.26879222217402e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0356128712570948,0.00429955706031259,0.0271857394188822,0.0440400030953075,1.33717969368118e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,39966,0.0238607883939174,0.00288413674623831,0.0182078803712903,0.0295136964165444,1.45043220576901e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0637437943391665,0.00771099404531918,0.0486302460103409,0.0788573426679921,1.50704996345234e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,39929,0.0200941162692103,0.0024344071172859,0.0153226783193299,0.0248655542190906,1.69834853597298e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF22,Kinesin-like protein KIF22,39575,0.109471007498828,0.0132660332069394,0.0834695824132266,0.135472432584429,1.73608398272639e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRBP,Acrosin-binding protein,39919,0.0351754289457022,0.00426331662076987,0.0268193283689932,0.0435315295224111,1.74861052738067e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XRCC4,DNA repair protein XRCC4,41839,0.0324752725815197,0.00394559270500344,0.024741910879713,0.0402086342833264,2.03306258759159e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0290513088034867,0.00353115932329445,0.0221302365298296,0.0359723810771439,2.12907635017312e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.057789866788247,0.00702484841834706,0.0440211638882868,0.0715585696882073,2.13812244758003e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK6,Kallikrein-6,42158,0.027140212169965,0.00330027830340973,0.0206716666952819,0.0336087576446481,2.15308495225738e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENR,Density-regulated protein,39657,0.0504367833162026,0.00613965522605571,0.0384030590731335,0.0624705075592718,2.35944039224259e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42070,0.0321778385796428,0.00392512691714898,0.0244845898220307,0.0398710873372548,2.66574109666701e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0472506796740874,0.00577028316449628,0.0359409246716747,0.0585604346765001,2.87758511125399e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0453491375443158,0.00554649093103609,0.0344780153194851,0.0562202597691466,3.18580553094254e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0596966193828238,0.00730812762100406,0.0453726892456558,0.0740205495199918,3.45820805113468e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDHB,Succinate dehydrogenase,39930,0.0572369312711954,0.00700994551272404,0.0434974380662563,0.0709764244761346,3.55151099907083e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,42296,0.0411290407194292,0.00503888171809771,0.0312528325519577,0.0510052488869007,3.57108534486662e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0350179593987686,0.00429002193977285,0.0266095163968138,0.0434264024007233,3.63566445871721e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17D,Interleukin-17D,41913,0.0297203049315123,0.00364285296365692,0.0225803131227447,0.0368602967402798,3.69376839067379e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMS,Spermine synthase,39586,0.0559174133725956,0.00686280629705058,0.0424663130303765,0.0693685137148147,4.10448299139604e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA4,Ephrin-A4,41992,0.0281473974814502,0.00345591117399929,0.0213738115804116,0.0349209833824888,4.13641841296681e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0645436658335788,0.00792308695570518,0.0490144154003967,0.080072916266761,4.15281290966428e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSHB,Thyrotropin subunit beta,42145,0.0591734283830849,0.0072705237455087,0.0449232018418878,0.0734236549242819,4.33782176771461e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0601623750751893,0.00739384717817046,0.0456704346059752,0.0746543155444034,4.49242347658449e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0186271070265791,0.00229004990632509,0.0141386092101819,0.0231156048429763,4.51741203798732e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN2,Dynactin subunit 2,42070,0.0824153094148214,0.0101357516959622,0.0625492360907354,0.102281382738907,4.6217770097646e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,39575,0.0510752386695806,0.00629193126609605,0.0387430533880324,0.0634074239511289,5.26382228117261e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0327599240810076,0.00403715486827541,0.0248471005391878,0.0406727476228274,5.37641727997221e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,42145,0.075552305569737,0.00933183784140016,0.0572619034005927,0.0938427077388813,6.15204387947094e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0771837155702429,0.00953599256347266,0.0584931701458365,0.0958742609946493,6.37712814379156e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTNB,Dystrobrevin beta,39900,0.0392966829994097,0.00485549838857846,0.0297799061577959,0.0488134598410235,6.40465734448451e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0303895295243871,0.00375690788717563,0.0230259900655228,0.0377530689832513,6.51982596439965e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0490420837096118,0.00608191949732899,-0.0609626459243767,-0.037121521494847,8.02839604940352e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD83,CD83 antigen,42119,0.0297316027162296,0.00368823699261822,0.0225026582106979,0.0369605472217613,8.18619177599578e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0466547567388795,0.00579515305944557,0.0352962567423662,0.0580132567353928,9.07562958873494e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMD,Dystrophin,39638,0.0442408540726348,0.00549781474301436,0.0334651371763266,0.0550165709689429,9.35464816778216e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,39959,0.0159056222624551,0.00197804431448797,0.0120286554060587,0.0197825891188515,9.78704708594755e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,41913,0.0309807638065265,0.00385939855762768,0.0234163426335762,0.0385451849794767,1.07904466393679e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,39930,0.0370058131413969,0.00461707027366726,0.0279563554050091,0.0460552708777847,1.20935579762848e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42070,0.0619788884284108,0.00773699122575711,0.0468143856259269,0.0771433912308948,1.23355084017324e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0484519916265018,0.00605701759097031,0.0365802371482,0.0603237461048036,1.35458080408058e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPOCK1,Testican-1,42016,0.0223230944615956,0.00279206732000903,0.0168506425143779,0.0277955464088133,1.3991186949999e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7,Complement component C7,39722,-0.0284783437967573,0.00356618361027623,-0.0354680636728987,-0.0214886239206159,1.53528506643812e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIT,Vitrin,39958,0.032693141993511,0.00410574849272718,0.0246458749477657,0.0407404090392562,1.8423949065774e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0524628870979211,0.00659388769094552,0.0395388672236679,0.0653869069721743,1.91533391238359e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0486066929510149,0.00611608163273879,0.0366191729508469,0.060594212951183,2.05801885390697e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,39895,0.0385865191878243,0.00485795135092359,0.0290649345400141,0.0481081038356345,2.16118424495459e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA4,Laminin subunit alpha-4,42185,0.0289648772353093,0.00365438143268922,0.0218022896272384,0.0361274648433802,2.43735924541112e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXN,"Frataxin, mitochondrial",42262,0.0614179271925355,0.00776498872419108,0.046198549293121,0.07663730509195,2.77966729390411e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,42076,0.0371318938875416,0.00470116644773445,0.0279176076499821,0.0463461801251012,3.0418325261928e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH1,Protocadherin-1,42264,0.0173673165681629,0.00220100605834786,0.0130533446938011,0.0216812884425247,3.23433463601299e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPA,Apolipoprotein(a),39775,-0.15389624624464,0.0195069738230851,-0.192129914937887,-0.115662577551393,3.32222742153694e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPK2,Death-associated protein kinase 2,39657,0.0464705800314402,0.00591438100294686,0.0348783932656644,0.0580627667972161,4.29154089855127e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR3,Toll-like receptor 3,42296,0.051270720152128,0.00653098363986518,0.0384699922179922,0.0640714480862637,4.45445030258929e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0526223754933405,0.0067308980486371,0.0394298153180118,0.0658149356686692,5.83889327945315e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGMN,Legumain,42185,0.0303146603890602,0.00387978799443986,0.022710275919958,0.0379190448581623,5.96985669075885e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,39934,0.0554020463318821,0.00709023309318212,0.0415051894692452,0.0692989031945191,6.03619237135801e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,41839,0.0460579496139979,0.00589643713047633,0.0345009328382642,0.0576149663897315,6.09218183051602e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,39560,0.0418081320049264,0.00535653910733806,0.0313093153545438,0.052306948655309,6.48828425398483e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS22,Brain-specific serine protease 4,39657,0.0288658789932468,0.00369877655382531,0.0216162769477492,0.0361154810387444,6.52925515300321e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0271143531151844,0.00347728446851961,0.020298875556886,0.0339298306734828,6.76492009555956e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA2,Carbonic anhydrase 2,42103,0.0552560428522869,0.00708940950059195,0.0413608002311267,0.0691512854734472,6.95600629123301e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLC,Galectin-10,42119,-0.0558216189928914,0.00717033409923202,-0.0698754738273862,-0.0417677641583967,7.47170931778016e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0425691975545743,0.00546904693529118,-0.053288529547745,-0.0318498655614036,7.5535055656007e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0259840663005411,0.00334189582696818,0.0194339504796834,0.0325341821213987,8.07235587940531e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0611777228658229,0.00786993738717578,0.0457526455869584,0.0766028001446875,8.19020697776706e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGA,Chromogranin-A,39966,-0.0706096848756056,0.00908223570594775,-0.0884108668592632,-0.052808502891948,8.22880961961392e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.035846442049616,0.00461609748824621,0.0267988909726534,0.0448939931265786,8.84973752661273e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA6,Integrin alpha-6,42119,0.0422536550234299,0.00544284834916995,0.0315856722590568,0.052921637787803,8.87783066944264e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,39657,0.0532853727195128,0.00687219172475588,0.0398158769389913,0.0667548685000344,9.70347837187092e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA,Lymphotoxin-alpha,42119,0.0330955232480711,0.00427924921487652,0.0247081947869132,0.0414828517092291,1.11608990019733e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPA1,Inositol monophosphatase 1,42016,0.0505481175040178,0.00653617551670678,0.0377372134912725,0.0633590215167631,1.11984951956121e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL14,C-C motif chemokine 14,42152,0.0333898994772507,0.0043193761846884,0.0249239221552614,0.0418558767992399,1.14863995290188e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAA4,Serum amyloid A-4 protein,39979,0.027216312929367,0.00352105347818796,0.0203150481121186,0.0341175777466154,1.16964139388011e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,42181,-0.0229477679757657,0.00296976507315304,-0.0287685075191456,-0.0171270284323857,1.17690495487723e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0461410131027671,0.00599272236714827,0.0343952772631565,0.0578867489423777,1.48077132542909e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0317730180762842,0.00413027669553777,0.0236776757530301,0.0398683603995382,1.5397999522535e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,39757,0.0290148640314841,0.00377327352199147,0.0216192479283808,0.0364104801345873,1.60032184608923e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0217688730105131,0.00283537190491391,0.0162115440768819,0.0273262019441444,1.73065298807085e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB6,Integrin beta-6,41913,0.0251562285167121,0.00328427002545927,0.018719059266812,0.0315933977666123,1.99348070974261e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD46,Membrane cofactor protein,42107,0.0234490292635214,0.00306160282486575,0.0174482877267845,0.0294497708002582,1.99994391890156e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0292350608247607,0.00381875453081506,0.0217503019443631,0.0367198197051582,2.05628104400161e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.038474684896352,0.00502827265700531,0.0286192704886216,0.0483300993040824,2.12070945895182e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0343784123043268,0.00449327007918858,0.0255716029491172,0.0431852216595364,2.12966017746602e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0131808810474957,0.00172424138275023,0.00980136793730523,0.0165603941576861,2.23751130865802e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSE,Cathepsin E,39736,0.0433657991762112,0.0056720841887194,0.0322485141663211,0.0544830841861012,2.25289977254614e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL1,Fc receptor-like protein 1,42145,0.0373737167866535,0.00489339402843125,0.0277826644909283,0.0469647690823788,2.36139483888784e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB2,Lysosome membrane protein 2,41777,0.0269460362227066,0.00352827310638518,0.0200306209341917,0.0338614515112216,2.37319617751459e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0833510334097065,0.0109181910670087,0.0619513789183695,0.104750687901043,2.42670747052531e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,39649,0.0480593501255348,0.0063021991268499,0.035707039836909,0.0604116604141606,2.62411209142079e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.035433684972991,0.00464931868275837,0.0263210203547846,0.0445463495911974,2.68255123778494e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,41913,0.053409329840471,0.00701453780379948,0.039660835745024,0.067157823935918,2.83413010900722e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGF,Hepatoma-derived growth factor,42243,0.0742453482853416,0.00976267469620403,0.0551105058807817,0.0933801906899015,3.03447957634447e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPL,Periplakin,39657,0.0262010381817706,0.00344859260492821,0.0194417966761114,0.0329602796874299,3.26026570119097e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPR,Nucleoprotein TPR,39575,0.0395931394440814,0.00521881912785743,0.0293642539534809,0.049822024934682,3.54952980742756e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,41843,0.046767622595245,0.0061733229494576,0.0346679096143082,0.0588673355761819,3.80680067607861e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0336568065742502,0.00444396866860205,0.0249466279837902,0.0423669851647102,3.8707385975271e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDA,Cytidine deaminase,39946,0.0385488885615711,0.00509039286424086,0.028571718547659,0.0485260585754832,3.93389365848621e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0454297611919527,0.00600916175709984,0.033651804148037,0.0572077182358684,4.29158828453118e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS2,Growth arrest-specific protein 2,39757,0.0420225770597253,0.00556902288359529,0.0311072922078785,0.0529378619115721,4.84597408280424e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST2,Bone marrow stromal antigen 2,42249,0.0411078881251507,0.00544942294384196,0.0304270191552204,0.0517887570950809,4.86289485502772e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,39586,0.0609808749117076,0.00808311650408187,0.0451379665637072,0.0768237832597081,4.9091266985416e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGN,Biglycan,41820,-0.0951659520606899,0.012619357502204,-0.11989989276501,-0.07043201135637,4.95748228927428e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0193481870882303,0.00257473408298474,0.0143017082855802,0.0243946658908804,6.06469718820158e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42125,-0.0750885267338182,0.00999766427508949,-0.0946839487129936,-0.0554931047546428,6.25381094769894e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0508573454954451,0.00677494055352269,0.0375784620105407,0.0641362289803496,6.45157785599313e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN1,Tetraspanin-1,41900,0.0583140935434164,0.00778374151932099,0.0430579601655472,0.0735702269212855,7.22283785897558e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0270728007801782,0.00361556413459671,-0.0341593064839878,-0.0199862950763687,7.53487538012394e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0265834783403404,0.00355289998777009,0.019619794364311,0.0335471623163697,7.75528823469079e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,41820,0.0534014894759907,0.00713848931801847,0.0394100504126745,0.0673929285393069,7.8540133314213e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENAH,Protein enabled homolog,41913,0.0385252378155099,0.00515111048227362,0.0284290612702536,0.0486214143607662,7.95648700652468e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOB,Elongin-B,39575,0.0313361562812741,0.00419037297838392,0.0231230252436416,0.0395492873189065,8.11383821846929e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0431322613050787,0.00576789888965363,0.0318271794813575,0.0544373431287998,8.1187989533067e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0393855095096089,0.00527041705927291,0.029055492073434,0.0497155269457838,8.32258367597774e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42296,0.0587241797314367,0.00786618847028107,0.0433064503296858,0.0741419091331876,8.80606017205749e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL1,Chordin-like protein 1,42166,0.0260088715259558,0.00349539108258391,0.0191579050040913,0.0328598380478202,1.06007673574601e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,39638,0.0249764826950696,0.00335957812632514,0.0183917095674723,0.0315612558226669,1.12813205334567e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA1,Carbonic anhydrase 1,41890,0.0447014236814678,0.00602493738686514,0.0328925464032122,0.0565103009597235,1.24788869586695e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA2,Carboxypeptidase A2,42205,0.052661006133842,0.00710936326728506,0.0387266541299633,0.0665953581377207,1.36506122594657e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAT,Catalase,39827,0.0412953870047592,0.00558821294548771,0.0303424896316033,0.0522482843779151,1.57573284456062e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP1,Interstitial collagenase,41693,0.0711223212317098,0.00963374421647762,0.0522401825674137,0.090004459896006,1.64569097842007e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL5,Insulin-like peptide INSL5,39930,0.0807882056793719,0.0109427409868822,0.0593404333450828,0.102235978013661,1.65839688560761e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0206724428944458,0.00280381233625879,-0.026167915073513,-0.0151769707153786,1.7869753736535e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_E,,42119,0.0231132432558063,0.00313717650755302,0.0169643773010024,0.0292621092106102,1.83889596944772e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX7,Syntaxin-7,39657,0.0384576792470462,0.00524285796957412,0.028181677626681,0.0487336808674115,2.36796632710034e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH15,Cadherin-15,42230,0.0542088412334701,0.00739419499860667,0.039716219036201,0.0687014634307392,2.40823322607283e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0528763068678585,0.00722022176474605,0.0387246722089562,0.0670279415267607,2.55482044571798e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0347212455031999,0.00474266576579794,0.0254256206022359,0.0440168704041639,2.63144351168262e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42093,0.0320290718518743,0.00438830316415089,0.0234279976501385,0.04063014605361,3.06719644884053e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,42002,0.0367030342155364,0.00503176577166341,0.0268407733030761,0.0465652951279967,3.17155708475215e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0892781552260503,0.0122509696195204,0.0652662547717903,0.11329005568031,3.36908960590256e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.031537900995353,0.00432918217708658,0.0230527039282633,0.0400230980624427,3.43678689097884e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0369413247418025,0.00507356354722231,0.0269971401892468,0.0468855092943582,3.49691755526317e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0933581887789867,0.0128229315426577,0.0682252429553776,0.118491134602596,3.54437415116693e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,39575,0.0936406123562794,0.0128835843759817,0.0683887869793552,0.118892437733204,3.89034021097808e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA1,BolA-like protein 1,39586,0.0423178803599493,0.00582610215539285,0.0308987201353793,0.0537370405845193,4.02746442775138e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR2,Complement factor H-related protein 2,39904,0.0442767027734586,0.00609781571456456,0.032324983972912,0.0562284215740051,4.09238120723476e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,39575,0.0393242470860439,0.00541729744645626,0.0287063440909896,0.0499421500810982,4.16279106703651e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100P,Protein S100-P,41900,0.041488274770812,0.00571942050651784,0.0302782105780371,0.052698338963587,4.27255918740051e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0375419952065942,0.00517656169917222,0.0273959342762167,0.0476880561369718,4.32539900447215e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLU,Clusterin,39979,0.0233156975642186,0.00321748760584926,0.0170094218567541,0.0296219732716832,4.55163632090442e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRDT,Bromodomain testis-specific protein,39575,0.0283024521700392,0.0039085912753623,0.0206416132703291,0.0359632910697493,4.74893260989768e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SBSN,Suprabasin,39954,-0.0273250566518057,0.00379600967089751,-0.0347652356067648,-0.0198848776968466,6.47854149346638e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMM2,Phosphomannomutase 2,39575,0.0461539060247101,0.00641196325728302,0.0335864580404354,0.0587213540089849,6.50503649108242e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LF,CMRF35-like molecule 1,42262,0.0461561044848162,0.00641833485460305,0.0335761681697943,0.0587360407998382,6.75193815620853e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0169768108434663,0.00236262724054392,-0.0216075602349324,-0.0123460614520002,7.04955527730838e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP9,Caspase-9,39657,0.049030814865235,0.00682225707248557,0.0356591910031633,0.0624024387273068,7.05544886403075e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.039812472409098,0.00554605715179742,0.0289422003915751,0.050682744426621,7.42268860353597e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0466293756206895,0.00650012317832039,0.0338891341911816,0.0593696170501975,7.77506819402433e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN2,Alpha-actinin-2,39575,-0.0494480450734586,0.00690243746242628,-0.0629768224998141,-0.0359192676471031,8.34681796863297e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.064741661942074,0.00903946578604434,0.0470243090014271,0.0824590148827209,8.43667898985506e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,39638,0.0394457599082272,0.00551301971451658,0.0286402412677748,0.0502512785486797,8.89655396133047e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFA,Protransforming growth factor alpha,42119,0.0345974186319834,0.00483816845933274,0.0251146084516912,0.0440802288122755,9.0618668306393e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0240198656174565,0.00336031863323656,-0.0306060901386001,-0.0174336410963128,9.25826230291806e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA4,Annexin A4,42088,0.0551208125109631,0.00774389039255925,0.039942787341547,0.0702988376803792,1.15061906123096e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,39575,0.0332330730451652,0.00467131229981286,0.024077300937532,0.0423888451527984,1.19500277538119e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42129,0.0578027284000237,0.00815561886187484,0.0418177154307491,0.0737877413692984,1.43348880834663e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0475331617997589,0.00670606398569578,0.0343892763877951,0.0606770472117226,1.4410203595262e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0334063517484194,0.00472155601114376,0.0241521019665776,0.0426606015302612,1.5817976656602e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA4,Carbonic anhydrase 4,42310,-0.0183402480384105,0.00259336180277921,-0.0234232371718578,-0.0132572589049633,1.60117293561868e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,42097,0.0628551189905251,0.00888777670374703,0.0454350766511809,0.0802751613298693,1.60134990428025e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3C,Protein FAM3C,42129,0.0229565264850668,0.00324756367669065,0.0165913016787531,0.0293217512913804,1.63885505007615e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD93,Complement component C1q receptor,41654,-0.0237251263053633,0.00336357131697618,-0.0303177260866366,-0.01713252652409,1.8319694213931e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42310,0.0270031130397013,0.00383085372595997,0.0194946397368198,0.0345115863425829,1.8902747763613e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD276,CD276 antigen,42123,-0.027055679460412,0.00383979270169667,-0.0345816731557375,-0.0195296857650866,1.92867584841526e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.028129651372424,0.0039975550423656,0.0202944434893874,0.0359648592554606,2.08195896697272e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APLP1,Amyloid-like protein 1,42145,-0.0381853809609142,0.00543059642724402,-0.0488293499583124,-0.0275414119635159,2.14077679106947e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,39990,0.0198123770864344,0.00282343339737747,0.0142784476275746,0.0253463065452943,2.39338578670874e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0247287760538712,0.00352560575763312,-0.0316389633388321,-0.0178185887689103,2.44660949669284e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY75,Lymphocyte antigen 75,42119,0.0290064193431895,0.00413691264109286,0.0208980705666475,0.0371147681197315,2.4677635265012e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0444993107926761,0.00636059712241819,0.0320325404327364,0.0569660811526157,2.78005436787352e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,39638,0.0589341173616328,0.00842548858022066,0.0424201597444003,0.0754480749788653,2.81124387684461e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1A,Protein phosphatase 1A,41843,0.0234477575971856,0.00335402338698275,0.0168738717586994,0.0300216434356718,2.86146238770432e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0272764794840653,0.00390891086234403,-0.0349379447742596,-0.019615014193871,3.13409086486832e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,39575,-0.0345046729082019,0.00494700364475688,-0.0442008000519254,-0.0248085457644784,3.2378548209053e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF7,SLAM family member 7,42119,-0.0444844355156826,0.00638260924802885,-0.0569943496418192,-0.0319745213895461,3.32500681815704e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0424666477248428,0.00609355201816693,0.0305232857692357,0.05441000968045,3.36932458140246e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,42249,-0.021180635960719,0.00304070059854522,-0.0271404091338676,-0.0152208627875703,3.41717785267383e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0317566087034977,0.00456673343057204,-0.0407074062274189,-0.0228058111795765,3.71704400584076e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.035420498371748,0.00509330551606522,0.0254376195602601,0.0454033771832358,3.73745234810028e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,41839,0.0262736271823952,0.00378016003334192,0.018864513517045,0.0336827408477454,3.81307617287363e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0258048759316582,0.00371946037153154,0.0185147336034564,0.03309501825986,4.16339635440445e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD302,CD302 antigen,42070,0.0230744896388855,0.003328909223103,0.0165498275616036,0.0295991517161674,4.35209242864081e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH5,Cadherin-5,42310,-0.0225046415609888,0.0032475795376826,-0.0288698974548467,-0.0161393856671309,4.40670884191934e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0362786419233423,0.00523575122920208,0.0260165695141062,0.0465407143325784,4.42943065630416e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSC2,Desmocollin-2,41984,-0.0260217891849604,0.00376126506326978,-0.0333938687089692,-0.0186497096609517,4.77670957094414e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCOR1,REST corepressor 1,41900,0.0329515005453404,0.0047715754879578,0.0235992125889431,0.0423037885017377,5.21923999154104e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0316684874478921,0.00460285676715103,0.022646888184276,0.0406900867115081,6.24491073700535e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42145,0.0450931182091528,0.00657238616747685,0.0322112413208982,0.0579749950974074,7.13523787137019e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0259087702373379,0.00378627310265741,0.0184876749561293,0.0333298655185464,8.10063582908988e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,39736,-0.0235081035847649,0.00344169120631566,-0.0302538183491436,-0.0167623888203862,8.90952858281443e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX6,Syntaxin-6,41843,0.0479016597238719,0.00701705106171417,0.0341482396429122,0.0616550798048317,9.08232704901464e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0271645478815377,0.00398128929656447,0.0193612208602713,0.034967874902804,9.30005031560213e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F3,Tissue factor,42174,-0.0190445709209708,0.00279405246629263,-0.0245209137549044,-0.0135682280870373,9.74877032789985e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2,Brorin,41973,0.0298412728471279,0.00438017535350862,0.021256129154251,0.0384264165400048,9.98103328880343e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0178460084928769,0.00262042784821716,-0.0229820470753826,-0.0127099699103713,1.01423222616918e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0171120420468634,0.00251441378337383,0.0121837910314507,0.0220402930622761,1.04883051031072e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCT,Secretin,39649,0.0350073292822975,0.00514825134009612,0.0249167566557091,0.0450979019088859,1.10132753894848e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA14,Carbonic anhydrase 14,42262,-0.0266625253715759,0.00392393924034569,-0.0343534462826534,-0.0189716044604983,1.12927478728465e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.045349835656686,0.00667357986894962,0.0322696191135447,0.0584300521998272,1.13548296703857e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0320034634493271,0.00471883730829054,0.0227545423250777,0.0412523845735766,1.24560104320349e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA9,Carbonic anhydrase 9,42262,-0.0338416924491606,0.00499174672573191,-0.0436255160315951,-0.024057868866726,1.25517997830979e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0406220244314625,0.00599669565343849,0.0288685009507231,0.052375547912202,1.31617202931386e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0294140815933017,0.0043450804189414,-0.0379304392144268,-0.0208977239721765,1.34566114460897e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDK,Midkine,42129,0.036990237328121,0.00547169111582866,0.0262657227410968,0.0477147519151452,1.43358427702459e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0456704516556906,0.00676571028361971,-0.0589312438115852,-0.0324096594997959,1.53491196995717e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMB,RGM domain family member B,42249,0.020227493607403,0.00299757314208694,0.0143522502489126,0.0261027369658934,1.55989687844172e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0477168679391923,0.00709809337813217,0.0338046049180532,0.0616291309603313,1.87178822570179e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSTB,Cystatin-B,41959,0.03116379186636,0.0046372875784908,0.022074708212518,0.0402528755202019,1.88753585409912e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,39757,0.0514284381967897,0.00765248021152408,0.0364295769822025,0.0664272994113769,1.89937765808067e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,39579,0.0400347588294055,0.00595826471176627,0.0283565599943436,0.0517129576644674,1.91773893709188e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0359939050348759,0.00535866483192793,0.0254909219642971,0.0464968881054546,1.93140340514158e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0293023671000614,0.00436777746503023,0.0207415232686021,0.0378632109315207,2.04277198247218e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0419756371116039,0.00626175489159609,0.0297025975240755,0.0542486766991322,2.13402149518917e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRSF1,G-rich sequence factor 1,39486,0.0596154152306263,0.00889486453065002,0.0421814807505523,0.0770493497107003,2.1541180078461e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX5,Sorting nexin-5,39638,0.0213442731764664,0.00318589217607842,0.0150999245113527,0.0275886218415801,2.19128127941484e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0187268658500521,0.00279628289637177,0.0132461513731635,0.0242075803269408,2.22719827603362e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0358995312740003,0.00536533039449424,0.0253834837007916,0.046415578847209,2.32068170278244e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0282184437471333,0.00422559745550354,0.0199362727343464,0.0365006147599202,2.53773528839257e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL20,C-C motif chemokine 20,42296,0.0617517732815288,0.00924961958362809,0.0436225188976177,0.0798810276654398,2.54762786680659e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0246720611317109,0.00369826430467661,-0.0319206591688771,-0.0174234630945448,2.63661637019265e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0455429405924954,0.00683024442041428,0.0321556615284834,0.0589302196565074,2.72000038046626e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA,Adenosine deaminase,42296,0.025296725721958,0.00379571811890851,0.0178571182088974,0.0327363332350187,2.75645479834709e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBS,Cystathionine beta-synthase,39638,0.0367677678737404,0.00553144168516386,0.0259261421708192,0.0476093935766615,3.13126072069766e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIT,Citron Rho-interacting kinase,39649,0.032499192414274,0.00489894399474001,0.0228972621845835,0.0421011226439644,3.42168618583723e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMBS,Porphobilinogen deaminase,42262,0.0284964727821869,0.00429843461117841,0.0200715409442772,0.0369214046200966,3.49473127494411e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0337342398371294,0.00510075593506267,-0.0437317214698522,-0.0237367582044066,3.8908563971717e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0267328111076943,0.00404132359948448,0.0188118168527047,0.0346538053626839,3.89089006192641e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARCO,Macrophage receptor MARCO,42145,0.0182408868490507,0.00276140967804909,0.0128285238800745,0.0236532498180269,4.10573945450443e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0368242970355468,0.00557521891249364,-0.0477517261040344,-0.0258968679670593,4.12375318344664e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GC,Vitamin D-binding protein,39979,0.0182173937994555,0.00276181118054659,0.0128042438855842,0.0236305437133268,4.40599497518512e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0285719577121943,0.00433565857511053,0.0200740669049776,0.0370698485194109,4.59352817237118e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP6,Gastrotropin,41881,0.0400000285702724,0.00607540536963918,0.0280922340457796,0.0519078230947652,4.75406949916674e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A12,Protein S100-A12,41910,0.0516631180663793,0.00785272055398226,0.036271785780574,0.0670544503521845,4.91308262729938e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM2,Myomesin-2,39575,-0.039175005286757,0.00595717284456683,-0.0508510640621079,-0.027498946511406,5.04868522275672e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH1,Neurexophilin-1,41839,0.0272911011921317,0.00415530019681306,0.0191467128063781,0.0354354895778854,5.29781894858937e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0770898603677679,0.0117381106092402,0.054083163573657,0.100096557161879,5.30344522842239e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0190096153990191,0.0028963999213604,-0.0246865592448854,-0.0133326715531527,5.49559060553818e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGT,Angiotensinogen,39990,0.015269257519298,0.00232653618979983,0.0107092465872903,0.0198292684513056,5.49930887103433e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42145,0.0199840072434544,0.00307028967604392,0.0139662394784083,0.0260017750085005,7.84027221569689e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,39966,0.0384326363874077,0.005906597141968,0.0268557059891504,0.0500095667856649,8.00318953577249e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COLEC12,Collectin-12,42123,0.0190145244951283,0.00292733031928777,0.0132769570693243,0.0247520919209324,8.56432712466635e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRELP,Prolargin,42123,0.016252626611016,0.00250338013797579,0.0113460015405835,0.0211592516814486,8.75028436049722e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR4,Complement factor H-related protein 4,39945,0.0506691278352923,0.00781964810389379,0.0353426175516605,0.0659956381189241,9.56989155644525e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,39638,0.0171102019685568,0.00264360504505345,0.011928736080252,0.0222916678568616,1.006149317439e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR2,Folate receptor beta,42249,-0.020092967949998,0.00310666853089156,-0.0261820382705454,-0.0140038976294505,1.02902731933642e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,39934,0.020127481827831,0.0031116428121645,0.0140286619159886,0.0262263017396734,1.03094830737408e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN8,Tetraspanin-8,39930,0.065954925920048,0.0101978295093493,0.0459671800817234,0.0859426717583726,1.03707532353527e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMD,Osteomodulin,42185,-0.0283768929359227,0.0043882898897371,-0.0369779411198074,-0.019775844752038,1.03727022210843e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42070,0.0401742372232855,0.00621680512523227,0.0279892991778302,0.0523591752687407,1.06742565802979e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0494671445561264,0.00765654969609615,0.0344603071517779,0.0644739819604748,1.08451492836016e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,42119,0.0306322386736461,0.00474675302394747,0.021328602746709,0.0399358746005831,1.13169249823575e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBI3_IL27,Interleukin-27,42247,-0.0211314233203453,0.0032746404515897,-0.0275497186054611,-0.0147131280352294,1.13321683104256e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPO,Erythropoietin,42119,0.0502978585202116,0.00779945742459136,0.0350109219680125,0.0655847950724107,1.16502128313306e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.032392925687727,0.00503607541524022,0.0225222178738562,0.0422636335015978,1.30986480177513e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0368486875543228,0.00573443484687803,0.0256091952544419,0.0480881798542038,1.35536371650159e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0270203318093441,0.00420734779146281,0.018773930138077,0.0352667334806112,1.39848389634721e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0230108607878637,0.00358462534557417,0.0159849951105383,0.030036726465189,1.41405447408773e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0226596011510626,0.00353288336789598,0.0157351497499865,0.0295840525521388,1.46569915695635e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNC,Tenascin,42217,-0.0331016652897563,0.00516195854066182,-0.0432191040294534,-0.0229842265500591,1.47763792165637e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST5,Cystatin-D,41846,0.0385011904094812,0.00601923146120425,0.0267034967455209,0.0502988840734415,1.64468794996397e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB2,Calretinin,41839,0.0201137814104771,0.00314814590877679,0.0139434154292746,0.0262841473916796,1.72463847765815e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP8,Caspase-8,42224,0.0417098302751421,0.00653149147375531,0.0289081069865817,0.0545115535637025,1.75854972013627e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOB,Apolipoprotein B-100,39990,0.0155503659934351,0.00243666008592829,0.0107745122250156,0.0203262197618545,1.81769921463458e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFAP1,Actin filament-associated protein 1,39736,0.0569887305605503,0.00894260915797465,0.03946121661092,0.0745162445101807,1.93041629296178e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN2,Nectin-2,42129,0.0210596046986706,0.00330559472209602,0.0145806390433625,0.0275385703539788,1.94009832633276e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,42123,0.0301708164653521,0.00474467154143546,0.0208712602441386,0.0394703726865656,2.09758323679627e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB8,Serpin B8,42296,0.0396338347344251,0.00624943113760486,0.0273849497047195,0.0518827197641306,2.33938076974274e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,39638,0.0295016113829372,0.00465476364747313,0.0203782746338899,0.0386249481319845,2.4193850573073e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.062397619527288,0.00984700918692064,0.0430974815209235,0.0816977575336524,2.43873003681331e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP2,Neuropilin-2,42137,-0.0190603784093895,0.00300858359299839,-0.0249572022516663,-0.0131635545671127,2.44324471371799e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0272185408749307,0.00429593493639271,0.018798508399601,0.0356385733502605,2.4493588847933e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300A,CMRF35-like molecule 8,39736,0.0207239921936414,0.00327111200093057,0.0143126126718174,0.0271353717154653,2.45768709769244e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTB,Lymphotoxin-beta,39919,0.0232918556890175,0.0036775203580524,0.0160839157872348,0.0304997955908002,2.48623496166815e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0544053174170365,0.00861387747537021,0.0375221175653109,0.0712885172687621,2.76812429934845e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS4,Thrombospondin-4,42189,0.0306632773691999,0.00485829578062876,0.0211410176391676,0.0401855370992323,2.84872001401434e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0203721797858308,0.00323439726429464,0.0140327611478133,0.0267115984238483,3.11748791737821e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0274822319593666,0.00436599416887262,-0.036039580530357,-0.0189248833883763,3.19524511295358e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0255030375423425,0.00406076015600274,-0.0334621274481079,-0.0175439476365771,3.5015516563502e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD248,Endosialin,39966,-0.0271362544786816,0.00432913181030148,-0.0356213528268726,-0.0186511561304907,3.78258076374844e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR2,Complement receptor type 2,42217,0.0312483525642202,0.00498748039561579,0.0214728909888132,0.0410238141396271,3.83166700851327e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0207142096753951,0.00331012651504151,0.0142263617059137,0.0272020576448765,4.04429011388844e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LXN,Latexin,41960,-0.0457389592756394,0.00734050275890007,-0.0601263446830835,-0.0313515738681953,4.77266627778859e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0252220807408162,0.00404814649414612,0.0172877136122898,0.0331564478693426,4.78662488038264e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0356534538621467,0.00573486038128737,0.0244131275148234,0.0468937802094699,5.24670309503107e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI2,Serpin I2,39930,0.0383542932643642,0.00617895122087283,0.0262435488714535,0.050465037657275,5.58048971559546e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A13,Protein S100-A13,39657,0.0235327857546268,0.00380658173120423,0.0160718855614665,0.0309936859477871,6.54723161689971e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL8,Interleukin-8,42035,0.0448293242695875,0.0072536996732544,0.0306120729100089,0.0590465756291661,6.58706730375747e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXN,Thioredoxin,39854,0.0282910583448481,0.00459411588343574,0.019286591213314,0.0372955254763821,7.61304531467557e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0300263984246637,0.00488165250480765,0.0204583595152407,0.0395944373340867,7.96645610796798e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,41987,0.0243498678687866,0.0039693080999896,0.016570023992807,0.0321297117447662,8.78139311750096e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42137,-0.0176788865079695,0.00288259417335027,-0.023328771087736,-0.012029001928203,8.8649585507109e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO1,Roundabout homolog 1,42144,0.0157048736071996,0.00256150081095282,0.0106843320177321,0.0207254151966671,8.96860200198943e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0344001938332314,0.00561551112579342,0.0233937920266763,0.0454065956397865,9.3230583715353e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0164921625171182,0.00269511591970162,0.011209735314503,0.0217745897197333,9.65921691199706e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS1,Nephrin,39657,0.0217719390308476,0.00355963863584993,0.0147950473045818,0.0287488307571135,9.89889233550105e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0442412825261081,0.00726487763364174,0.0300021223641703,0.0584804426880459,1.16158330686431e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XG,Glycoprotein Xg,42261,0.0225483333988573,0.00370358732456311,0.0152893022427136,0.029807364555001,1.17216046785588e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPF,Centromere protein F,39757,0.0350711965969622,0.00576348816976904,0.0237747597842149,0.0463676334097095,1.202661910322e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN3,Calsyntenin-3,39929,0.0196627178462946,0.00323441312530505,0.0133232681206967,0.0260021675718925,1.24654220189365e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD6,Programmed cell death protein 6,42145,-0.0457503310315487,0.00754389597316559,-0.0605363671389532,-0.0309642949241441,1.35845085691327e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0244087664909386,0.00402896369936175,0.0165119976401896,0.0323055353416876,1.41256901929118e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,39657,0.02677876620618,0.00442051795879108,0.0181145510069495,0.0354429814054105,1.42455388156199e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.018408976593247,0.00304652256517608,-0.0243801608209921,-0.0124377923655019,1.55609614384287e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UMOD,Uromodulin,42274,-0.034749383549178,0.00575517578924567,-0.0460295280960995,-0.0234692390022565,1.60141206347226e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0348013893205662,0.0057652801837734,0.0235014401603703,0.0461013384807621,1.62553774484862e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0453159180126192,0.00753248149816211,0.0305522542762215,0.060079581749017,1.84311309471516e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,42181,0.0176593724196174,0.002939811235604,0.0118973423978336,0.0234214024414012,1.93847688945314e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDM1,Nuclear protein MDM1,39649,0.0202112793313142,0.00336511452834838,0.0136156548557514,0.026806903806877,1.95997407418121e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,39736,0.0157841471805662,0.00263004542430227,0.0106292581489338,0.0209390362121987,2.01622550590483e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRN,Progranulin,42077,0.0161299271884775,0.00268934185496477,0.0108588171527466,0.0214010372242085,2.05226617028421e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0264392227125164,0.00440825304089587,0.0177990467523605,0.0350793986726723,2.05284120567645e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.031388420105809,0.00523355441699094,0.0211306534485068,0.0416461867631113,2.06613165910406e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.025709163578029,0.00429739960034377,0.0172862603613552,0.0341320667947028,2.25417106895474e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0287605645859221,0.00480948460402669,0.0193339747620298,0.0381871544098145,2.28831712226317e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,41955,0.022551506441844,0.00377428423269393,0.0151539093457639,0.0299491035379241,2.35886523088744e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX1,Heme oxygenase 1,42007,-0.0313829189796305,0.00527179639507467,-0.0417156399139768,-0.0210501980452841,2.69876630664288e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0175738007680403,0.00295365792522313,0.011784631234603,0.0233629703014776,2.75004266200101e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0163946767230561,0.00275598922133471,0.0109929378492401,0.0217964155968721,2.76947181077593e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL3,Myosin light chain 3,39638,-0.0499623516296273,0.00840576462384435,-0.0664376502923623,-0.0334870529668924,2.86874902181409e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3B,Protein FAM3B,42070,0.0223230820639964,0.00376264793892291,0.0149482921037075,0.0296978720242853,3.05097928006266e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA7,Carbonic anhydrase 7,39757,-0.0212843613036381,0.00358714813384922,-0.0283151716459825,-0.0142535509612936,3.05343695877097e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CABP2,Calcium-binding protein 2,39649,0.0415295314653003,0.0069998837512003,0.0278097593129477,0.0552493036176528,3.06576261198032e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0283720325885995,0.0047874860383468,0.0189885599534398,0.0377555052237592,3.18881942947495e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYZL2,Lysozyme-like protein 2,39560,0.0230408889850987,0.00388964036005719,0.0154171938793867,0.0306645840908108,3.24324110092593e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,39919,0.0366723424170685,0.00619801881232616,0.0245242255449092,0.0488204592892278,3.37800543817986e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,39897,0.0171035083475358,0.00289210040564622,0.0114349915524693,0.0227720251426024,3.43834322021381e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGCR6,Protein DGCR6,39586,0.0264820874032408,0.00447792221207213,0.0177053598675795,0.0352588149389022,3.44002939287675e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0362669287753979,0.00615069120752112,0.0242115740086565,0.0483222835421393,3.82406040908212e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0222011060348435,0.00376579681239402,0.0148201442825512,0.0295820677871358,3.82432918649117e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0176346659508756,0.00299139652268987,0.0117715287664035,0.0234978031353478,3.83201879435744e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0131030980111304,0.00222293430049509,0.00874614678216005,0.0174600492401008,3.84795588192117e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0154398041167163,0.00262072123632077,0.0103031904935276,0.020576417739905,3.93700182061363e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0163485100491506,0.00277875658821635,0.0109021471362465,0.0217948729620546,4.1147675556935e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1A,Lithostathine-1-alpha,42105,-0.0313157321695104,0.0053329290750853,-0.0417682731566776,-0.0208631911823432,4.40304301034664e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.02338739913489,0.00399890795412531,0.0155495395448044,0.0312252587249756,5.1023598660929e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LUZP2,Leucine zipper protein 2,39919,0.0281008894233411,0.00480553206807191,0.0186820465699201,0.037519732276762,5.12461457410047e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR15L,Protein GPR15L,39930,0.0389621854278554,0.00666865352229959,0.0258916245241482,0.0520327463315626,5.28108095359993e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,39575,0.0217660125283361,0.00372850617712543,0.0144581404211703,0.029073884635502,5.44157315754464e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL34,Interleukin-34,41814,0.0227721862318447,0.00391197862283714,0.015104708131084,0.0304396643326055,5.98035902191859e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH3,Cadherin-3,42249,0.0229034017817241,0.00393988688978599,0.0151812234777435,0.0306255800857046,6.26547422649462e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB37,Ras-related protein Rab-37,41913,0.0504955110372286,0.008689069978136,0.033464933880082,0.0675260881943752,6.33772825719232e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0331936436363194,0.00573439501986231,0.0219542293973892,0.0444330578752495,7.25698118384331e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0172496123693958,0.00298233879408337,0.0114042283329924,0.0230949964057992,7.4585834613598e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0203225190577041,0.0035216703935655,-0.0272249930290925,-0.0134200450863157,8.06684452550808e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML1,Trem-like transcript 1 protein,39990,0.0326885247631727,0.00566556794168978,0.0215840115974607,0.0437930379288846,8.14903302234261e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42057,0.0291895783022313,0.00506537474364327,0.0192614438046905,0.0391177127997721,8.46572587327972e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.022649800050819,0.00393747370794581,0.0149323515832452,0.0303672485183928,8.98823775762361e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,39966,0.0241971146581056,0.00421166967326326,0.0159422420985096,0.0324519872177016,9.41392525509622e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBD,Thrombomodulin,42145,0.0181451459051,0.00316000516542192,0.011951535780873,0.0243387560293269,9.5502047269102e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.032787575229527,0.00571210356511935,0.021591852241893,0.0439832982171609,9.67067977231683e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0312186480497025,0.00544569550368965,0.0205450848624708,0.0418922112369342,1.00979271217353e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB2A2,Mammaglobin-A,39575,-0.0190201859513477,0.00332968969154552,-0.0255463777467769,-0.0124939941559185,1.1435789070543e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,41932,0.02518292884943,0.00441004150184789,0.0165392475058081,0.0338266101930518,1.15142292848479e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALY,RNA-binding protein Raly,39919,0.0292840190597403,0.00514468482359233,0.0192004368054993,0.0393676013139813,1.28611589362169e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,41920,0.0174811084331072,0.00307239112227634,0.0114592218334455,0.0235029950327688,1.29911472661226e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0195264275960745,0.00343734855239158,-0.026263630758762,-0.012789224433387,1.36933622161552e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0308612590798798,0.00543371950712944,0.0202111688459061,0.0415113493138535,1.37778296546001e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0410093014782577,0.00723349079732458,0.0268316595155015,0.0551869434410138,1.46231272475786e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0592215352725654,0.0104445146825197,0.0387502864948268,0.0796927840503039,1.46311200814575e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0396688496544971,0.00699619601323085,0.0259563054685646,0.0533813938404295,1.46352997918077e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSG,Basigin,42284,0.0126543507293796,0.00223376136681113,0.00827617845042974,0.0170325230083294,1.49949951665825e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,39979,0.0111118765921721,0.00196404606872866,0.00726234629746395,0.0149614068868803,1.57168509340709e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.036374020991124,0.00643824478452669,0.0237550612134517,0.0489929807687963,1.63948731700063e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0188490662947914,0.00333608467330076,-0.0253877922544609,-0.0123103403351219,1.64395947090627e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK4,Dickkopf-related protein 4,41992,0.027876264249467,0.00493709743284723,0.0181995532810865,0.0375529752178476,1.6728265455723e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNU13,NHP2-like protein 1,39575,0.0379980452979419,0.00674631078045099,0.024775276168258,0.0512208144276258,1.82072023932547e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0231712955241728,0.00412409316076041,0.0150880729290824,0.0312545181192632,1.97294308433322e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.022537848490705,0.00402196506670208,0.0146547969599689,0.030420900021441,2.14895109283117e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,39919,0.0173966128420622,0.00310457642437567,0.0113116430502858,0.0234815826338385,2.14928384976301e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFIC,Nuclear factor 1 C-type,39934,0.0273681855533933,0.00489025178591037,0.0177832920530089,0.0369530790537776,2.23831024863356e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA7A,Semaphorin-7A,42272,0.0170539161002137,0.00305524495107217,0.0110656359961122,0.0230421962043151,2.42502685675794e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAP,Prosaposin,39886,0.017033415688109,0.00305242753291796,0.0110506577235898,0.0230161736526282,2.45662540287131e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0139759547439957,0.002506341827799,-0.0188883847264817,-0.00906352476150965,2.50467086144483e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC16,Mucin-16,42070,0.11370926874175,0.0204222044662494,0.0736817479879014,0.153736789495599,2.62723745502542e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPB2,Coatomer subunit beta',39575,0.0255922163036301,0.00460185089544128,0.0165725885485652,0.034611844058695,2.74059621311496e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,41843,0.0317303152621631,0.00570876257572961,0.020541140613733,0.0429194899105931,2.77873904393712e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42230,-0.0132759658851363,0.00239309236967751,-0.0179664269297043,-0.00858550484056842,2.94980604306317e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX2,Sorting nexin-2,39919,0.0506611998620214,0.00913584371964866,0.03275494617151,0.0685674535525328,2.99995392128638e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC2,Stanniocalcin-2,42113,0.0141810574519989,0.00256825988752264,0.00914726807245449,0.0192148468315432,3.42008604717449e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CX3CL1,Fractalkine,42016,-0.0197230576899178,0.00357683870821548,-0.0267336615580201,-0.0127124538218155,3.57043858145984e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0139490080684615,0.00253470684661154,0.00898098264910289,0.0189170334878201,3.79675133224557e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.024526841520839,0.00445814458537928,0.0157888781334956,0.0332648049081824,3.84580632567004e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REN,Renin,42145,-0.0476439275403593,0.00867835164065113,-0.0646534967560356,-0.0306343583246831,4.09227475440977e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN3,CCN family member 3,42299,0.0198877723136785,0.0036341514526926,0.012764835466401,0.027010709160956,4.51614056764776e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR3,Small proline-rich protein 3,39929,0.0368136600498605,0.00673746106775658,0.0236082363570576,0.0500190837426634,4.75302747042027e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0211376283667171,0.00386872683123948,0.0135549237774877,0.0287203329559465,4.7644921574109e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMPD3,AMP deaminase 3,39929,0.040178413800067,0.00736721930089676,0.0257386639703094,0.0546181636298247,5.03756012755347e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0228209039800772,0.00420342985528389,0.0145821814637207,0.0310596264964336,5.7832450162959e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0196548715662649,0.00362536587697757,0.0125491544473888,0.0267605886851409,6.01183988101054e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF4,Neurotrophin-4,41843,0.0218264397488662,0.00405392435099353,0.0138807480209189,0.0297721314768136,7.40801802636508e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0270641461577229,0.00503193063174541,0.0172015621195019,0.0369267301959439,7.6395418584895e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,39638,0.0231175725673764,0.00430370385328018,0.0146823130149473,0.0315528321198056,7.96472670048132e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,39958,0.0196582737900123,0.00366364446121064,0.0124775306460394,0.0268390169339852,8.2188814870689e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENSA,Alpha-endosulfine,39919,0.0303899864650983,0.00566880271688654,0.0192791331400007,0.0415008397901959,8.44273882118946e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM2,Junctional adhesion molecule B,42249,0.0156581942386408,0.0029228512013684,0.00992940588395871,0.0213869825933228,8.59103867696709e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,41814,0.0308617335802823,0.00576527357635098,0.0195617973706344,0.0421616697899302,8.79352728483432e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAST,Gastrin,39929,0.0748577556901745,0.0139967432847825,0.0474241388520009,0.102291372528348,9.0548156162966e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SATB1,DNA-binding protein SATB1,39934,0.0167285963039283,0.00312979017029465,0.0105942075701508,0.0228629850377058,9.21926031017207e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH1,Cadherin-1,41697,0.0229386708406618,0.0042970707353273,0.0145164121994203,0.0313609294819034,9.54345662922202e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0372118272253379,0.00697481385008308,0.0235411920791751,0.0508824623715008,9.72953881691903e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0218599339861292,0.00409971773645677,0.0138244872226739,0.0298953807495844,9.89765321515845e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1B,Interleukin-1 beta,41825,0.0321872337993789,0.00603771795620636,0.0203533066052144,0.0440211609935433,9.92646037413384e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,39795,-0.00465088989180907,0.000875489547119406,-0.00636684940416311,-0.00293493037945504,1.10307745879759e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAP,Cartilage-associated protein,39649,0.0280098744331791,0.00527855592106899,0.0176639048278839,0.0383558440384743,1.14005001813155e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0230484327742049,0.00435229891153687,0.0145179269075926,0.0315789386408171,1.20438771805731e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE3,Eosinophil cationic protein,42081,0.0616687785427587,0.0116455809496701,0.0388434398814054,0.0844941172041121,1.20578127711481e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGA,Fibrinogen alpha chain,39735,0.0176358086409071,0.00333017404228479,0.0111086675180289,0.0241629497637853,1.20778907321819e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0251424832922113,0.0047702855979842,-0.0344922430642604,-0.0157927235201623,1.38028581826633e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0269727385882742,0.00512201517621055,0.0169335888429015,0.0370118883336469,1.42033495795049e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0267575191041316,0.00508448765764718,-0.0367231149131201,-0.0167919232951431,1.4421858785016e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSH,Pro-cathepsin H,41865,0.0419794010317223,0.00798575908557392,0.0263273132239974,0.0576314888394472,1.48872006119423e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0243332761255422,0.00463253204887496,0.0152535133097473,0.0334130389413371,1.52160508603926e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST1,Cystatin-SN,38503,0.0599499756068652,0.011413294482544,0.0375799184210789,0.0823200327926515,1.53044365936784e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",39757,0.0264916617767739,0.00504562734027142,0.016602232189842,0.0363810913637059,1.54542733970757e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP13,Collagenase 3,41839,-0.0181251827578858,0.00345600776713918,-0.0248989579814786,-0.011351407534293,1.59083633490671e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM,Paralemmin-1,39859,0.0171686538461061,0.00327441543411727,0.0107507995952363,0.023586508096976,1.60611301997819e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0440845519682842,0.00840867406647202,0.027603550797999,0.0605655531385693,1.60636724708705e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK3,NT-3 growth factor receptor,42249,-0.0118973406713879,0.00226970788967966,-0.01634596813516,-0.00744871320761574,1.61394228369134e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0243062090807227,0.00464040971858236,0.0152110060323013,0.0334014121291441,1.64850326569285e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0287645388432771,0.00549237484245637,0.0179994841520626,0.0395295935344916,1.65549028861328e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0474689783684163,0.0091063624508923,0.0296205079646674,0.0653174487721652,1.88884871964675e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR1,Complement receptor type 1,39970,0.0197667664173834,0.00379398009696538,0.0123305654273313,0.0272029674074356,1.92110206134695e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,39638,0.018257303362982,0.0035105988381164,0.0113765296402739,0.0251380770856901,2.02177365108744e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL,Podocalyxin,42070,0.00840971106529386,0.00161926682329281,0.00523594809163995,0.0115834740389478,2.09351157923244e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,39934,0.0199875484184183,0.00384921679728035,0.0124430834957488,0.0275320133410878,2.10940380517822e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD1,Polycystin-1,39958,0.0150514585236572,0.00290987417500373,0.00934810514064992,0.0207548119066646,2.34859147067893e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0153098463677502,0.00296373957764337,0.00950091679556916,0.0211187759399312,2.43693834186036e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0273489150932722,0.00530284482461602,-0.0377424909495196,-0.0169553392370248,2.54618533845385e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0318345775248165,0.00618757522966606,0.019706930074671,0.043962224974962,2.71379755378465e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300C,CMRF35-like molecule 6,42249,0.0193950715124461,0.00376979401697689,0.0120062752391714,0.0267838677857208,2.71429276278252e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC2,Mucin-2,39966,0.0510412829168092,0.00992339509827799,0.0315914285241843,0.070491137309434,2.74113478534493e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSF,Cathepsin F,42181,0.0221664204980034,0.0043130520633292,0.0137128384538782,0.0306200025421287,2.79469684651733e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0150667085937998,0.00293273996563694,0.00931853826115138,0.0208148789264482,2.82400258789416e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIM,Vimentin,41900,0.0630902019634213,0.0122865713748053,0.039008522068803,0.0871718818580396,2.86295707093367e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0299680604953614,0.00584687440321092,0.018508186665068,0.0414279343256548,3.01790702090184e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0367640035470658,0.00719529067849644,0.0226612338172128,0.0508667732769189,3.28530814825504e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0169878380165315,0.0033284349612494,0.0104641054924826,0.0235115705405803,3.38338713195484e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVALB,Parvalbumin alpha,42208,0.0608914368776649,0.0119513230403384,0.0374668437186016,0.0843160300367281,3.53497962720752e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL3,Fc receptor-like protein 3,41913,0.0291601366755366,0.00573122852807412,0.0179269287605114,0.0403933445905619,3.66906273844899e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0150976371995121,0.0029753291624573,0.0092659920410958,0.0209292823579284,3.94248120608249e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,39649,-0.017107703920595,0.00337149066960274,-0.0237158256330164,-0.0104995822081736,3.9540158700004e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MET,Hepatocyte growth factor receptor,42158,-0.0104084316231672,0.0020520106160755,-0.0144303724306752,-0.00638649081565925,3.98209911499758e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNLY,Granulysin,42137,0.0292323339001552,0.00577495708996922,0.0179134180038155,0.0405512497964948,4.20517498182969e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTP1,Glutathione S-transferase P,41759,-0.0377850921110543,0.00748623130301587,-0.0524581054649654,-0.0231120787571432,4.54133410635047e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN2,Transcobalamin-2,42286,-0.0163212896936352,0.00323739705705761,-0.0226665879254681,-0.00997599146180225,4.67836137852722e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0286926329698147,0.00569548579387989,0.0175294808138101,0.0398557851258193,4.77018326045265e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0273633238131409,0.00543747960203962,0.0167058637931432,0.0380207838331385,4.92170075872192e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPG,Macrophage-capping protein,42015,0.0315536409010993,0.00629826342759147,0.01920904458302,0.0438982372191785,5.51526888541103e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0203863877466149,0.00407072587087818,0.0124077650396937,0.0283650104535362,5.58337004628947e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0277943004732014,0.00555598949101201,0.0169045610708179,0.038684039875585,5.72922715995316e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX3,Syntaxin-3,39929,0.0203938827925839,0.00407854001242271,0.0123999443682354,0.0283878212169324,5.81011851026492e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0168392861323148,0.00336798085433618,0.0102380436578159,0.0234405286068137,5.82665193717051e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0184578073151271,0.00369813077527627,0.0112094709955856,0.0257061436346686,6.07860802350153e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42310,-0.0144560020908825,0.00289718123507155,-0.0201344773116227,-0.00877752687014224,6.12212720605906e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCA2A,Guanylin,42083,-0.0187697212414427,0.00376819283243314,-0.0261553791930116,-0.0113840632898737,6.4008789238619e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0125689289348508,0.00252700574092998,-0.0175218601870736,-0.00761599768262808,6.66268225193448e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D17,TBC1 domain family member 17,41839,0.0229249972041831,0.00461261733238808,0.0138842672327025,0.0319657271756637,6.77681174705069e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL25,C-C motif chemokine 25,42296,0.0261093814518517,0.00525424539553095,0.015811060476611,0.0364077024270923,6.80425367390186e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0389783066852091,0.00787008805342032,0.0235529341005052,0.0544036792699129,7.40671927007229e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZU1,Azurocidin,41751,0.0399076617914299,0.0080592797867091,0.0241114734094801,0.0557038501733797,7.44558501478645e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASET2,Ribonuclease T2,42258,0.0141934665085407,0.0028686772157782,0.00857085916561543,0.019816073851466,7.59745137734694e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.021956731255276,0.00444053853634249,-0.0306601867865073,-0.0132532757240447,7.72025162520727e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0101120888869574,0.00205753245774773,-0.0141448525041429,-0.00607932526977183,8.99670628531873e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC1,Syndecan-1,42145,0.0212638884525464,0.00432924355377127,0.0127785710871547,0.0297492058179381,9.13502090352364e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPQ,Carboxypeptidase Q,39960,0.0196737574214548,0.0040055087958546,0.0118229601815797,0.0275245546613298,9.15595635602656e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0166246371109936,0.00338624393332016,0.00998759900168606,0.0232616752203011,9.26336671048177e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0181588830401531,0.00370449075006593,0.0108980811700239,0.0254196849102824,9.62520831734533e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.017935089750603,0.00366763405698293,0.0107465269989164,0.0251236525022895,1.0216629029079e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC3,Membrane primary amine oxidase,42217,-0.0154659009090485,0.00317231737997121,-0.021683642973792,-0.00924815884430489,1.09886041619773e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD209,CD209 antigen,42171,-0.0203365507254059,0.00417251109565766,-0.0285146724728949,-0.0121584289779169,1.10633633449516e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,39657,0.0153020925971832,0.00315906592138077,0.00911032339127687,0.0214938618030895,1.29063886353104e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSM,Oncostatin-M,42051,0.0357025250722481,0.0073921556317888,0.0212139000339421,0.0501911501105542,1.38185769851069e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0205252322606274,0.00425669376342252,0.0121821124843193,0.0288683520369356,1.43765467792595e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICOSLG,ICOS ligand,42070,0.0098616308673133,0.00204607520227131,0.00585132347086154,0.0138719382637651,1.45285247050722e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0290958434132457,0.0060542539242535,0.0172295057217089,0.0409621811047826,1.55757133990749e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99,CD99 antigen,42137,-0.0102387017315834,0.00213354589013627,-0.0144204516762504,-0.00605695178691628,1.61232029230063e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSV,Cathepsin L2,42200,0.0205484048877661,0.00428551618730099,0.0121487931606562,0.0289480166148761,1.64521404897902e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,42310,-0.0129916541975377,0.00271411376421161,-0.0183113171753924,-0.00767199121968291,1.71313846160477e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAM,Signal transducing adapter molecule 1,39919,0.018496991676157,0.00386905291972691,0.0109136479534923,0.0260803353988218,1.76837871141056e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK3,Dickkopf-related protein 3,42310,-0.0150629402170777,0.00315468238089328,-0.0212461176836285,-0.00887976275052688,1.81756246361408e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00936643616637997,0.00196427721349464,0.00551645282793048,0.0132164195048295,1.88008792426418e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0226461890041206,0.00478979652060546,-0.0320341901845073,-0.0132581878237339,2.29020491484831e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS53,Serine protease 53,39929,0.0193111428778748,0.00408547995168651,0.0113036021725692,0.0273186835831804,2.3086118521093e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0192849041591044,0.00408356865750398,0.0112811095903966,0.0272886987278122,2.35228959825673e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA12,Carbonic anhydrase 12,42070,-0.0164622541912207,0.00350270515555936,-0.0233275562961171,-0.00959695208632437,2.62906134240627e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0152304430343355,0.00324855258725075,0.00886327996332408,0.021597606105347,2.7804879871288e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN4,Contactin-4,42137,-0.0117932214526337,0.00251601451742099,-0.0167246099067788,-0.00686183299848852,2.79582665799728e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB1A1,Uteroglobin,42165,0.0268709129945789,0.00573370276303099,0.0156328555790381,0.0381089704101196,2.80639322247345e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP12,Macrophage metalloelastase,42146,0.0274013236392263,0.00584862627191944,0.0159380161462642,0.0388646311321884,2.82562461057822e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0198844255784327,0.00424983976086833,0.0115547396471308,0.0282141115097346,2.91228071951679e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3,Galectin-3,42196,0.0148047241611839,0.00317005665163959,0.00859141312397029,0.0210180351983975,3.03821415060454e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG3,Desmoglein-3,42196,0.0175192264797218,0.00375928850500977,0.0101510210099026,0.0248874319495409,3.18822819373554e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD27,CD27 antigen,42181,-0.0212660582225296,0.00457042134677276,-0.0302240840622043,-0.012308032382855,3.30270006741858e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNG,Interferon gamma,41913,0.0567867563154245,0.0122239257188767,0.0328278619064261,0.0807456507244229,3.42434145074256e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK4,Kallikrein-4,42262,-0.0309553339001368,0.00669814151107364,-0.0440836912618411,-0.0178269765384324,3.84495706889842e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAN,Neurocan core protein,42249,0.0184870857128424,0.00400983816512514,0.0106278029091971,0.0263463685164877,4.05479083045682e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A11,Protein S100-A11,42027,0.0227869413853511,0.00495220797806864,0.0130806137483366,0.0324932690223656,4.23563087511249e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0132654149816886,0.00288833054734585,0.00760428710889075,0.0189265428544865,4.41350961282228e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0219500370440898,0.00478111375327848,0.0125790540876639,0.0313210200005156,4.46017216905917e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0576560099908354,0.0125854958315872,0.0329884381609245,0.0823235818207464,4.66613945355616e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD1,Bromodomain-containing protein 1,39757,-0.0148910191253686,0.00325465926744556,-0.0212701512895619,-0.00851188696117533,4.80683568073513e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,41802,0.0142483559160561,0.00311635055212028,0.00814030883390035,0.0203564029982119,4.87180279252748e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0307597058823158,0.00674506791405476,0.0175393727707685,0.0439800389938631,5.161833312666e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,39638,0.0305904642285365,0.00672896417052737,0.0174016944543029,0.0437792340027701,5.52334956217602e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMS1,PMS1 protein homolog 1,39649,0.0239014989101886,0.00529110881540328,0.0135309256319982,0.0342720721883791,6.32841646119157e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR1,Cadherin-related family member 1,41839,0.0200101275276452,0.00443106880392357,0.011325232671955,0.0286950223833354,6.36022712854367e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,39929,0.0186605439267759,0.00413710486169665,0.0105518183978505,0.0267692694557014,6.53154259727679e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEO1,Neogenin,39934,0.0108715153731701,0.00241628467771948,0.00613559740483993,0.0156074333415003,6.88661907987092e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,39649,0.03181428660781,0.00707634162602326,0.0179446570208045,0.0456839161948156,6.9992727669864e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,39736,0.0252403040644411,0.00561527131575222,0.0142343722855668,0.0362462358433155,7.0292239283065e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0272911826527704,0.00609247031819416,0.0153499408291098,0.0392324244764309,7.54466633517769e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSB,Cathepsin B,42153,-0.024313309967162,0.00543238877798441,-0.0349607919720115,-0.0136658279623126,7.6810896632039e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,41814,0.0349259127937248,0.00782747306736175,0.0195840655816957,0.0502677600057538,8.18826060959545e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0141052550992003,0.00316955959050961,0.0078929183018015,0.0203175918965992,8.66268642656264e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRUNE2,Protein prune homolog 2,39757,0.0137374846196497,0.00308928955207186,0.00768247709758884,0.0197924921417105,8.79972878924242e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0167108217647314,0.00376248416269774,0.00933635280584388,0.024085290723619,9.02092581399766e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0129307171009311,0.0029132370641642,0.00722077245516929,0.0186406617466929,9.12559091759092e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0113830942693929,0.00256679754321133,0.00635217108469869,0.0164140174540871,9.2903479267216e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0492032914693519,0.011129528822934,0.0273894149764014,0.0710171679623025,9.91743672113033e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOSB,Protein fosB,41839,0.018208776106407,0.00412104589065106,0.0101315261607309,0.0262860260520831,1.00185273896326e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH12,Protocadherin-12,39934,0.0120475707096483,0.00272736019226299,0.00670194473281279,0.0173931966864837,1.0086808023708e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROCR,Endothelial protein C receptor,39575,-0.0163572839927005,0.00370588796251079,-0.0236208243992217,-0.00909374358617939,1.02511855214779e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCC,Netrin receptor DCC,39649,0.0105617792181514,0.00239314033899145,0.00587122415372818,0.0152523342825747,1.0274585879609e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,39929,0.113622192980412,0.0258112199968738,0.0630322017865397,0.164212184174285,1.08216539625178e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRH,Corticoliberin,41830,0.0404133197378597,0.00918195760177886,0.0224166828383731,0.0584099566373463,1.08405234553785e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0141403703478865,0.00323547110530387,0.0077988469814909,0.0204818937142821,1.24952147798272e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF5,Fibroblast growth factor 5,41913,-0.0159430582537964,0.00364975511531106,-0.0230965782798061,-0.00878953822778676,1.26190790929971e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,41839,0.040026886726487,0.00920108599719656,0.0219927581719818,0.0580610152809923,1.37009642563927e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MILR1,Allergin-1,41913,-0.0237439113497501,0.00547567721550791,-0.0344762386921456,-0.0130115840073546,1.45999003938088e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYGD,Gamma-crystallin D,39929,0.0453935896728155,0.0104887382617085,0.0248356626798668,0.0659515166657642,1.51870239492952e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAFB2,Scaffold attachment factor B2,39934,0.0126094942472267,0.00291472065966696,0.00689664175427947,0.018322346740174,1.53043395398485e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0330229812049774,0.00764150481832277,0.0180456317610647,0.04800033064889,1.56309108903674e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGN,Secretagogin,41913,-0.0205173499113767,0.00475555729049044,-0.029838242200738,-0.0111964576220155,1.61195174753595e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,41997,0.0151377352604594,0.0035102516811196,0.00825764196546496,0.0220178285554538,1.62620861753772e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF16,Fibroblast growth factor 16,39657,0.0214320910823294,0.00497493180211895,0.0116812247501763,0.0311829574144826,1.66147742611075e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLVRB,Flavin reductase,42137,0.0293780172133825,0.006821282701228,0.0160083031189757,0.0427477313077894,1.66787161545762e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLASP1,CLIP-associating protein 1,39560,0.0345516573010911,0.00804222335650006,0.018788899522351,0.0503144150798312,1.75184912801325e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN1,Nectin-1,39657,0.0151194854984061,0.00353063885801217,0.00819943333670225,0.0220395376601099,1.86478467109236e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECM1,Extracellular matrix protein 1,39720,0.0166752909453582,0.00390513859231832,0.0090212193044143,0.0243293625863021,1.97017245842697e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTG,Protogenin,42262,0.0112117746565534,0.00262922174679118,0.00605850003284267,0.0163650492802641,2.01882887539896e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHCY,Adenosylhomocysteinase,42145,0.0306256231908077,0.007194034965804,0.0165253146578319,0.0447259317237835,2.08503872134179e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,42249,0.0132923418226717,0.0031284035605519,0.00716067084398993,0.0194240128013534,2.16227109644077e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0138802435760956,0.00327078033762242,0.00746951411435562,0.0202909730378355,2.21307249941921e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,39990,0.0119661889926601,0.0028209142886642,0.00643719698687823,0.0174951809984419,2.2333354107548e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0255154145939283,0.00603264350477509,0.0136914333245691,0.0373393958632875,2.35991133840068e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0151510023437636,0.0035859913544194,0.00812245928910162,0.0221795453984257,2.40434641080607e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOBR,Apolipoprotein B receptor,39638,-0.0193095633755354,0.00459774263065352,-0.0283211389316163,-0.0102979878194545,2.69257962911254e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0165383446523704,0.00394657588688005,0.00880305591408554,0.0242736333906553,2.80068204589143e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WIF1,Wnt inhibitory factor 1,42262,-0.0150763789300542,0.00360152040018744,-0.0221353589144216,-0.0080173989456868,2.85546553549624e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSR,Insulin receptor,39657,0.00765923002666288,0.00183353640229093,0.00406549867817267,0.0112529613751531,2.9725647379758e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX2,Peroxiredoxin-2,39819,0.026925880535731,0.00646343887183362,0.0142575403469372,0.0395942207245249,3.12483309213348e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD59,CD59 glycoprotein,41638,0.0105133861233223,0.00252710723764634,0.0055602559375355,0.0154665163091091,3.19943541290307e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0235720486612069,0.00567519923411562,-0.0346954391600735,-0.0124486581623403,3.29409657154234e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERC2,ERC protein 2,39649,0.0327647653122393,0.00789318492710768,0.0172941228551083,0.0482354077693703,3.33480833811998e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0191325111777893,0.00463079641941593,-0.0282088721598445,-0.010056150195734,3.62446436266506e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,41900,0.0228889824239665,0.00554738666678808,0.0120161045570619,0.0337618602908712,3.71239540631226e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,39934,-0.0344834972408366,0.00837772941390574,-0.0509038468920919,-0.0180631475895814,3.88081167341262e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,42181,0.0150817955456307,0.00366671058725248,0.00789504279461587,0.0222685482966456,3.92566059268026e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDI2,Protein DDI1 homolog 2,39736,0.0329820151309603,0.00802130179510043,0.0172602636125635,0.0487037666493572,3.95399346979377e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0361353569714791,0.00879184461332859,0.018903341529355,0.0533673724136031,3.98345915101038e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2,Ataxin-2,39586,0.0465661321783603,0.0113455061114432,0.0243289401999316,0.0688033241567889,4.08352094639267e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0221615139326446,0.00540022732307697,0.0115770683794137,0.0327459594858754,4.09245567505772e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0227892466287401,0.00556370526085128,0.0118843843174715,0.0336941089400086,4.23174204772897e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0333349199208949,0.00814359647433316,0.0173734708312019,0.0492963690105878,4.28159802753485e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM25,Transmembrane protein 25,39934,-0.0205172497022785,0.0050133893771149,-0.0303434928814237,-0.0106910065231333,4.29721194887481e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,39757,0.0195240700651309,0.00477301652680486,0.0101689576725934,0.0288791824576684,4.3345050871641e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP9,Fatty acid-binding protein 9,42119,0.0246459934235715,0.00603453478294903,0.0128183052489914,0.0364736815981516,4.44918087935616e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTPN,Myotrophin,41900,0.0141760130622673,0.00347760962299965,0.00735989820118803,0.0209921279233467,4.60107833665855e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWF,von Willebrand factor,42310,-0.0322470756278839,0.00792513794925337,-0.0477803460084205,-0.0167138052473473,4.74878058484888e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL2,Fc receptor-like protein 2,42229,0.0217821719400831,0.00535748006535831,0.0112815110119808,0.0322828328681854,4.81473124767075e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42119,0.0268833171121886,0.00662568030859196,0.0138969837073484,0.0398696505170289,4.98918342688995e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0832904702717007,0.0205498675816396,0.043012729811687,0.123568210731714,5.08290814457159e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0135667558813756,0.0033517398426495,-0.0201361659729686,-0.0069973457897826,5.20837424307353e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPS,Colipase,42115,0.0319248762108219,0.0078971954772152,0.0164463730754801,0.0474033793461637,5.31641656686072e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0377049901928709,0.00934180496396832,0.019395052463493,0.0560149279222488,5.47027492943822e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN2,Calsyntenin-2,42296,-0.0172195653615297,0.00428457731081197,-0.0256173368907212,-0.00882179383233826,5.87671304352539e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD55,Complement decay-accelerating factor,41714,0.0112907128060049,0.00282036766929976,0.0057627921741774,0.0168186334378325,6.2815040679164e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDS,Iduronate 2-sulfatase,42296,0.00392806394401675,0.000984409291342921,0.00199862173298462,0.00585750615504887,6.63402958446079e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPO,Myeloperoxidase,42137,0.0191877873809838,0.00481622949697738,0.00974797756690809,0.0286275971950594,6.81239356534598e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0152767997380632,0.00383735556638151,-0.022798016648171,-0.00775558282795547,6.90434312328689e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0382467246374879,0.0096151437435338,0.0194010429001617,0.0570924063748142,6.99291768701892e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0207792373312728,0.00522596060298197,-0.0310221201131175,-0.0105363545494282,7.04009530314848e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN8,Septin-8,39906,0.0138391340486502,0.00349042934786131,0.00699789252684207,0.0206803755704584,7.3885075324484e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0159134423116415,0.00401638576070929,0.00804132622065128,0.0237855584026317,7.47524103727431e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0141900226316647,0.00358409134894343,0.0071652035877356,0.0212148416755938,7.5670800788942e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ULBP2,UL16-binding protein 2,42016,0.0166827892668502,0.0042157152327967,0.00841998741056869,0.0249455911231318,7.61967229495983e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0106480531188449,0.00269141201139236,-0.0159232206611739,-0.00537288557651587,7.6500493098606e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA4,Carboxypeptidase A4,39518,0.0185882197582745,0.00471058306347428,0.00935547695386488,0.027820962562684,7.99470426422973e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00935597234291176,0.00237515696228802,0.00470066469682724,0.0140112799889963,8.21996589629938e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACHE,Acetylcholinesterase,39736,0.0143750271645319,0.00366807427857551,0.00718560157852389,0.0215644527505399,8.94648661711895e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCP1,Plastin-2,39966,0.0200812864378068,0.00512631817008249,0.0100337028244451,0.0301288700511685,9.00732106311484e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0178601642332014,0.0045627616502487,0.00891715139871398,0.0268031770676889,9.11063091329379e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP4,Guanylate-binding protein 4,41839,0.0205676638845031,0.00525466186148769,0.0102685266359872,0.0308668011330189,9.11682457861883e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,42275,-0.0161439653636128,0.0041307589476173,-0.0242402529009427,-0.00804767782628288,9.34220291139407e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAM,Basal cell adhesion molecule,42137,-0.0102680671593535,0.002628613592327,-0.0154201498003145,-0.00511598451839262,9.41883727672288e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPJ,Centromere protein J,39757,0.0293606112780045,0.00751836769844711,0.0146246105890481,0.0440966119669608,9.47084110452183e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG3,Proteoglycan 3,39966,-0.0207879572200908,0.00532531510989349,-0.031225574835482,-0.0103503396046996,9.53154559264853e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0144233830910594,0.00370015703517215,0.00717107530212193,0.0216756908799968,9.74400670235862e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,39930,0.0222315868692587,0.00571186823364587,0.0110363251313128,0.0334268486072046,9.99190430259527e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0218071842618683,0.00562270553088926,0.0107866814213253,0.0328276871024112,0.0001057322564355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1,Methionine aminopeptidase 1,41839,0.0120637623108448,0.00311131587135402,0.0059655832029909,0.0181619414186987,0.000106096387624372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42185,0.0120114080253181,0.00309938198470548,0.00593661933529537,0.0180861967153409,0.000106941022044309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0293755500542537,0.00758744023316558,0.0145041671972492,0.0442469329112583,0.000108738949567646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0110713371917589,0.00287563619001396,0.00543509025933156,0.0167075841241863,0.000118640649193888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD1,Leiomodin-1,39934,-0.014271725714475,0.00371164894721909,-0.0215465576510244,-0.00699689377792558,0.000121153880752327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOC,Brother of CDO,41900,-0.00956483190038567,0.00248850676234662,-0.0144423051545851,-0.00468735864618629,0.000121805277075161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO4,Roundabout homolog 4,39638,-0.00749545812954808,0.00195328776594954,-0.0113239021508092,-0.00366701410828697,0.000125059998609704
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0425528298075791,0.0111067216246312,0.0207836554233019,0.0643220041918562,0.000128190111552202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,39657,0.0263839205058666,0.00690052183629394,0.0128588977067305,0.0399089433050028,0.000132310272470915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB1,Calbindin,42070,0.0184986580611634,0.00484365408793551,0.00900509604880978,0.027992220073517,0.00013451106161014
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARCL1,SPARC-like protein 1,42169,-0.0110820287910466,0.00292597423296041,-0.016816938287649,-0.00534711929444419,0.000152847961258721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,39958,0.0135757417820443,0.00358996265652848,0.00653941497524845,0.0206120685888401,0.000156633016127623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0109744763086881,0.00290273708016651,0.00528511163156178,0.0166638409858145,0.000157169297377566
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPN,Asporin,39958,0.0112597972211095,0.00297862867819441,0.00542168501184846,0.0170979094303705,0.000157507711892443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0104583461750442,0.00279167511891052,-0.0159300294081088,-0.00498666294197959,0.000180409554765557
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0306891697482918,0.00819713951105681,0.0146227763066204,0.0467555631899631,0.000182114996877021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB1,Lamin-B1,39908,0.0244681530861874,0.00653938794902992,0.0116509527060888,0.0372853534662861,0.000183714500619624
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMB,Granzyme B,42119,0.027168356786431,0.00726278876989217,0.0129332907974423,0.0414034227754196,0.000184222152484761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0177101239698404,0.00474209196717005,0.0084156237141871,0.0270046242254937,0.000188909635358513
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0170607648401105,0.00456850892793427,-0.0260150423388617,-0.00810648734135934,0.000189094768286691
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD3,Extracellular superoxide dismutase,39990,-0.0241927502739656,0.00649739405090319,-0.0369276426137359,-0.0114578579341954,0.000197462915448483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF3,Trefoil factor 3,42143,-0.0143548431887444,0.00386053381038809,-0.021921489457105,-0.00678819692038372,0.000201331450475941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0147834738418711,0.00397775040290091,-0.0225798646315569,-0.00698708305218529,0.000202972259918651
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,39767,0.0158500034944588,0.00426897652172258,0.00748280951188255,0.024217197477035,0.000205948068737582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB44,Ras-related protein Rab-44,39919,0.0178290313361735,0.00480233259038011,0.00841645945902846,0.0272416032133185,0.000206143827492686
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,39560,0.0228136491385879,0.00614665293713172,0.0107662093818098,0.0348610888953661,0.000207008620163019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI1,Neuroserpin,39713,0.011473744462393,0.00310053591870201,0.00539669406173702,0.0175507948630489,0.000216156032494517
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0107978832953434,0.00291833740011032,-0.0165178245995596,-0.00507794199112715,0.000216613482170944
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KEL,Kell blood group glycoprotein,41839,0.0143281994584241,0.00387825152384859,0.00672682647168085,0.0219295724451673,0.00022120736562392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0414278866295779,0.0112580707789,0.0193620679029339,0.063493705356222,0.000234295079865558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG4,Regenerating islet-derived protein 4,42144,0.0200558761014599,0.00545772732499792,0.00935873054446397,0.0307530216584558,0.000238985074161527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0152442134542053,0.00415112226284613,0.00710801381902692,0.0233804130893838,0.000241501931804553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRTN,Neurturin,41913,0.019477982435889,0.00530602716081286,0.00907816920069579,0.0298777956710822,0.000242627227103947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP1,Dipeptidase 1,41997,-0.0179961922018101,0.00492005116120781,-0.0276394924777774,-0.00835289192584283,0.000255439588350002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17C,Interleukin-17C,41913,-0.0277627080063458,0.00759046358989957,-0.0426400166425489,-0.0128853993701426,0.000255592320714204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0113685220218594,0.00311351228997971,-0.0174710061102196,-0.00526603793349915,0.00026184437956179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.024927963953752,0.00683039557056137,0.0115403886354517,0.0383155392720523,0.000263867044209203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD3,Bromodomain-containing protein 3,39575,0.0185412803784642,0.00508329478664749,0.00857802259663517,0.0285045381602933,0.000266038265526222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1,Programmed cell death protein 1,42232,0.0163252222488323,0.00448737043093339,0.00752997620420287,0.0251204682934618,0.000275737424295387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,39575,0.0172235235566375,0.00475193997959392,0.00790972119663346,0.0265373259166416,0.000290802694375191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0121326600047648,0.00337079443786069,0.00552590290655785,0.0187394171029717,0.000320176416261981
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0215483112721217,0.005988621147988,0.00981061382206528,0.0332860087221782,0.00032182600436512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTL1,Cytokine-like protein 1,39966,0.00979487365896596,0.00273227017160303,0.00443962412262403,0.0151501231953079,0.000338640238538155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAX,Apoptosis regulator BAX,41814,0.0352064473931154,0.00983232719321901,0.0159350860944062,0.0544778086918247,0.000343926733245058
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN2,Prefoldin subunit 2,41839,0.0211671095804688,0.00591313969740353,0.00957735577355786,0.0327568633873797,0.000345254460883331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,39979,0.00590479196420274,0.00165064669552717,0.00266952444096949,0.00914005948743599,0.000348656908109723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0148657199292499,0.00415965135386544,0.00671280327567363,0.0230186365828262,0.000353102292951517
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIF,Leukemia inhibitory factor,41839,0.0191630575328535,0.00536499294848926,0.00864767135381456,0.0296784437118924,0.000355698966814616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0164289470741425,0.00462304603158725,0.00736777685223146,0.0254901172960535,0.000381128955275817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK8,Kallikrein-8,41668,0.0139446026836585,0.00392798865571117,0.00624574491846462,0.0216434604488524,0.000386493774145164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA11,Serpin A11,42310,-0.0158561146198004,0.00447130163482874,-0.0246198658240647,-0.00709236341553604,0.000392137955297475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0133729238587855,0.0037729079642923,-0.0207678234687984,-0.00597802424877259,0.000394735134206939
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,42185,0.0246183012660989,0.00695491117423841,0.0109866753645916,0.0382499271676062,0.000401920674406218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0108577673699782,0.00307737247704737,0.00482611731496537,0.016889417424991,0.000419955195373525
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG1,Arginase-1,42015,0.0190837776285945,0.00541085731021963,0.00847849730056401,0.029689057956625,0.000421793505166352
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0290500519158166,0.00825065335300758,-0.0452213324877114,-0.0128787713439217,0.000431706413739821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0138527321866383,0.00393822140235225,0.00613381823802789,0.0215716461352487,0.000437351855930011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELENOP,Selenoprotein P,39979,0.00848788263898251,0.00242145909537782,0.00374182281204197,0.013233942465923,0.000457889421151369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A16,Protein S100-A16,41814,-0.0228436851017784,0.00652343122654977,-0.0356296103058159,-0.0100577598977408,0.000463669631338186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,41843,0.0135420745583948,0.0038703215168491,0.00595624438537056,0.021127904731419,0.000468622141210856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0207427082311318,0.00593285021332293,0.0091143218130189,0.0323710946492448,0.000473686476074047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0214359864746167,0.0061312612466429,0.00941871443119662,0.0334532585180368,0.000473806719195434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0151646001390292,0.00433870138945216,-0.0236684548623554,-0.00666074541570295,0.00047558853304025
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANPEP,Aminopeptidase N,42187,0.0101870333556617,0.00291855341982645,0.00446666865280186,0.0159073980585215,0.000483756777501547
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0172460933145107,0.00494142247510556,0.00756090526330378,0.0269312813657176,0.000484722793784746
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH17,Protocadherin-17,42145,0.0139641521469395,0.00400844794290124,0.00610759417885306,0.0218207101150259,0.000496131589014946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0133427322379297,0.0038312922458839,0.00583339943599726,0.0208520650398622,0.000498198536720551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPE,Carboxypeptidase E,42134,-0.0145577508836642,0.00418422268365163,-0.0227588273436214,-0.00635667442370705,0.000504493824912039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAN,Brevican core protein,42016,0.0128579127939701,0.00369733827576696,0.00561112977346684,0.0201046958144733,0.00050750207049741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1B,Lithostathine-1-beta,42310,-0.0212280859391513,0.00610709964344878,-0.0331980012403109,-0.00925817063799173,0.000510587437897594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCG22,Protein PBMUCL2,39575,-0.0215934987437921,0.00621657641032769,-0.0337779885080344,-0.00940900897954987,0.000515630607900941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,39929,0.0102485273081572,0.00295313482000573,0.00446038306094595,0.0160366715553684,0.000521639889517062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX18,Sorting nexin-18,39930,0.016242150251263,0.00468167508715016,0.00706606708044864,0.0254182334220773,0.000523750909765354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0143055057863961,0.00412566869311021,-0.0223918164248921,-0.00621919514790004,0.000527387830165457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA1,Annexin A1,39699,0.0165037130479966,0.00476113334059108,0.00717189170043807,0.0258355343955551,0.000529589810191716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,39657,0.0114684579481443,0.00331330668625505,0.00497437684308437,0.0179625390532041,0.000539538342120631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0192014465601091,0.00555556996027517,0.00831252943796977,0.0300903636822484,0.000549820727953884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17A,Interleukin-17A,41877,-0.0158821788663395,0.0045955856766764,-0.0248895267926253,-0.00687483094005378,0.00055004357807766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0109110135512785,0.00316195741210879,0.0047135770235453,0.0171084500790118,0.00056119234712873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B2M,Beta-2-microglobulin,39979,0.0112436483074393,0.00325931977689381,0.00485538154472742,0.0176319150701512,0.000563261931379469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,39575,-0.00973265679135302,0.00282706022828846,-0.0152736948387984,-0.00419161874390765,0.000578134517190541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.010975535703097,0.00318963476110885,0.00472385157132365,0.0172272198348704,0.00058135519934883
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB6,Heat shock protein beta-6,42262,0.0149451608107721,0.00435398759830394,0.00641134511809634,0.0234789765034478,0.000599766246728828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0153641548378261,0.0044798697617739,-0.024144699570903,-0.00658361010474925,0.000606666116953331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFLAM,Pikachurin,39930,0.0113389784741974,0.0033085864542876,0.00485414902379374,0.0178238079246011,0.000612149131902146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0149316702887371,0.00436383339411601,-0.0234847837412045,-0.0063785568362697,0.000624192775876686
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY2,Protein canopy homolog 2,41900,0.0222869077113018,0.00651838588897252,0.00951087136891568,0.035062944053688,0.000630208760324279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCC1,Regulator of chromosome condensation,39919,0.0190592263211292,0.00557916133416942,0.00812407010615717,0.0299943825361013,0.000637375484307064
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_DRA,,42060,-0.0132892149384088,0.00389489309962945,-0.0209232054136825,-0.00565522446313504,0.000646875747207118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0142884356672016,0.00419177247710548,0.00607256161207487,0.0225043097223284,0.000655038532419421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB2,Lamin-B2,39929,0.0104474475660494,0.00306936876329105,0.00443148478999893,0.0164634103420999,0.00066691172007734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0162964824875356,0.00480620327003004,-0.0257166408967945,-0.00687632407827675,0.000699072233677698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0205868423408073,0.00608216179070187,0.00866580523103164,0.0325078794505829,0.000714824865321399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0242404378789865,0.00716389728550797,0.0101991991993909,0.0382816765585821,0.000717249743044978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0131720968652187,0.00389323296296749,0.00554136025780245,0.020802833472635,0.000718552369928793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE1,Ribonuclease pancreatic,39990,0.00894648028947515,0.00264478742157959,0.00376269694317915,0.0141302636357711,0.000720228448182427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A14,Protein S100-A14,39934,0.0187426417991843,0.0055416136066902,0.00788107913007145,0.0296042044682971,0.000721606030271892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,42137,-0.0223919804169134,0.00662525889894022,-0.0353774878588362,-0.00940647297499052,0.000727461911851115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEG1,Protein LEG1 homolog,39398,-0.0255205931160807,0.00756892685991533,-0.0403556897615147,-0.0106854964706466,0.00074952037824258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0122333361652598,0.00363046397482262,0.0051176267746075,0.0193490455559122,0.000754800423035517
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QL2,Complement C1q-like protein 2,39657,0.0154886765027182,0.00460841511179723,0.00645618288359566,0.0245211701218408,0.000779364755677398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,41913,0.017141593844985,0.00513985925089976,0.00706746971322143,0.0272157179767485,0.000855227061163087
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.0107050386639255,0.00321462081871723,-0.0170056954686113,-0.00440438185923977,0.000870409767834247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBB,Inhibin beta B chain,39736,0.0186104630513415,0.00559417335788034,0.00764588326989606,0.029575042832787,0.000881469500940727
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0164005237510082,0.00493913721078129,0.00671981481787683,0.0260812326841395,0.00090132791260574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,39560,0.0149198535870549,0.00450217391896832,0.00609559270587694,0.0237441144682328,0.000922954284919457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,39575,0.0150898185672016,0.00455530266173422,0.00616142535020258,0.0240182117842007,0.000927375266122764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF15,Growth/differentiation factor 15,42310,-0.016209463275568,0.00489971040389542,-0.025812895667203,-0.00660603088393297,0.000941229676838758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0111127504953585,0.00336105900166434,0.00452507485209636,0.0177004261386206,0.000948225327504566
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR4,Proline-rich protein 4,39652,-0.0251459277654772,0.00760981449109373,-0.040061164168021,-0.0102306913629335,0.000954801782981741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0181003691129213,0.00549607237405416,-0.0288726709660674,-0.00732806725977515,0.000992623380438932
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300E,CMRF35-like molecule 2,42232,0.0146799085201427,0.00447277628570453,0.00591326700016182,0.0234465500401236,0.00103311773046745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,39657,-0.0101958022971087,0.00311179135150512,-0.0162949133460587,-0.00409669124815863,0.00105424037150756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAN,Aggrecan core protein,41994,0.00957230340905047,0.00292592029316337,0.00383749963445027,0.0153071071836507,0.00107229051988791
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOH,Beta-2-glycoprotein 1,42137,-0.0127377660549831,0.00391916238094253,-0.0204193243216304,-0.00505620778833574,0.00115636202207422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0228886536907829,0.00704511516903339,-0.0366970794220884,-0.0090802279594775,0.00116147040840468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMOD4,Tropomodulin-4,39560,-0.0139077725821656,0.00428748074310269,-0.0223112348386469,-0.00550431032568431,0.00118295733496991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42181,0.0103069179755889,0.00317818397991069,0.00407767737496397,0.0165361585762139,0.00118555027434261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0174703729612959,0.00538998978512034,0.00690599298246001,0.0280347529401317,0.00119295672724998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,39854,0.0233665270626679,0.00721704980053173,0.0092211094536257,0.0375119446717101,0.00120853280000698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C8B,Complement component C8 beta chain,39979,0.0104618365375339,0.00323770840343474,0.00411592806680182,0.016807745008266,0.00123601797689124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGN,Mimecan,42137,0.0149571302194778,0.00463162631706099,0.00587914263803829,0.0240351178009174,0.00124369039079521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0120093287505807,0.00371995912941303,0.00471820885693119,0.0193004486442303,0.00124799584063498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0210543683320889,0.00652468336008793,0.00826598894631659,0.0338427477178613,0.00125451036840249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0119460680034169,0.00370451852773051,0.00468521168906511,0.0192069243177687,0.0012639266955301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0125219424413436,0.00388482756368494,0.0049076804165211,0.0201362044661661,0.00127092861562243
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUK1,Guanylate kinase,39575,-0.0138821927572101,0.00430833862082039,-0.022326536454018,-0.00543784906040209,0.00127595613567027
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH6,Cadherin-6,42145,-0.0133961186206437,0.00416511082082054,-0.021559735829452,-0.00523250141183547,0.00130173824878428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00666040933630293,0.0020738929071988,-0.0107252394344126,-0.00259557923819328,0.00132388417289503
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD109,CD109 antigen,42137,-0.0117162888900477,0.00365424064289352,-0.018878600550119,-0.00455397722997645,0.00134804868589473
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLMP,CXADR-like membrane protein,42262,0.00758361133753139,0.00236926605834899,0.00293984986316736,0.0122273728118954,0.00137347102388277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0246974973756489,0.00773799461455032,-0.0398639668201676,-0.0095310279311303,0.00141815342670272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL21,C-C motif chemokine 21,42185,0.0130675997971672,0.0040972769306366,0.0050369370131195,0.021098262581215,0.00142922880520044
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP4,Bone morphogenetic protein 4,41992,-0.0161688021250484,0.00507127104238689,-0.0261084933681267,-0.00622911088197006,0.00143434410367853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.019058142065679,0.00598120752184985,0.00733497532285325,0.0307813088085047,0.00144489826975323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH3,Neurexophilin-3,39657,0.0102178612606219,0.00321146212866872,0.00392339548843124,0.0165123270328126,0.00146825737203628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0136304851668894,0.00429507496347707,-0.0220488320953045,-0.00521213823847437,0.00151006601975399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHISA5,Protein shisa-5,39966,0.00880602401781632,0.00277866793991204,0.00335983485558871,0.0142522131800439,0.00153289111915951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,42249,-0.0436053080334126,0.0137600024580703,-0.0705749128512303,-0.0166357032155948,0.00153307292457347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE,Angiotensin-converting enzyme,39990,-0.00913364187196925,0.00289102985927571,-0.0148000603961496,-0.00346722334778887,0.00158560047645425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.00957586291670424,0.0030383780028297,-0.0155310838022505,-0.00362064203115802,0.00162707810140659
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.0101478073637475,0.00322612465332625,0.00382460304322806,0.0164710116842669,0.00166237335964659
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0187354456248799,0.00595654760751715,0.00706061231414625,0.0304102789356135,0.00166315550578386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT2,Angiopoietin-2,42262,-0.012570546064688,0.00399686260628824,-0.020404396773013,-0.00473669535636308,0.00166384119150514
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RA,Interleukin-17 receptor A,42137,0.0149088059142742,0.00475211548596335,0.00559465956178603,0.0242229522667623,0.00170877896796631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN10,Ataxin-10,41839,0.024604103379779,0.00786124757586459,0.00919605813108436,0.0400121486284735,0.00175307728444871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,39930,0.0260105748076401,0.00832313450974027,0.00969723116854919,0.042323918446731,0.00178197390485525
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42212,0.0279313275307002,0.00895496474730957,0.0103795966259735,0.045483058435427,0.00181790103276384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0186659692833003,0.0059900823519017,0.00692540787357299,0.0304065306930277,0.00183689692337447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,39560,0.0121701357842782,0.00390650875521874,0.0045133786240495,0.019826892944507,0.00184201998786723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0110898143420874,0.00356016394886064,-0.0180677356818543,-0.00411189300232058,0.00184435292246974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0112484606972942,0.00361946017271979,0.00415431875876337,0.018342602635825,0.00188894745016283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLFM4,Olfactomedin-4,39347,0.0412512192537721,0.0132774358692847,0.015227444949974,0.0672749935575701,0.00189574609640973
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,39560,0.0204730185732698,0.0065994707030765,0.00753805599523981,0.0334079811512997,0.00192562461138039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFAP,Glial fibrillary acidic protein,41820,0.0150779134124924,0.00488060404841451,0.00551192947759997,0.0246438973473849,0.00201008498564412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITM2A,Integral membrane protein 2A,42119,-0.0205267148165076,0.00664592529603496,-0.0335527283967361,-0.00750070123627907,0.00201498444887821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL5,Fc receptor-like protein 5,42137,-0.0195324830590593,0.00633329005884602,-0.0319457315743975,-0.00711923454372108,0.00204581897403392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0112426959318674,0.00364839847208577,-0.0183935569371555,-0.00409183492657931,0.0020635166658732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0126282796002594,0.00410431348204008,0.0045838251754608,0.0206727340250579,0.00209626925910818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0284423741257731,0.00924799254383057,0.0103163087398652,0.046568439511681,0.0021064957859282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,41740,0.0330523364268717,0.0107473484787121,0.011987533408596,0.0541171394451474,0.00210655895710908
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00575633251478568,0.00187807495070568,0.00207530561140255,0.00943735941816881,0.00218085455212527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18BP,Interleukin-18-binding protein,42217,0.0102525154479892,0.00335862138434853,0.00366961753466603,0.0168354133613123,0.00227308244145297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDRG1,Protein NDRG1,41839,0.0215964284219534,0.0070758590038345,0.00772774477443783,0.0354651120694691,0.002276753908858
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0122102235582669,0.0040097750261217,-0.0200693826094654,-0.00435106450706832,0.00233142728914279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0201441727269011,0.00663826494882428,-0.0331551720265967,-0.00713317342720553,0.00241447758049783
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42119,-0.00780082146638065,0.00257114531607789,-0.0128402662858933,-0.00276137664686799,0.00241803109039411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0207539973475624,0.00688484714944704,0.00725969693464618,0.0342482977604786,0.00258017296356499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JCHAIN,Immunoglobulin J chain,41913,-0.0197826251898012,0.00656368306582312,-0.0326474439988145,-0.00691780638078793,0.00258354003544224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36G,Interleukin-36 gamma,39624,0.0216494254967177,0.00719024442344055,0.00755654642677419,0.0357423045666612,0.00261026470593547
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK2,Protein AHNAK2,39638,0.0100352745219981,0.00333611177515179,0.00349649544270058,0.0165740536012956,0.00263500848490613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALCAM,CD166 antigen,42310,0.00631460398312279,0.00210719247960795,0.00218450672309121,0.0104447012431544,0.00273415966669171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42181,0.013502859878781,0.0045111207582897,0.00466106319253316,0.0223446565650288,0.00276530637964809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN2,Neuroligin-2,39586,-0.0149456367941747,0.00500560661382338,-0.0247566257572685,-0.00513464783108086,0.0028348011295904
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST7,Cystatin-F,42148,0.0301589385254341,0.010108639793877,0.0103460045294352,0.0499718725214329,0.00285497256571794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0161302846192694,0.00540896003098947,0.00552872295852999,0.0267318462800087,0.00286864107990767
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,39657,0.0333658828138352,0.0111996734327638,0.0114145228856181,0.0553172427420524,0.0028964543785964
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0145461899532149,0.00488694390912963,-0.0241246000151089,-0.00496777989132079,0.0029202944491899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.013047066678288,0.00438534585774147,0.00445178879711467,0.0216423445594612,0.00293363805564871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC1,Glypican-1,42262,0.00936089531143931,0.003163713903966,0.00316001605966595,0.0155617745632127,0.00309337699807012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,41913,0.0124976545380218,0.00422902675414902,0.00420876209988971,0.0207865469761539,0.00313005441015527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,41913,0.019683818584626,0.0066655989971953,0.00661924455012326,0.0327483926191288,0.00315205064145574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,39929,0.0179658188899156,0.00609303878129863,0.00602346287857032,0.029908174901261,0.00319888212883721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0236062549794687,0.00801324918268299,0.00790028658141008,0.0393122233775274,0.00322666996092477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA2,Adenosine deaminase 2,42096,-0.0137817796657415,0.00469594282719501,-0.0229858276070437,-0.00457773172443926,0.00334296045827086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0112227122708809,0.00383796651021087,-0.0187451266308942,-0.00370029791086763,0.00345989890828377
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.01154877525662,0.00395489815749286,-0.019300375645306,-0.00379717486793404,0.00350474299776107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,39574,-0.0196935140155955,0.00676597974535075,-0.0329548343164829,-0.00643219371470802,0.00361383439669349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42113,-0.00741935727191172,0.00255529603813677,-0.0124277375066598,-0.00241097703716366,0.00369588698560083
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMH,Granzyme H,41900,0.0244604134123661,0.00842518575459056,0.00794704933336864,0.0409737774913636,0.00369919780489296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF3,Neurotrophin-3,42119,0.0106397912378848,0.00368631305029708,0.00341461765930249,0.0178649648164671,0.00390422274164583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42100,0.0147513690976704,0.00511385650499088,0.0047282103478883,0.0247745278474525,0.00392546231385729
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXTL1,Exostosin-like 1,39575,0.0146635632652132,0.00509521283206905,0.0046769461143579,0.0246501804160686,0.00401092056729667
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",41839,-0.0181058328687406,0.00629839381930893,-0.0304506847545861,-0.00576098098289509,0.00405088404958085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPS10,40S ribosomal protein S10,39575,-0.0128305133119468,0.00446980499880428,-0.0215913311096032,-0.00406969551429042,0.00410624713602421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,41913,0.00871637288282215,0.00303694113053892,0.00276396826696588,0.0146687774986784,0.00410967780046969
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD7,T-cell antigen CD7,39636,0.0136750306641909,0.00479198605442604,0.00428273799751589,0.023067323330866,0.0043289770643534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0132386967600059,0.00464197573461571,0.00414042432015914,0.0223369691998527,0.00435298735232512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0308762570321363,0.0108336396215938,-0.0521101906904601,-0.00964232337381241,0.00437957936304315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0116983362054177,0.00411108704066661,0.00364060560571114,0.0197560668051243,0.00444132543684396
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDN1,Endothelin-1,39638,0.00894427017728975,0.00314714135056928,0.00277587313017396,0.0151126672244055,0.00449094641247223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00630181338657664,0.00222881843669621,-0.0106702975225012,-0.00193332925065207,0.00470091750365339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0162628448537693,0.00575796704768978,-0.0275484602672413,-0.00497722944029736,0.00474538187524651
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0187436615345397,0.00664043711095303,0.00572840479707181,0.0317589182720077,0.00477109039354251
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42247,0.00856860048580655,0.00303691439928688,0.00261624826320426,0.0145209527084088,0.0047871311820748
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D2,DCN1-like protein 2,39560,-0.0240971042240455,0.00854579754075393,-0.0408468674039232,-0.00734734104416779,0.00481457289090129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00829047067095094,0.00294240278775299,0.00252336120695508,0.0140575801349468,0.00484554938710239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",39958,0.016389709714781,0.00582163815061536,0.00497929893957495,0.0278001204899871,0.00488142835936915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX5,Syntaxin-5,39657,0.0119422246959491,0.00425735743710486,0.00359780411922362,0.0202866452726747,0.00503920428490285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42296,0.00740290737622109,0.00264150204917366,0.00222556335984073,0.0125802513926015,0.00507736131611167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO1,R-spondin-1,42016,0.0102320508348721,0.0036511261083544,0.00307584366249748,0.0173882580072467,0.00507908457998868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYT1,Synaptotagmin-1,39929,0.0120132058402469,0.00428738326838965,0.00360993463420313,0.0204164770462906,0.00508746124396403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL4,Delta-like protein 4,39638,0.0264334240205734,0.00944489347768975,0.00792143280430152,0.0449454152368453,0.00513977676659047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0156163419314288,0.00558816310694841,0.00466354224180992,0.0265691416210477,0.00520484393613819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0167967077268168,0.00601694168296567,-0.0285899134254296,-0.00500350202820413,0.00525432333168915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG4,Desmoglein-4,42018,0.0143158236344251,0.00512967633490202,0.00426165801801716,0.0243699892508331,0.00526546466546621
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0208296609178451,0.00750331219158539,0.00612316902233775,0.0355361528133525,0.00550963023278395
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP1,Caspase-1,41839,0.0204709828987586,0.00738462980618889,0.00599710847862835,0.0349448573188888,0.00557725620305462
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0155412585303576,0.0056204048700951,0.00452526498497118,0.026557252075744,0.00569902296234521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,39586,0.0131712991215107,0.00476405570755812,0.00383374993469677,0.0225088483083246,0.00570659843556929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOC,Myocilin,42137,-0.0131916628270187,0.00479026472670608,-0.0225805816913626,-0.00380274396267478,0.0058977628019622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0182160258472239,0.00663626192242136,-0.0312230992151698,-0.00520895247927805,0.00606235120125564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.015828230761647,0.00576796131057324,0.00452302659292348,0.0271334349303706,0.00607465204215506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,42070,0.00612479185469443,0.00223523213148017,0.00174373687699329,0.0105058468323956,0.00614986776640182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00930204390339825,0.00339712881784871,0.00264367142041478,0.0159604163863817,0.00618745753915976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0136435152734427,0.00498508108468269,-0.0234142741994208,-0.0038727563474646,0.00621267717006213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRAS,GTPase Hras,39750,0.0289989737098634,0.0106072167012265,0.00820882897545938,0.0497891184442674,0.00626895456809915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0158484594187367,0.00580050537630651,0.00447946888117596,0.0272174499562975,0.00629858421258979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0106223094731932,0.00388792884427663,0.003001968938411,0.0182426500079754,0.00630270782459635
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN1,Calsyntenin-1,41839,0.0148300789759252,0.00543186894706574,0.0041836158396764,0.0254765421121741,0.0063379967422078
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO6,Unconventional myosin-VI,39934,0.0109330814203033,0.00400471005062099,0.00308384972108619,0.0187823131195205,0.00634214432413003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK15,Kallikrein-15,39900,0.0153407753144852,0.00562857098286334,0.00430877618807301,0.0263727744408973,0.0064299419188341
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,41907,0.0242599139938474,0.00896133797391089,0.00669569156498205,0.0418241364227127,0.00679450035953116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,39934,0.0100459070883338,0.00371077215398888,0.00277279366651557,0.017319020510152,0.00679492877192241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0163934562280355,0.00605561094616385,0.00452445877355432,0.0282624536825166,0.00679731693472808
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00830024578018615,0.00309891517921115,0.0022263720289323,0.01437411953144,0.00740737140416664
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK14,Kallikrein-14,42262,-0.0132481387687007,0.00495907782470268,-0.022967931305118,-0.00352834623228345,0.00756043040426885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00779271338985465,0.00292724528352117,-0.0135301141455561,-0.00205531263415316,0.00777587378023757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0202501977302204,0.00761357137089012,-0.035172797617165,-0.00532759784327573,0.00783086869390351
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0167561526349819,0.00630053798438487,0.00440709818558757,0.0291052070843763,0.00783536963767809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42145,0.0130954203817766,0.00492645841771015,0.00343956188306474,0.0227512788804885,0.00786558610838933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1,DNA topoisomerase 1,39930,0.0342957668575039,0.0129136523642471,0.00898500822357948,0.0596065254914282,0.00792369314508236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MB,Myoglobin,42310,-0.0159294043540609,0.00600617009159575,-0.0277014977335885,-0.00415731097453319,0.00800675251660933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTN,Titin,39575,-0.0195860928517224,0.00741386453712249,-0.0341172673444825,-0.00505491835896234,0.0082578896165618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RYR1,Ryanodine receptor 1,39575,-0.00952661678548517,0.00361441255454556,-0.0166108653923945,-0.00244236817857587,0.0084074505240358
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42070,-0.00682713964710633,0.00259039238791482,-0.0119043087274194,-0.00174997056679328,0.00840943169052889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARTN,Artemin,41913,0.0127398385344635,0.00484146151836165,0.00325057395847464,0.0222291031104523,0.00851310345699207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0144058677621336,0.00549485776100708,-0.0251757889737075,-0.00363594655055971,0.00875912083144562
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0324922803022727,0.0124045594475226,0.00817934378512851,0.056805216819417,0.00881891184416238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI3,Elafin,41966,0.0157642558461241,0.00601995813037544,0.00396513791058821,0.0275633737816599,0.00883740986476506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,39929,0.0131927083351942,0.0050433123395511,0.00330781614967404,0.0230776005207144,0.00891154240180608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,39757,0.0148390189411471,0.00567665484950606,0.0037127754361152,0.025965262446179,0.00895980144315233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSAP,Gamma-secretase-activating protein,41843,0.0235931176562299,0.00902659365287731,0.00590099409659035,0.0412852412158694,0.00896599557083137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0415058436915793,0.0159431251915626,0.0102573183161166,0.072754369067042,0.00924154271142771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00804339719663549,0.00309218404409535,-0.0141040779230624,-0.0019827164702086,0.00929995404126726
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA6C,Semaphorin-6C,39657,0.00717573364485867,0.00276224785772613,0.00176172784371545,0.0125897394460019,0.00939508546128062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB5,Serpin B5,41900,0.0135110642920411,0.00521312866032766,0.00329333211779887,0.0237287964662833,0.00955967992311487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0110738914288934,0.00427616964489127,-0.0194551839328803,-0.00269259892490652,0.00961926237426801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST6,Cystatin-M,41864,0.0137976991144487,0.00532877122450024,0.00335330751442819,0.0242420907144691,0.00962809403142506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN5,Contactin-5,42170,0.0102519864474842,0.00396455988819477,0.00248144906662241,0.0180225238283459,0.0097226107116903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0102652296559355,0.00401091357997666,-0.0181266202726898,-0.00240383903918124,0.010498361008204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0100381068349363,0.00392881553712935,0.00233762838216273,0.0177385852877098,0.0106297639034422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15,Interleukin-15,42119,0.00898947232596231,0.00352747524106231,0.00207562085348019,0.0159033237984444,0.0108323115235225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,41843,0.0202250946310089,0.00795279985149966,0.00463760692206962,0.0358125823399483,0.0109973507468816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,42145,0.00927210702181458,0.00365380510819912,0.0021106490097443,0.0164335650338849,0.0111708170452534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0219655970551514,0.00867142454153934,0.00496960495373427,0.0389615891565685,0.0113195406520772
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,39757,-0.011338019841283,0.0044932379075918,-0.0201447661401629,-0.00253127354240306,0.0116379799922637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,39757,0.010016927032724,0.00397431063238589,0.0022272781932476,0.0178065758722003,0.0117353624263067
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKCQ,Protein kinase C theta type,41913,0.0115453341896437,0.00458094497408557,0.00256668204043597,0.0205239863388514,0.0117372352469065
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX9,Transcription factor SOX-9,39649,0.00740130343219284,0.00296000459263265,0.00159969443063285,0.0132029124337528,0.0124184090878279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.010900778669074,0.00436743328896158,0.0023406094227093,0.0194609479154387,0.0125770046414224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0102137418706242,0.00410257530049265,0.00217269428165858,0.0182547894595898,0.0128011305215204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00681434270645366,0.00274075723951514,-0.0121862268959033,-0.00144245851700398,0.0129221903028435
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,39586,0.0198690541098729,0.00800522121946602,0.00417882051971953,0.0355592877000264,0.0130791229806542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.010365764589881,0.00418432979555072,0.00216447819060161,0.0185670509891604,0.0132511115626881
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA1,Ephrin-A1,42113,0.00780736149489125,0.00315369799851925,0.00162611341779352,0.013988609571989,0.0133126262096015
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,41913,0.0151567763817292,0.00612277371939773,0.00315613989170968,0.0271574128717488,0.0133182377408114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB2,Integrin beta-2,42079,-0.00761124809989156,0.00307802052441275,-0.0136441683277405,-0.00157832787204257,0.0134191443443766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.0087600608511222,0.00354396797801522,0.00181388361421237,0.015706238088032,0.0134550361582864
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAD,Chondroadherin,39736,0.012413243149167,0.00502516945156393,0.00256391102410168,0.0222625752742323,0.0135181010761063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,39586,-0.0153578910972413,0.00622234882308741,-0.0275536947904926,-0.00316208740398998,0.0135952304258274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,39736,0.00788802348166411,0.00320520479038931,0.00160582209250105,0.0141702248708272,0.013869920447694
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.013878599632554,0.00565954447451926,-0.0249713068026117,-0.0027858924624962,0.0142119615580206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0140513964743579,0.00573563416089328,0.00280955351900704,0.0252932394297087,0.0143047176183075
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,39736,0.00765543103971689,0.00312991467614144,0.00152079827447967,0.0137900638049541,0.0144648241607947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0179559740342642,0.00740344009628604,0.00344523144554352,0.0324667166229848,0.0153093185806873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE6,Ribonuclease K6,39937,0.00837481365281241,0.0034545724006253,0.00160385174758682,0.015145775558038,0.0153547608009446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,39919,0.0155837603665729,0.0064284722869906,0.00298395468407128,0.0281835660490744,0.0153586472933856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY96,Lymphocyte antigen 96,42016,-0.00948385384104702,0.0039158115051217,-0.0171588443910855,-0.00180886329100849,0.0154511371414494
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0126959435663387,0.00527340030324388,0.00236007897198071,0.0230318081606967,0.0160761013856347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,39657,0.0145622747585105,0.00606087517266879,0.00268295942007963,0.0264415900969413,0.0162923045339227
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,39649,0.0130214140266985,0.00543342215509926,0.00237190660270396,0.023670921450693,0.0165671997795767
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42185,0.0069222616740674,0.00289052390335992,0.00125683482348196,0.0125876885246528,0.0166423463500914
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON1,Spondin-1,42144,0.00835806305322453,0.00349205851280103,0.00151362836813451,0.0152024977383146,0.0167043400617599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100G,Protein S100-G,39934,-0.012501713452455,0.00523555742130721,-0.0227634059982172,-0.00224002090669291,0.0169636450308131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0111280255828863,0.0046775036873001,0.00196011835577809,0.0202959328099945,0.0173709479116701
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00840136981255224,0.00353624066474117,-0.0153324015154449,-0.00147033810965954,0.0175281838387518
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.010845285978137,0.00456778682000028,0.00189242381093647,0.0197981481453376,0.017596227362636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY6D,Lymphocyte antigen 6D,42041,0.0100963892978721,0.00425502430376961,0.00175654166248369,0.0184362369332606,0.0176670469877279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42281,0.0132353084083449,0.00557806078250803,0.00230230927462916,0.0241683075420606,0.0176702548160309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171B,Protein FAM171B,39919,0.00673451689908565,0.00284232558613452,0.00116355875026198,0.0123054750479093,0.017835166601675
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0174085413811897,0.00735859524672519,0.00298569469760828,0.031831388064771,0.0180082795770236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0177540539994192,0.0075123613614329,0.0030298257310107,0.0324782822678277,0.0181263472175182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD7,FERM domain-containing protein 7,39649,0.0085455618834238,0.00364061478868895,0.00140995689759347,0.0156811668692541,0.0189283160549382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEB,Nebulin,39575,-0.00994478493971829,0.00426146132154809,-0.0182972491299526,-0.00159232074948403,0.0196316991213203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,39575,0.0230370644391382,0.0098852271093534,0.00366201930480558,0.0424121095734709,0.0198002097412731
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPLX2,Complexin-2,39560,-0.00764219125898309,0.0032829476031822,-0.0140767685612202,-0.00120761395674598,0.0199384736985329
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0167828720753306,0.00721208953036811,0.00264717659580912,0.0309185675548521,0.0199802842577961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00969872836735722,0.00418281492207547,-0.0178970456146251,-0.0015004111200893,0.0204291504500394
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPTC,Opticin,42070,-0.0112667405666631,0.00485955733100564,-0.0207914729354342,-0.00174200819789204,0.0204386562950777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200,OX-2 membrane glycoprotein,42119,-0.00674220539881602,0.0029124800484818,-0.0124506662938403,-0.00103374450379169,0.020631327229463
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0208638798702308,0.00903163338348285,-0.0385658813018572,-0.0031618784386044,0.0208986723486827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.00913047942813772,0.0039533381069267,0.00138193673856139,0.0168790221177141,0.0209302505165398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALB,Ras-related protein Ral-B,39657,0.00728275822709308,0.00317432657722232,0.00106107813573733,0.0135044383184488,0.0217937215393076
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTR,Methionine synthase,39575,0.0159717714418207,0.00699434241071591,0.00226286031681748,0.0296806825668239,0.0224183507991191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0145708382500077,0.00642598102011903,-0.027165761049441,-0.00197591545057441,0.0233763087831538
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00737035133365189,0.00325438093518876,0.000991764700681911,0.0137489379666219,0.0235441243093095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0177048726640655,0.00782844753161545,0.00236111550209923,0.0330486298260318,0.0237375028414176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00944441990590681,0.00418114569548365,0.00124937434275885,0.0176394654690548,0.0239145492984291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,39570,0.0245628010347032,0.0108936552059593,0.00321123683102303,0.0459143652383834,0.0241667467671529
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.00925085503551599,0.00410888076937412,0.00119744872754272,0.0173042613434893,0.0243743708779856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELL,L-selectin,39979,0.0056160937227922,0.00249483486031327,0.000726217396578193,0.0105059700490062,0.0243989453861504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PZP,Pregnancy zone protein,39979,0.00796710311458258,0.00355502021156665,0.000999263499911945,0.0149349427292532,0.0250397640822806
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0139544074936027,0.00624539266541297,0.00171343786939328,0.0261953771178121,0.0254764492778354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS4,Galectin-4,42123,-0.0134761205224769,0.00604017915729408,-0.0253148716707733,-0.00163736937418052,0.0256921869543635
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0164339207329206,0.00737077622180587,0.00198719933818112,0.0308806421276601,0.0257900864112673
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK11,Kallikrein-11,42062,0.0076846744834514,0.0034539771833259,0.000914879204132637,0.0144544697627702,0.0261060044439236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0168438266734242,0.00757572021546835,-0.0316922382957422,-0.00199541505110624,0.0262093652617617
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0132985874180282,0.00600275600125338,0.00153318565557162,0.0250639891804849,0.026748543715643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0293536615243788,0.0132626679610118,0.00335883232079572,0.055348490727962,0.0268970770758677
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00940039061202285,0.00424866079456848,0.00107301545466863,0.0177277657693771,0.0269483065835389
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGA4,Pepsin A-4,39990,0.01751738273373,0.00802281951232702,0.00179265648956903,0.0332421089778909,0.029023414170462
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0158430627647527,0.00726376085565141,-0.0300800340418295,-0.00160609148767597,0.029192472373071
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00832815288550536,0.00381882222117613,0.000843261332000155,0.0158130444390106,0.0292144060298056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G1B,Phospholipase A2,42299,-0.0103624134101169,0.00477120910677866,-0.0197139832594031,-0.00101084356083074,0.029883081819886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,39649,-0.00655955739651903,0.00302171228112217,-0.0124821134675185,-0.000637001325519574,0.0299669040724204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX101,Testis-expressed protein 101,39649,0.0143213316584563,0.0065978068034691,0.00138963032365687,0.0272530329932557,0.0299811300428769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.0104722754677445,0.00483075197646852,0.00100400159386625,0.0199405493416228,0.0301922813012948
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,39757,0.0158686892935649,0.00732592281236148,0.0015098805813364,0.0302274980057934,0.0303245725185078
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00624274317826619,0.00289090939054874,0.000576560772790659,0.0119089255837417,0.0308336022280053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.0072546627157857,0.00336094787253064,-0.0138421205459457,-0.000667204885625647,0.0309091344844046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA8,Carbonic anhydrase-related protein,39657,0.00615520583672037,0.00285171346843233,0.000565847438592997,0.0117445642348477,0.0309163607938073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,39657,-0.00505514359765568,0.00234858652657105,-0.00965837318973493,-0.000451914005576429,0.0313858970449613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.00711499135234494,0.00332150915713234,0.000604833404365555,0.0136251493003243,0.0322035488850768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0177554994582716,0.00829477271877871,0.00149774492946532,0.0340132539870779,0.0323309648664268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0196355406918912,0.00917648145449511,0.00164963704108077,0.0376214443427016,0.0323953664143376
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00900236487185657,0.00421736347688102,-0.0172683972865434,-0.000736332457169767,0.0328161597155451
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP7,Retinoid-binding protein 7,39930,0.0142559464084355,0.00668649323617514,0.00115041966553225,0.0273614731513388,0.0330240784125644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0093729278043924,0.00439635883465414,0.000756064488470293,0.0179897911203145,0.0330267268534764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L,Seizure 6-like protein,42181,0.00623935484166193,0.00294720618598224,0.000462830717136739,0.0120158789661871,0.034274541556994
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0140579020078655,0.00666871967163557,0.000987211451459824,0.0271285925642712,0.0350503079193819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.00945746951580266,0.004488026575622,-0.0182540016040218,-0.000660937427583531,0.0351163667172912
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPS,Calcyphosin,39929,0.0214202866889036,0.0101684411100156,0.0014901421132731,0.0413504312645342,0.0351789037205708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,42137,-0.00644363157282286,0.00305919557830414,-0.012439654906299,-0.000447608239346754,0.0351953000701128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.00883265134113066,0.00419581009826016,-0.0170564391337206,-0.000608863548540747,0.0353004588032152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00981899708253139,0.00467280372124486,-0.0189776923761713,-0.000660301788891451,0.0356360187234646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00709369286525744,0.00337616603145716,-0.0137109782869135,-0.000476407443601403,0.0356541208587002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,39638,0.0127401057121378,0.0060780612435808,0.00082710567471948,0.0246531057495562,0.0360977615015648
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.011780385120381,0.00562446947646636,0.000756424946506953,0.0228043452942551,0.036235471592935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,39930,0.00680368451073869,0.00325259788295426,0.000428592660148343,0.013178776361329,0.0364813613645819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC1,Hamartin,39657,0.0164907359757529,0.00792133204158866,0.000964925174239099,0.0320165467772666,0.037382451522053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GM2A,Ganglioside GM2 activator,39733,0.00855968058844132,0.00412386804837902,0.000476899213618449,0.0166424619632642,0.0379498215084075
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00673558577159617,0.00324569151617157,-0.0130971411432925,-0.000374030399899892,0.0379876010940129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPN1,Epsin-1,39757,0.00956112769591488,0.00463097342441321,0.000484419784064978,0.0186378356077648,0.0389835110472327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00542050650650003,0.00262849983616723,0.000268646827612265,0.0105723661853878,0.0392114954903476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUCL3,Mucin-like protein 3,39560,-0.00937863603309727,0.00456380577697099,-0.0183236953559604,-0.000433576710234132,0.03990233260175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,41843,0.0103936580738167,0.00507826163947286,0.000440265260449879,0.0203470508871835,0.0407076347834483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP8,Neutrophil collagenase,42224,0.0156586279791422,0.00766478788583529,0.000635643722905031,0.0306816122353794,0.0410785336411965
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH7B,Myosin-7B,39560,-0.00936467154735931,0.00459344284411566,-0.018367819521826,-0.00036152357289262,0.0415034983228364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0191999121642161,0.00942525715004023,-0.037673416178295,-0.000726408150137275,0.0416667969388835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5L,CD5 antigen-like,39925,0.0104629566798209,0.00514203428007352,0.000384569490876806,0.020541343868765,0.0418953152094084
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42145,0.00685797021341098,0.00338998041318272,0.00021360860357284,0.0135023318232491,0.0430915407442492
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0092822546164987,0.00459718373267202,0.000271774500461543,0.0182927347325359,0.0434948470212142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0119287265439234,0.00591094922384352,0.000343266065190105,0.0235141870226567,0.0436079510582086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,39638,0.020786382086611,0.0103113531895184,0.000576129835155013,0.0409966343380671,0.043837404310297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00961298803269458,0.00481021810230961,0.000184960552167752,0.0190410155132214,0.0456881365748847
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD82,CD82 antigen,39757,-0.00884335840183568,0.00443600372984087,-0.0175379257123238,-0.000148791091347571,0.0462264683141589
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GL3,Endophilin-A3,39690,0.0181522285817729,0.00912129487898356,0.000274490618965111,0.0360299665445807,0.0466051603856522
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42070,0.022202407409319,0.0111594429528813,0.000329899221671648,0.0440749155969663,0.0466593556024818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.00747563205801129,0.00375923625445502,-0.0148437351167431,-0.00010752899927946,0.0467649705757746
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0122201441471349,0.00615310741029334,-0.0242802346713098,-0.00016005362295995,0.0470568214423846
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,39575,-0.0067406746906638,0.00339621695250642,-0.0133972599175764,-8.40894637512239e-05,0.0471960659692752
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42217,0.00693194057448668,0.00350295203380129,6.61545882361513e-05,0.0137977265607372,0.0478490263835952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,39736,-0.00861739893772172,0.00439666129354478,-0.0172348550730695,5.71976260365509e-08,0.0500222121443101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0146046283055,0.0074613851767162,-1.96866408637107e-05,0.0292289432518638,0.0503256819943128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00616330524645885,0.00315103764551833,-1.27285387570781e-05,0.0123393390316748,0.0504949481013283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI2B,Protein EVI2B,39560,-0.0083618052679763,0.00427950330523869,-0.0167496317462441,2.6021210291537e-05,0.0507361283920524
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0158174659323886,0.00811070820449887,-7.95221484292084e-05,0.0317144540132064,0.051173908144806
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1A,Interleukin-1 alpha,41913,0.0120867591196104,0.00619864875059559,-6.25924315569761e-05,0.0242361106707777,0.0512087338728811
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0120335164353577,0.00617859158742648,-7.65230759982027e-05,0.0241435559467136,0.0514817039831115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN3,Matrilin-3,41992,-0.00686115841201302,0.00353628480231445,-0.0137922766245493,6.99598005232966e-05,0.0523743379278173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0179321945541824,0.00925252561766932,-0.000202755656449474,0.0360671447648142,0.05263837419007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00607352664604928,0.00315017218225151,-0.0122478641232622,0.000100810831163674,0.0538810797520524
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEBP1,Heme-binding protein 1,41900,-0.0107342152321722,0.00556961994469929,-0.0216506703237828,0.000182239859438375,0.0539660604844782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00670412482692984,0.0034946038231291,-0.000145298666403192,0.0135535483202629,0.0550834386257894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBH,Dopamine beta-hydroxylase,39978,0.023343921948281,0.0122009189543274,-0.000569879202200765,0.0472577230987628,0.0557357371185287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFD,Complement factor D,39979,0.00414415917331355,0.00216879579665353,-0.000106680588127363,0.00839499893475447,0.0560539580833047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42310,-0.00669077214198251,0.00350569972753543,-0.0135619436079519,0.000180399323986927,0.0563421729997375
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00779881273187698,0.00408790818932433,-0.000213487319198701,0.0158111127829527,0.0564421647565429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0171217813748536,0.00898519243373806,-0.00048919579527305,0.0347327585449801,0.0567339994219804
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0059926972593614,0.00315232818195564,-0.000185865977271663,0.0121712604959945,0.0573182074369881
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPN3,Calpain-3,39919,-0.00793731846087242,0.00417655887185511,-0.0161233738497084,0.000248736927963598,0.0574001900884886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,39575,0.00945179816623981,0.0049744206996098,-0.000298066404995398,0.019201662737475,0.0574487816187376
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL3,Follistatin-related protein 3,42084,0.00664544046424907,0.00350450770694862,-0.000223394641370222,0.0135142755698684,0.0579476815314466
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.00986889231460684,0.00520624727388255,-0.000335352342202956,0.0200731369714166,0.0580363959015449
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDHB15,Protocadherin beta-15,39919,-0.00808224030742843,0.00426553123546427,-0.0164426815289384,0.000278200914081537,0.0581471068624193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHPK,Sedoheptulokinase,39757,-0.00809393433819581,0.00427891233230563,-0.0164806025095148,0.000292733833123214,0.0585719230608133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00577705194692945,0.00305566015806279,-0.0117661458567325,0.000212041962873615,0.0587022789886796
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GKN1,Gastrokine-1,41538,0.00574440813241732,0.00303961533457137,-0.000213237923342558,0.0117020541881772,0.0588007500838389
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.025552641672276,0.0135319342292321,-0.000969949417018983,0.052075232761571,0.0590046464601809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,39649,-0.0138546186437663,0.00737119019111985,-0.0283021514183612,0.000592914130828551,0.0601939114096166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00513530458145526,0.00274392416781674,-0.0105133959503761,0.00024278678746555,0.0612996900780391
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.0056978663849361,0.00304527268708908,-0.000270868081758508,0.0116666008516307,0.0613634170134645
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00964335517464962,0.00515722799241047,-0.0004648116904749,0.0197515220397741,0.0615273921535482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00587345033376432,0.00315330897830881,-0.000307035263720951,0.0120539359312496,0.0625362633188662
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00780834887414763,0.00421281860974618,-0.000448775600954891,0.0160654733492501,0.0638363296361198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00539745631309474,0.00291400056590428,-0.0111088974222671,0.000313984796077648,0.0640159028330722
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB118,Beta-defensin 118,39586,0.0112848737770031,0.00610316263917216,-0.000677324995774312,0.0232470725497805,0.0644816776799378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCN,Decorin,41900,-0.00454473627187434,0.00246324841149282,-0.00937270315840027,0.000283230614651584,0.065057219914238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTO1,Protein LTO1 homolog,41913,0.00815019347570443,0.0044244137784856,-0.000521657530127348,0.0168220444815362,0.0654833828417006
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRV1,Acrosomal protein SP-10,39657,0.0209572106881672,0.0113788887805176,-0.00134541132164726,0.0432598326979818,0.0655366622668097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,39919,0.0105096838752196,0.00570748551800106,-0.000676987740062487,0.0216963554905017,0.0655911645105941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.0060692710113073,0.00331068789672215,-0.000419677266268112,0.0125582192888827,0.0667898530940276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00622878462666702,0.00340777606045763,-0.012908025705164,0.000450456451829943,0.0675997899793814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGM2,Phosphoglucomutase-2,39649,0.0118673286095381,0.00650233776504671,-0.000877253409953462,0.0246119106290297,0.0680149682549618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,39657,-0.0134433154912616,0.00740353045198276,-0.0279542351771478,0.00106760419462464,0.0694284430543925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0125884620675407,0.00693729219797531,-0.00100863064049092,0.0261855547755723,0.0696113634428618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00669303834720427,0.00369698974775861,-0.0139391382528111,0.000553061558402604,0.0702607482953359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAYN,Layilin,41997,-0.00691580859266714,0.00383549598772143,-0.0144333807286012,0.000601763543266866,0.0713939164253255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0119436993700366,0.00662399919936136,-0.0010393390607117,0.0249267378007848,0.0714006972599346
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSHB,Follitropin subunit beta,39638,-0.00791638488529262,0.00439451619708819,-0.0165296366315855,0.000696866861000232,0.0716634290898792
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1B,Protein phosphatase 1B,39657,0.0118948851732997,0.00660394059303311,-0.00104883838904517,0.0248386087356446,0.0717017614399329
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL1,Delta-like protein 1,42181,-0.00590603581110001,0.00328697440577479,-0.0123485056464186,0.000536434024218568,0.0723895783021464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAN,Versican core protein,42249,-0.00578377076368931,0.00322181337313006,-0.0120985249750242,0.000530983447645603,0.0726453692158421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMCH,Pro-MCH,39575,-0.0158463729076434,0.00883597759741523,-0.0331648889985772,0.00147214318329046,0.0729377630565289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0134312611032154,0.0074917821062738,-0.00125263182508127,0.028115154031512,0.0730316908837766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNG,Uracil-DNA glycosylase,39919,0.00675769985288863,0.00377075520473387,-0.000632980348389757,0.014148380054167,0.0731381493284458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO3,R-spondin-3,42262,0.00538983510968714,0.00300876193474347,-0.000507338282410067,0.0112870085017843,0.0732545072736517
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0182576902758421,0.0101933809867428,-0.00172133645817374,0.0382367170098579,0.0732997080700235
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,39649,0.00704087900018129,0.00393164826106441,-0.000665151591504951,0.0147469095918675,0.0733493590156755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRLB,Fc receptor-like B,41843,0.011817857188498,0.00660573485441962,-0.00112938312616444,0.0247650975031605,0.0736328463374301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A3,Protein S100-A3,39919,0.00816914816496815,0.00457012500015013,-0.000788296835326111,0.0171265931652624,0.0738817004004199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS2,Podocin,39657,-0.0194553750391024,0.0109081144336663,-0.0408352793290883,0.00192452925088353,0.0745211416902206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5,Interleukin-5,41913,0.026370716905719,0.0147977214122363,-0.00263281706226414,0.0553742508737021,0.0747590434125183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSPN,Claspin,41820,0.00676572862379633,0.00381060203454834,-0.000703051363918419,0.0142345086115111,0.0758381619712596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX1,Neuronal pentraxin-1,42137,0.00792531714904471,0.00447349683381831,-0.000842736645239178,0.0166933709433286,0.0764808672372197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0158917618686047,0.00897113070017806,-0.0334751780409537,0.00169165430374428,0.0765163794596231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00431932990228743,0.00244680923216962,-0.000476416192765036,0.00911507599733989,0.0775371572628271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR4,Toll-like receptor 4,39657,0.00534248820909842,0.00303905254365061,-0.000614054776456775,0.0112990311946536,0.0787844788771834
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NINJ1,Ninjurin-1,41843,0.0102197182017796,0.00582180969483291,-0.00119102880009286,0.0216304652036522,0.0792106991575268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM3,Paralemmin-3,39575,0.0142501529885192,0.00812061461719686,-0.00166625166118666,0.030166557638225,0.0793193503036066
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD9,Enhancer of filamentation 1,39657,0.00635837781151636,0.00362480675303173,-0.000746243424425823,0.0134629990474585,0.079436145429764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00570393195806442,0.0032519437778978,-0.0120777417627441,0.000669877846615268,0.0794563519284106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH4,Myosin-4,39575,-0.00859750459166907,0.00490641896608517,-0.018214085765196,0.00101907658185785,0.0797506280387919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,42185,0.00405780346316109,0.00231619592192148,-0.000481940543805019,0.00859754747012719,0.0798091241190853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0159658159744048,0.00911835078373129,-0.00190615156170852,0.0338377835105182,0.0799764525113775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0119540097558141,0.00683327658926532,-0.0253472318707741,0.00143921235914591,0.080247790754878
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00908323593490767,0.0051945264472423,-0.00109803590168723,0.0192645077715026,0.0803852182094053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00500593758261491,0.00286509549762321,-0.0106215247579564,0.000609649592726586,0.0806228540136386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0129230704326448,0.007396756557204,-0.00157457241947503,0.0274207132847647,0.0806424689241025
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBN,Ameloblastin,41913,-0.00511045000972083,0.00293046037581746,-0.010854152346323,0.000633252326881381,0.0811984095238506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP2,Guanylate-binding protein 2,41913,0.0113221794164551,0.00649652462946632,-0.00141100885729888,0.0240553676902091,0.081390668669194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.0067907989268975,0.00390513662928125,-0.000863268866493745,0.0144448667202887,0.0820724522823547
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR1,Folate receptor alpha,42110,0.00548822549884657,0.00315948808521281,-0.000704371148170536,0.0116808221458637,0.082399085673145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,39638,0.00717055157443991,0.00414692423848333,-0.00095741993298742,0.0152985230818672,0.083814633562592
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00751283780425536,0.00437072989273315,-0.00105379278550161,0.0160794683940123,0.085660333458095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDNRB,Endothelin receptor type B,39657,0.00803459696372207,0.00469149320790213,-0.00116072972376611,0.0172299236512102,0.0868163211742272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B4,Protein ATP1B4,39560,-0.00767869651753833,0.0044856247627681,-0.0164705210525638,0.00111312801748715,0.0869534369025627
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,39929,0.00502025023086837,0.00293397047561538,-0.000730331901337779,0.0107708323630745,0.0870942214754979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF7,Fibroblast growth factor 7,39560,-0.0142262761642086,0.0083242129883658,-0.0305417336214055,0.0020891812929884,0.0874748951212793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00556453969813935,0.0032775343811213,-0.000859427688858395,0.0119885070851371,0.089576330682309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00270424702111687,0.00159331256060031,-0.00582713963989348,0.000418645597659733,0.0896771424625246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00936716296090774,0.00551959700195799,-0.00145124716292993,0.0201855730847454,0.0897106174769728
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00542046388684834,0.00320012310614764,-0.000851777401201036,0.0116927051748977,0.0903218040500332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00854387753541232,0.00504601285358363,-0.0013463076576116,0.0184340627284362,0.0904461066720187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSP90B1,Endoplasmin,41774,0.0115379497887264,0.0068147985675361,-0.0018190554036444,0.0248949549810971,0.0904652623979571
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAV,Integrin alpha-V,42262,-0.00301156258617416,0.00177968648732983,-0.00649974810134063,0.000476622928992304,0.090633100867375
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,39657,0.0073724053847608,0.00435719159958764,-0.00116769015043096,0.0159125009199526,0.0906725223550431
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0107636271006572,0.00637275418929844,-0.00172697111036776,0.0232542253116821,0.0912465133320502
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM25,RNA-binding protein 25,39560,-0.00846667813282368,0.00501487092108741,-0.018295825138155,0.00136246887250764,0.0913793667564922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0146857443986101,0.00874050479060661,-0.0318171337881991,0.00244564499097885,0.0929480592425491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK3,Prostate-specific antigen,39966,0.0205885709111311,0.0122617423965474,-0.00344444418610173,0.0446215860083639,0.0931619616619824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00718014174494931,0.00427964041487961,-0.00120795346821473,0.0155682369581133,0.0934253359729925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42100,-0.00312820393774732,0.00186532577790911,-0.00678424246244919,0.000527834586954545,0.0935601182510933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0537120134744077,0.0320678822949029,-0.00914103582360191,0.116565062772417,0.0939676898420922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00818928750055865,0.00491105495985264,-0.0178149552218698,0.00143638022075253,0.0954391616962334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00866327271363754,0.00519854984162195,-0.0188524304032166,0.00152588497594147,0.0956412696091574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0104848661798001,0.00629202194708336,-0.00184749683648326,0.0228172291960835,0.0956673143561423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00629408044326726,0.00378388606119288,-0.00112233623667079,0.0137104971232053,0.0962579386247364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,39575,0.0121033459392656,0.00727739197346545,-0.00216034232872665,0.0263670342072579,0.0963123004657236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00929740289215209,0.00559598342220877,-0.0202655303996813,0.0016707246153771,0.096653205293163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0163369494903745,0.0098448257321527,-0.00295890894464482,0.0356328079253938,0.0970546433059825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00617124585266178,0.00372265871166103,-0.00112516522219385,0.0134676569275174,0.0973955963894886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0145271370988042,0.0087658798152564,-0.0317082615367068,0.00265398733909832,0.0974997599790596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF9,Fibroblast growth factor 9,39539,0.00729462432158086,0.00441331519913886,-0.0013554734687313,0.015944722111893,0.0983865729967415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL1,Interferon lambda-1,41839,0.00805357223715887,0.00487349933747837,-0.00149848646429873,0.0176056309386165,0.0984515890726946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,41839,0.00838832754938133,0.00507739793487279,-0.00156337240296932,0.018340027501732,0.0985395505140249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTOA,Otoancorin,39586,-0.00929399315255523,0.00562760594691347,-0.0203241008085056,0.00173611450339517,0.0986650311796307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00984304703471209,0.00597788830299504,-0.0215597081085824,0.00187361403915819,0.0996738421661432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTKN2,Rhotekin-2,39575,-0.00897297206866722,0.00545273033635121,-0.0196603235279156,0.00171437939058116,0.0998763225190339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.006071079163288,0.00370636119738871,-0.00119338878359388,0.0133355471101699,0.101441395941419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0146727885180188,0.00896880343600118,-0.00290606621654354,0.0322516432525811,0.101872359305188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",39586,0.0143098413347579,0.00881323663443603,-0.00296410246873676,0.0315837851382525,0.104473652761303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42070,0.00450983948580389,0.00277931121715885,-0.000937610499827451,0.00995728947143522,0.104688406300041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,41839,0.0069253594255625,0.00427379558010274,-0.00145127991143888,0.0153019987625639,0.105165119467964
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAL,Galanin peptides,42185,-0.0115070771332698,0.00713027334032751,-0.0254824128803117,0.00246825861377214,0.106586675587921
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAG,S-arrestin,39586,-0.0090081827402032,0.00559989284197949,-0.019983972710483,0.00196760723007661,0.107724944876316
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0119411716892574,0.00742372481250371,-0.0264916723217647,0.00260932894324989,0.107751198318072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0075228828366178,0.00468012608274195,-0.016695929958792,0.00165016428555643,0.107993130867088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD8,Frizzled-8,39586,0.00741313429984028,0.00461222325307004,-0.00162682327617701,0.0164530918758576,0.108021691865197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00930715188970637,0.00579520076352395,-0.0206657453862133,0.00205144160680057,0.108300232285381
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0113178862153321,0.00706612174742595,-0.025167484840287,0.00253171240962274,0.109242855307886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR5,Proline-rich protein 5,39657,0.00807781701149224,0.00505144533443412,-0.00182301584399863,0.0179786498669831,0.109824723484958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00620097726789025,0.00387807619736885,-0.0138020066147332,0.00140005207895269,0.109853009815216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA4,Apolipoprotein A-IV,39979,0.00587626110676837,0.00368567548006971,-0.00134766283416827,0.013100185047705,0.11088516984044
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00368809177885105,0.00231599090549194,-0.00822743395361525,0.000851250395913153,0.111313033172003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.00614839071173567,0.00386402555023606,-0.0137218807901983,0.001425099366727,0.111590644685992
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00431592032179414,0.00271443870051917,-0.00963622017481171,0.00100437953122343,0.111865798219613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSG1,Tryptase gamma,39657,0.00445245234895445,0.00280503701396773,-0.00104542019842229,0.0099503248963312,0.112471929330698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,39575,0.00559129847695955,0.00352780717258987,-0.00132320358131659,0.0125058005352357,0.113012915017643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.00673055906783686,0.00424766100746327,-0.00159485650679115,0.0150559746424649,0.113095859682137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EP300,Histone acetyltransferase p300,39657,0.0052213776951871,0.00329631986104577,-0.0012394092324626,0.0116821646228368,0.11322183221528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00532303784808144,0.00336652545229306,-0.00127535203841297,0.0119214277345758,0.113863689128432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0104038546340876,0.00659038661461597,-0.0233210123987349,0.00251330313055971,0.114447240170519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00743452314467116,0.00471836623516498,-0.0166825209655945,0.0018134746762522,0.115132997106418
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00789722291554821,0.00501552345251334,-0.0177276488824743,0.00193320305137793,0.115387812150546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3G,Semaphorin-3G,39736,0.00766191292377538,0.00487799751874643,-0.00189896221296762,0.0172227880605184,0.116278748398144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00569761713761908,0.0036429875671617,-0.012837872769256,0.00144263849401786,0.117847394004454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,41839,0.00925968767743366,0.00595606527148406,-0.00241420025467509,0.0209335756095424,0.120049719208797
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBLN2,Fibulin-2,39966,-0.00534682042248841,0.00344073622678153,-0.0120906634269802,0.00139702258200339,0.120218059796882
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00794386570316961,0.00512107276508979,-0.00209343691640637,0.0179811683227456,0.120874859721061
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP10,Bone morphogenetic protein 10,39736,0.00467983132302032,0.0030299617069267,-0.00125889362255601,0.0106185562685967,0.122491235269602
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMA,Repulsive guidance molecule A,42249,-0.00531095570975642,0.00344442087798293,-0.012062020630603,0.00144010921109013,0.123120855707286
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.00494068238069695,0.00320614430233073,-0.0112247252132652,0.00134336045187129,0.123339006924392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0069382334327078,0.00455381789861388,-0.015863716513991,0.00198724964857541,0.127635259375063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00786937893974565,0.00517534419397734,-0.00227429568044994,0.0180130535599412,0.128400282018039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4,Interleukin-4,41913,0.0153246004399221,0.0101106725329707,-0.00449231772470048,0.0351415186045448,0.129622620416625
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN4,Nectin-4,42181,-0.00544464149264764,0.00360014649791081,-0.0125009286285528,0.00161164564325755,0.130470945130342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00791123908629334,0.00523601645350216,-0.0181738313351576,0.00235135316257088,0.130835858316372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YY1,Transcriptional repressor protein YY1,39657,0.00449354052253866,0.00298624107135374,-0.00135949197731467,0.010346573022392,0.132417419508446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD2,Glutamate decarboxylase 2,39657,-0.00729080800553701,0.00485023593595121,-0.0167972704400014,0.00221565442892737,0.132819579640464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00795211204078099,0.00535358915490307,-0.018445146784391,0.00254092270282904,0.137471993409244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX33,Testis-expressed protein 33,39757,-0.00608528816764834,0.00412908491468016,-0.0141782946004214,0.00200771826512477,0.140573913485706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0085625750227608,0.00583061596693955,-0.00286543227244071,0.0199905823179623,0.141981532247769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD177,CD177 antigen,42123,-0.0202258273303229,0.0137977753437583,-0.0472694670040892,0.00681781234344344,0.142705330033724
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR1,Toll-like receptor 1,39657,0.00419050437935832,0.00286525770252146,-0.00142540071758374,0.00980640947630039,0.143626455306499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,39657,0.0111885628888668,0.00765269415209377,-0.003810717649237,0.0261878434269706,0.143758026667438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,H2AP,Huntingtin-interacting protein M,39560,-0.00786954822078926,0.00539602316241267,-0.0184457536191181,0.00270665717753957,0.144759586090498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRAXIN,Draxin,42016,0.00664055196820169,0.004556978310474,-0.00229112552032736,0.0155722294567307,0.145077126516216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0118182276494263,0.00813720034096169,-0.00413068501885865,0.0277671403177112,0.146422275187217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.0057428020942852,0.00396545989616731,-0.00202949930220272,0.0135151034907731,0.147583047658715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00465911962447509,0.00323362397635447,-0.00167878336917968,0.0109970226181299,0.149654550955148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.0094381617199535,0.00657278321347183,-0.0223208168183583,0.00344449337845128,0.151045745444514
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TUBB3,Tubulin beta-3 chain,39586,-0.00439663192591274,0.00306566534213122,-0.0104053359964899,0.00161207214466445,0.151557181766077
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFRC,Transferrin receptor protein 1,42200,0.0057500152110588,0.00401171802358868,-0.00211295211517501,0.0136129825372926,0.151793702031027
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",39929,0.00905670843385457,0.00635145796182666,-0.00339214917132568,0.0215055660390348,0.153917284337861
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,39657,0.00495574006299246,0.00347953575976025,-0.00186415002613763,0.0117756301521226,0.154401400048343
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,39657,0.00311152406584525,0.00218473642801511,-0.00117055933306437,0.00739360746475486,0.15441383209447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00768966598293626,0.00540040929809348,-0.0182744682071995,0.00289513624132696,0.154502199695073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,39649,0.00841448592422369,0.00594044401326466,-0.00322878434177504,0.0200577561902224,0.156664892384716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNN,Tenascin-N,39966,0.00653838280163864,0.00462945058865668,-0.00253534035212845,0.0156121059554057,0.157875691478309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.00714365571726773,0.00507307972598339,-0.0170868919801952,0.00279958054565971,0.159114909174832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00698517281976642,0.0049636501250876,-0.00274358142540528,0.0167139270649381,0.159377039619371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0054515834474619,0.00387696057373382,-0.00214725927705639,0.0130504261719802,0.159708094456173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN1,Contactin-1,42310,-0.00401633757441482,0.0028599748786696,-0.00962188833660724,0.00158921318777759,0.160244397228048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM19,Probable RNA-binding protein 19,39575,-0.00722013263777935,0.00514941044300049,-0.0173129771060603,0.00287271183050162,0.160905305343811
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPE4,NXPE family member 4,39575,-0.00480188304712516,0.00342609191709178,-0.011517023204625,0.00191325711037472,0.161074114530828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNPO1,Transportin-1,39757,0.00529085359725065,0.00379864133054233,-0.00215448341061231,0.0127361906051136,0.163699594414378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0110253028595231,0.00796125384831584,-0.00457875468317595,0.0266293604022221,0.166119432574597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD9,COMM domain-containing protein 9,39919,0.00589288411002066,0.00426780639160401,-0.0024720164175232,0.0142577846375645,0.16737514533096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00602198175865997,0.0043660991227277,-0.00253557252188631,0.0145795360392063,0.16783739309913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42119,0.00715429496325709,0.00519380242225686,-0.00302555778436635,0.0173341477108805,0.168390504647445
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,39649,-0.0099142674439761,0.00721497843870405,-0.024055625183836,0.00422709029588383,0.169431389114769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00863106894595045,0.00630093820782535,-0.00371876994138723,0.0209809078332881,0.170775195536124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH23,Cadherin-23,39929,-0.00391923698878418,0.00286489774560556,-0.00953443657017108,0.00169596259260273,0.171332994882694
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,41913,-0.00934798084927197,0.00684523316535336,-0.0227646378533645,0.0040686761548206,0.172081633939817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00791523963504958,0.00580234101899108,-0.00345734876217295,0.0192878280322721,0.172549666596995
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00801291452444565,0.00588096056046586,-0.0195395972229587,0.00351376817406743,0.173062402985442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00607723918960434,0.00446865191102453,-0.00268131855600374,0.0148357969352124,0.173862104556356
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00854330765227477,0.00629856884481151,-0.0208885025881053,0.00380188728355579,0.175003219219869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANK2,Ankyrin-2,39575,-0.0101023961415508,0.00748475910089454,-0.0247725239793041,0.00456773169620255,0.177130776546613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKLR,Pyruvate kinase PKLR,42143,0.00900183147752969,0.0066713588254079,-0.00407403182026979,0.0220776947753292,0.177255144452297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAVL4,ELAV-like protein 4,39586,0.0118240803659657,0.00877984190213263,-0.00538440976221421,0.0290325704941457,0.178094845285934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.01085207592296,0.00811114577740925,-0.0267499216466821,0.00504576980076214,0.180949736851726
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00958645148554213,0.00718650025399093,-0.0236719919833644,0.00449908901228009,0.182247035292756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS2,Thrombospondin-2,42137,0.00549906666160883,0.00413823973885128,-0.00261188322653968,0.0136100165497573,0.183922508794051
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00584022645212782,0.00439652478858384,-0.0027769621334965,0.0144574150377521,0.184081962711626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH2,Growth hormone variant,41843,0.0229483507799504,0.0173715070542087,-0.0110998030462987,0.0569965046061994,0.18651286564946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA1,Laminin subunit alpha-1,39575,-0.00728117686059436,0.00553464045583052,-0.0181290721540222,0.00356671843283345,0.18834771476424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",39575,-0.00563901329552424,0.00431682708694468,-0.0140999943859358,0.00282196779488733,0.191482493946479
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL1,Follistatin-related protein 1,39638,-0.00324661619348228,0.00249074591912913,-0.00812847819497538,0.00163524580801082,0.192441043602314
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN4,Prefoldin subunit 4,39560,-0.00732161747652253,0.00565316271078607,-0.0184018163896632,0.00375858143661817,0.1953004189723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00676996084846861,0.00522956363244699,-0.00347998387112748,0.0170199055680647,0.195500815610684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00793930169794257,0.00613906785322149,-0.0199718746902567,0.00409327129437156,0.1959545197072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX1B,Syntaxin-1B,39649,0.0055106316670685,0.00430181345784522,-0.00292092271030813,0.0139421860444451,0.200219847767019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00470576114180524,0.00367689085108077,-0.00250094492631308,0.0119124672099236,0.200635042378394
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXOSC10,Exosome component 10,39575,-0.00798797335338539,0.00624228403870048,-0.0202228500692383,0.00424690336246755,0.200693357606371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOS,Proto-oncogene c-Fos,39539,-0.00493733961268079,0.00386675185288975,-0.0125161732443447,0.00264149401898311,0.201675234579738
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,39586,0.00813071127077301,0.00637376930195553,-0.00436187656105983,0.0206232991026059,0.202105551120541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",41900,0.0114414664305484,0.00899138211444877,-0.00618164251377119,0.029064575374868,0.203220427460946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,41839,0.00895523990569464,0.00704922841362409,-0.00486124778500858,0.0227717275963979,0.203969552187054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,39657,0.00758097694622024,0.00599006345608626,-0.00415954742770884,0.0193215013201493,0.205685825619942
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0143247568230147,0.0113456436804888,-0.0365622184367728,0.0079127047907434,0.206767808390833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00794664742262513,0.00629640835602558,-0.00439431295518501,0.0202876078004353,0.206942493552845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH17,Cadherin-17,42145,-0.0091719847585194,0.0073023607773389,-0.0234846118821036,0.00514064236506485,0.209126729919774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00970405491003224,0.00775015451460875,-0.0248943577586654,0.00548624793860091,0.21055601981079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00926758657698893,0.00740739652262113,-0.00525091060734849,0.0237860837613264,0.210914735133193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX2,Neuronal pentraxin-2,39966,-0.00457312945144801,0.00366573904769926,-0.0117579779849386,0.00261171908204253,0.212227928562918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR2,Toll-like receptor 2,39757,-0.00308954010577609,0.00247810432528514,-0.00794662458333496,0.00176754437178277,0.21252074887894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.00780503889003276,0.00627476463296568,-0.00449349979057998,0.0201035775706455,0.213566362465783
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00694275633996533,0.00558262637179391,-0.00399919134875074,0.0178847040286814,0.213660080013562
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,41843,0.00616922138807125,0.0049615695078399,-0.00355545484729495,0.0158938976234375,0.213742046289394
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00547388378079128,0.00442883614465403,-0.0141544026243132,0.00320663506273061,0.216498055372048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYAL1,Hyaluronidase-1,42077,-0.0030525999138656,0.00247055634530838,-0.00789489035067001,0.00178969052293882,0.216631758218935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4C,Semaphorin-4C,42070,-0.00365614242534732,0.00298222002546275,-0.0095012936752543,0.00218900882455967,0.22022759381042
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRND,Prion-like protein doppel,39929,0.00640974021444522,0.00523339436898042,-0.0038477127487564,0.0166671931776468,0.220684779038499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00515124232145124,0.0042286760718096,-0.0134394474221981,0.00313696277929558,0.223185924311854
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00655527469133839,0.00540253363916178,-0.00403369124141869,0.0171442406240955,0.225014155547545
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00502918593941138,0.00415145001138294,-0.00310765608289918,0.0131660279617219,0.225757205263289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2,T-cell surface antigen CD2,39575,-0.00504371525799022,0.00416719131007294,-0.0132114102257332,0.00312397970975274,0.226174803422341
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00539379880253751,0.00445812585647734,-0.00334412787615807,0.0141317254812331,0.226350047579049
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,41946,-0.00497136716233626,0.00413100422579724,-0.0130681354448989,0.00312540112022634,0.228831989369814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN1,Transcobalamin-1,39806,-0.00459029431253458,0.00381718849474096,-0.0120719837622269,0.00289139513715771,0.229182579872179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00681821934789886,0.00573708064970235,-0.0180628974213155,0.00442645872551774,0.234682466564587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00603777860595905,0.00508964467911378,-0.0160134821770221,0.00393792496510396,0.235534541895765
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL28,C-C motif chemokine 28,42075,0.00739330377546965,0.00631118296020611,-0.00497661482653433,0.0197632223774736,0.241434297510114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMCN2,Hemicentin-2,39721,-0.00726737986726384,0.006216743640525,-0.0194521974026928,0.00491743766816516,0.242428262870847
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRXN3,Neurexin-3,39649,0.00450269810684301,0.00385283566921487,-0.00304885980481814,0.0120542560185042,0.242561341154865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,39560,0.0054524783629447,0.00467352271524487,-0.00370762615893524,0.0146125828848246,0.24336735091628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,39657,0.0082464600389606,0.00707363265521148,-0.0056178599652539,0.0221107800431751,0.243719372448307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP6,Guanylate-binding protein 6,39575,-0.00556461792590598,0.00478816379663087,-0.0149494189673025,0.00382018311549053,0.245195285194387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,39966,0.00291333891938985,0.00252552211910173,-0.00203668443404954,0.00786336227282923,0.24870524807659
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKKL1,Dickkopf-like protein 1,42070,-0.0103287356313339,0.00896975167932477,-0.0279094489228104,0.00725197766014267,0.249543981925169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,41989,0.00342521773102946,0.0029802642882142,-0.00241610027387037,0.00926653573592928,0.250452829981355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBN2,Fibrillin-2,39649,0.0073648723778287,0.00643643474963782,-0.00525053973146142,0.0199802844871188,0.252545925197574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WNT9A,Protein Wnt-9a,41913,-0.00355686104541661,0.00312205892025052,-0.00967609652910763,0.00256237443827442,0.254611992907667
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36A,Interleukin-36 alpha,39657,-0.00698888101907712,0.0061502204563525,-0.019043313113528,0.00506555107537378,0.255829434751428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0029099383244166,0.00256560184067567,-0.00211864128330772,0.00793851793214093,0.256725581638913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,39695,-0.00417963987715394,0.00369184947669947,-0.0114156648514849,0.00305638509717702,0.257605807385211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00832460031081423,0.00738348960556884,-0.00614703931610068,0.0227962399377292,0.259571653062493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STEAP4,Metalloreductase STEAP4,39586,0.00878569882764602,0.00779762586127005,-0.00649764786044327,0.0240690455157353,0.259887781314044
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,39757,-0.00535075202030062,0.00475425393646882,-0.0146690897357795,0.00396758569517826,0.260415750115527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEF,Thyrotroph embryonic factor,39575,0.00514557287018697,0.00458621460649258,-0.00384340775853849,0.0141345534989124,0.261901811872698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN3,Perilipin-3,42145,0.00513518505413813,0.00458523958854222,-0.00385188453940462,0.0141222546476809,0.262759948465713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGF,Beta-nerve growth factor,42016,0.00145392327201983,0.00130516291214328,-0.001104196035781,0.00401204257982066,0.265308416707081
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0106185994371215,0.00954883734813672,-0.0293343206394695,0.00809712176522647,0.266148606724973
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,39929,0.00479588509756823,0.00434899471127485,-0.00372814453653046,0.0133199147316669,0.270156057350045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0117532036673908,0.0106861840694056,-0.00919171710864414,0.0326981244434258,0.271421438998086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00778709315528997,0.00708180593886434,-0.0216674327954641,0.00609324648488415,0.271533900961901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,39560,-0.00467932979373272,0.00427175219074035,-0.0130519640875838,0.00369330450011837,0.273360128407922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUOX2,Dual oxidase 2,41900,0.0082411866927669,0.007526680327569,-0.00651110674926834,0.0229934801348021,0.273567213974283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSB,Lupus La protein,41839,0.00689784216440118,0.00631189177892346,-0.00547346572228879,0.0192691500510912,0.274487116644035
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELB,Transcription factor RelB,39657,0.00548193174557236,0.00502206316039996,-0.00436131204881156,0.0153251755399563,0.275046085078745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,39575,-0.0084698672414589,0.00776943087272129,-0.0236979517519926,0.00675821726907483,0.275669751467269
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC4A1,Band 3 anion transport protein,39966,0.00554033670663589,0.00510017215750772,-0.00445600072207924,0.015536674135351,0.277367616891458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBX2,Chromobox protein homolog 2,39575,-0.00458012278823341,0.00422694565379414,-0.0128649362696699,0.00370469069320311,0.278586513084442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNW1,Interferon omega-1,39575,-0.00409286428001877,0.00377849241096586,-0.0114987094055119,0.00331298084547432,0.278743303584504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00764733775253231,0.00706460136677753,-0.0214939564314163,0.00619928092635165,0.279060058364976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.0037317119546662,0.00345037057918291,-0.0104944382898647,0.0030310143805323,0.279476469637067
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM1,Myomesin-1,39586,0.00564824604949529,0.00524509360488111,-0.00463213741607168,0.0159286295150623,0.28156522202457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,39575,0.00448725600605272,0.0041937098778513,-0.00373241535453584,0.0127069273666413,0.284644295627646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BEX3,Protein BEX3,39560,-0.00534467811802513,0.00501025151484001,-0.0151647710871115,0.00447541485106129,0.286108932315831
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00870967853896927,0.00816475019977507,-0.0247125889305284,0.00729323185258988,0.286111627061199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00652644991783724,0.00612069933571295,-0.0185230206158346,0.00547012078016014,0.286315305115849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOP56,Nucleolar protein 56,39575,0.0127337228689552,0.0119955148628878,-0.0107774862623049,0.0362449320002154,0.288467770953402
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.004795654164511,0.00452314406519397,-0.0136610165322912,0.00406970820326918,0.289050734109172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTNNA1,Catenin alpha-1,39586,-0.00383087926033361,0.00362217174719543,-0.0109303358848367,0.00326857736416944,0.290252229975923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00563508831512855,0.00533079369640597,-0.0160834439600843,0.00481326732982715,0.290497239309093
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00315907663043692,0.00299292710757289,-0.00902521376127978,0.00270706050040593,0.291208967007971
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJP3,Tight junction protein ZO-3,39586,-0.00469925836560376,0.00445512715731946,-0.0134313075939499,0.00403279086274239,0.291541003064141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABO,Histo-blood group ABO system transferase,39990,0.0163615679615977,0.0155172710933589,-0.0140522833813857,0.046775419304581,0.291717548359473
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP1,Retinol-binding protein 1,39649,0.00787885815789119,0.00752533046690991,-0.00687078955725224,0.0226285058730346,0.295132460905829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00700199034860208,0.00670323324093754,-0.00613634680363549,0.0201403275008396,0.296245000448742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,41839,0.00567517944272832,0.00546012446852807,-0.0050266645155867,0.0163770234010433,0.298644020296022
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRC,Chymotrypsin-C,42122,0.00724851729754298,0.0069973476370351,-0.00646628407104582,0.0209633186661318,0.300269663875237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00517750768056442,0.00500067273779816,-0.00462381088551998,0.0149788262466488,0.300518120492124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK1,Kallikrein-1,42016,-0.0141277318534598,0.0136888559559853,-0.040957889527191,0.0127024258202714,0.302062232525681
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00541729809597825,0.00525752999690744,-0.0157220568899168,0.00488746069796033,0.302846524204976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL24,Interleukin-24,41913,-0.00529530030882728,0.00516580437757632,-0.0154202768888769,0.0048296762712223,0.30534976954788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.00311959014954762,0.00304980303775921,-0.00909720410355567,0.00285802380446044,0.30638181615801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00236860027915227,0.00232839916728611,-0.00219506208872852,0.00693226264703305,0.309045425086883
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRK1,Protein BRICK1,41839,0.0049397129257136,0.00486959406937067,-0.00460469145025292,0.0144841173016801,0.31041078538759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00496463311970991,0.0048971037506518,-0.00463369023156761,0.0145629564709874,0.310701193323768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00837370793728987,0.00826397932810195,-0.00782369154578995,0.0245711074203697,0.310949610240437
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00238115784309911,0.00235576801944921,-0.00223614747502135,0.00699846316121956,0.312144342574846
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00535607006232237,0.00531772912866405,-0.00506667902985917,0.0157788191545039,0.31385589955061
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,42054,0.00674888484060248,0.00672978592722833,-0.00644149557676504,0.01993926525797,0.315957082301335
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00362121541605987,0.00361541458157793,-0.0107074279959526,0.00346499716383287,0.316552756799766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0036253900988756,0.00362290678381279,-0.00347550719739748,0.0107262873951487,0.317000803177653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REST,RE1-silencing transcription factor,39560,-0.00365809179483837,0.00366664248530304,-0.0108447110660323,0.00352852747635558,0.318462411394156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,39657,0.00977976344896907,0.00980770476296594,-0.00944333788644417,0.0290028647843823,0.318713000678929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00324749847711704,0.00326186863395143,-0.00964076099966185,0.00314576404542776,0.31946918700889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPA33,Cell surface A33 antigen,42070,0.0141527949382396,0.0143225689359139,-0.0139194401761517,0.042225030052631,0.323098703194088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00382578088932495,0.00387871855491291,-0.0114280692569543,0.00377650747830436,0.323981581737936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00589758079867746,0.00601507487809054,-0.00589196596238001,0.0176871275597349,0.326877426156715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00439019688477613,0.00447767959268854,-0.0131664488864457,0.00438605511689341,0.326879343706914
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD160,CD160 antigen,42296,0.0050707896758248,0.00518735617458771,-0.00509642842636711,0.0152380077780167,0.328324728835937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AREG,Amphiregulin,42070,-0.0040942847272275,0.00419362301662018,-0.012313785839803,0.00412521638534805,0.32892737819933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGR,Progesterone receptor,39657,0.0103644680607417,0.0107296722836444,-0.0106656896152013,0.0313946257366847,0.334083746134551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00284126215160186,0.00295298363630049,-0.0029465857755471,0.00862911007875081,0.335983428556801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,39586,0.0110537638043207,0.0116373948486882,-0.0117555300991082,0.0338630577077496,0.342210055519173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRC1,Macrophage mannose receptor 1,39990,0.00287066848552671,0.00304174397165197,-0.00309114969891114,0.00883248666996457,0.345313634790432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,39586,0.00745964664396946,0.00790537957312826,-0.00803489731936192,0.0229541906073008,0.345386405510452
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG3,Secretogranin-3,42144,-0.00330643195434388,0.00356390129698855,-0.0102916784964414,0.00367881458775368,0.353550518719317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASQ2,Calsequestrin-2,39575,0.00470736426689172,0.0050956416520378,-0.00528009337110238,0.0146948219048858,0.355609690852202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RETN,Resistin,42105,0.00423342446784516,0.0046023573802326,-0.00478719599741073,0.0132540449331011,0.357673708418315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.026259592916745,0.0285597503743779,-0.0822367036505257,0.0297175178170357,0.357874289948349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.0035876049903484,0.00390257057468584,-0.0112366433167327,0.00406143333603585,0.357962651816255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLI2,Zinc finger protein GLI2,39657,-0.00323371092045629,0.00355362804599043,-0.0101988218905975,0.00373140004968495,0.362855791093505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00599058799951172,0.00659037544410778,-0.018907723869963,0.00692654787093952,0.363375134542777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42262,-0.00575468251231454,0.00637836267655044,-0.0182562733583534,0.00674690833372432,0.366956239756567
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.00431599800543472,0.00478571944928227,-0.00506401211515852,0.013696008126028,0.367156364934289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00364614685332137,0.00404540505312282,-0.0115751407574421,0.00428284705079937,0.367445580066324
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,39575,-0.00471305319741954,0.00524709820841061,-0.0149973656859043,0.00557125929106525,0.369087505513825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,39560,0.0030007526392817,0.00334191365639752,-0.00354939812725744,0.00955090340582084,0.369250872269033
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN4,Alpha-actinin-4,41913,0.00301733490344917,0.00337952201837334,-0.00360652825256258,0.00964119805946091,0.37196494886641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00251772936191516,0.00282539238996157,-0.00302003972240952,0.00805549844623983,0.3728901323791
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0111897008074231,0.0125862652659786,-0.0134793791138949,0.0358587807287411,0.37400072681992
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00523250325791467,0.00589543030032675,-0.0167875466465551,0.00632254013072576,0.37480104894653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH4,Cadherin-4,39586,0.00440372454506998,0.00498278067550345,-0.00536252557891678,0.0141699746690567,0.376829704352782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0065703620615202,0.00744125275583949,-0.0211552174629656,0.00801449333992519,0.377274788756126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.00374572597322998,0.00425777768707414,-0.00459951829343534,0.0120909702398953,0.379020273611493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.0056108057528448,0.00638558213260726,-0.018126546732755,0.00690493522706543,0.379600500243308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL6,Fc receptor-like protein 6,42119,0.0064121818348515,0.00735185779059964,-0.0079974594347238,0.0208218231044268,0.383122821090859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00331332958303053,0.00380067346494872,-0.01076264957433,0.00413599040826896,0.383346959254766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,39919,0.00410957594200676,0.00472217066897648,-0.00514587856918714,0.0133650304532007,0.384169881605934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,39575,-0.0036208087307217,0.00416227952801291,-0.011778876605627,0.0045372591441836,0.384368595888687
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,39560,0.00372164298718885,0.00428094038395622,-0.00466900016536533,0.012112286139743,0.384673806507878
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYMP,Thymidine phosphorylase,42070,0.00613165844581065,0.00712128757801849,-0.00782606520710559,0.0200893820987269,0.389235593359401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00385421998593826,0.00450613483291153,-0.00497780428656834,0.0126862442584449,0.392385969157559
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TG,Thyroglobulin,39919,-0.00958429947641826,0.0112157437060694,-0.0315671571403143,0.0123985581874778,0.392824047877636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OBP2B,Odorant-binding protein 2b,41979,-0.00523576352669029,0.00613856471912514,-0.0172673503761756,0.006795823322795,0.393713616758443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00456929085167829,0.0053627387610469,-0.00594167711997363,0.0150802588233302,0.394208092772285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC8,Histone deacetylase 8,39657,0.00547461028788359,0.00644619797484553,-0.00715993774281364,0.0181091583185808,0.395745337618477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0153239725673231,0.0181166403746885,-0.0201846425670664,0.0508325877017126,0.397651225559158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLGN,Calmegin,39649,0.00413843123261736,0.00489404156583172,-0.00545389023641281,0.0137307527016475,0.397790852182299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D1,DCN1-like protein 1,39586,-0.00681881280679574,0.00807545717788792,-0.0226467088754561,0.00900908326186458,0.398471450291369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",39575,0.00566018142242269,0.00674521298239714,-0.0075604360230757,0.0188807988679211,0.401408746190735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPE,Coatomer subunit epsilon,41839,0.00416367614984043,0.00497370629102458,-0.00558478818056774,0.0139121404802486,0.402530383425699
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42144,0.00214139979241391,0.00255893771041659,-0.00287411812000261,0.00715691770483043,0.4027020289901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRING1,SREBP regulating gene protein,39560,0.00555930188506684,0.00664936614381291,-0.00747345575680646,0.0185920595269401,0.403136599235465
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00393728657688997,0.00475000558597682,-0.0053727243716246,0.0132472975254045,0.407175028434817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3D,Protein FAM3D,39930,0.00769248581930235,0.00937119557320075,-0.0106750575041711,0.0260600291427758,0.411740478240282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTH3,Cytohesin-3,39560,0.00641974871741862,0.00782969797255598,-0.00892645930879109,0.0217659567436283,0.412277887867872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,39541,0.00424133671559061,0.005179033005796,-0.00590956797576955,0.0143922414069508,0.412836343850895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,41843,-0.00281835827095952,0.0034520029215631,-0.00958428399722319,0.00394756745530415,0.414262383370262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00322047661603771,0.00394687882328901,-0.0109563591096842,0.00451540587760875,0.41454277647095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.00457473299523683,0.00560714688007714,-0.00641527488971437,0.015564740880188,0.414588592755726
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00343416668224025,0.00421906432111822,-0.011703532751632,0.00483519938715146,0.41568291738003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN6,Prefoldin subunit 6,39649,0.00563028314130314,0.00694786042727284,-0.00798752329615162,0.0192480895787579,0.417749515721511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00267758665550949,0.00332907527479486,-0.00384740088308844,0.00920257419410742,0.421235704442229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00307099715979381,0.00382934813366669,-0.0105765195017805,0.00443452518219291,0.42259147693601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,42042,0.00285096672520749,0.00356706174141903,-0.0041404742879738,0.00984240773838879,0.424160785127121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00226930375192993,0.00285676663328477,-0.00332995884930822,0.00786856635316809,0.427002551448307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD48,CD48 antigen,42166,0.00259967347641806,0.00329169962677287,-0.00385205779205677,0.00905140474489289,0.429678059747269
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRL,Prolactin,42249,0.0061796264463253,0.00788114750367751,-0.00926742266088262,0.0216266755535332,0.432993651135564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT1,Diamine acetyltransferase 1,39575,-0.00405632556152464,0.00517991386008914,-0.0142089567272994,0.00609630560425008,0.433592654605227
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,42181,0.00665436257420447,0.0085094631194455,-0.0100241851399087,0.0233329102883177,0.434230802359884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,39958,-0.00297659463553572,0.00380966660436956,-0.0104435411801001,0.00449035190902863,0.434626593925039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDAN1,Codanin-1,39929,0.00180633769288792,0.00234046350034618,-0.00278097076779059,0.00639364615356643,0.440257098209766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHH,Sonic hedgehog protein,39657,-0.00350472528505524,0.00456750225334358,-0.0124570297016087,0.00544757913149819,0.442909036349392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13,Interleukin-13,41913,-0.00399352546240521,0.00520614172363453,-0.0141975632407289,0.00621051231591847,0.443047752783229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,39560,0.00515014684080797,0.00672381744560605,-0.00802853535257989,0.0183288290341958,0.443719109016574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42262,0.00434813488910968,0.00568634294403096,-0.006797097281191,0.0154933670594104,0.444485573250145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA3,Carbonic anhydrase 3,42287,-0.00481120778475083,0.00629614810461319,-0.0171516580697927,0.00752924250029102,0.444790444015008
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00631445977724334,0.00827152749587819,-0.00989773411467791,0.0225266536691646,0.445242931760105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF174,Zinc finger protein 174,39657,0.00300246322325161,0.00393723671164972,-0.00471452073158185,0.0107194471780851,0.445729387699287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL6B,Myosin light chain 6B,39649,0.00744880770125821,0.0097767713688372,-0.0117136641816627,0.0266112795841791,0.446142936758425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00478235660101511,0.00633805842971299,-0.00764023792122236,0.0172049511232526,0.450537627871387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,39649,0.00501920131642946,0.00666273464582958,-0.00803975858939652,0.0180781612222554,0.451270984600079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN7,Tetraspanin-7,39586,-0.00786384157451967,0.0104495253978805,-0.0283449113543655,0.0126172282053262,0.451733549932186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMP,Olfactory marker protein,39586,-0.00386447617404284,0.00513580825414205,-0.0139306603521613,0.00620170800407558,0.451792248790444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,41843,-0.00244890774889322,0.00327074754219081,-0.0088595729315872,0.00396175743380077,0.454033082000936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGB,Secretogranin-1,42210,0.00337424676919056,0.00452675779621932,-0.00549819851139931,0.0122466920497804,0.456042614911634
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00596548735222159,0.00800420260052686,-0.00972274974481106,0.0216537244492542,0.456109711647737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00270193562445505,0.00363711163070373,-0.00442680317172426,0.00983067442063437,0.45757004221102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPT,Microtubule-associated protein tau,41839,0.00420717884163229,0.0056647436937623,-0.00689571879814181,0.0153100764814064,0.457679318638652
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00289582228312505,0.00391745224956265,-0.0105740286922678,0.00478238412601774,0.459794819992563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.010964908876783,0.0148458103267958,-0.0400626971173027,0.0181328793637366,0.460173628856455
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00286213716838975,0.00393285468684031,-0.0105705323545967,0.00484625801781726,0.466781719972728
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00587692623752016,0.00813075579740418,-0.010059355125392,0.0218132076004323,0.469816948899123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNR,Tenascin-R,42016,0.00323535791583068,0.00448703363997638,-0.00555922801852302,0.0120299438501844,0.470893742123631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF20,Fibroblast growth factor 20,39657,-0.00331597878752607,0.00462087106272441,-0.0123728860704659,0.00574092849541378,0.473013550185608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN15,Lipocalin-15,39934,-0.00465729902845721,0.00649239075365999,-0.0173823849056308,0.00806778684871636,0.473174606939313
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00503582635258219,0.00703501850143447,-0.0188244626153937,0.00875280991022936,0.474115778187371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD2,Bromodomain-containing protein 2,39586,0.00266619439528558,0.00375226386197894,-0.00468824277419315,0.0100206315647643,0.477374369390355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00324065296107307,0.0045630964339566,-0.012184321971628,0.00570301604948187,0.477603108523281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLON5,IgLON family member 5,39560,-0.00701875580398969,0.0099245846616667,-0.0264709417408564,0.012433430132877,0.479451629459065
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00331481705919873,0.00468791823563677,-0.0125031368010468,0.00587350268264934,0.47952019409624
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00458125115430896,0.00648908212730671,-0.0081373498152122,0.0172998521238301,0.480207020692968
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1,Integrin beta-1,42167,0.00159329671271234,0.00225814346116377,-0.00283266447116864,0.00601925789659333,0.480462623086383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0036624623292995,0.00521820552670626,-0.00656522050304477,0.0138901451616438,0.482777053119744
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00381578071562659,0.00546009703991119,-0.00688600948259934,0.0145175709138525,0.484658981014424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00749186661654422,0.0107359025053567,-0.0135505022939549,0.0285342355270434,0.485295998525429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,39560,0.00480880986551804,0.00690631248486778,-0.0087275626048228,0.0183451823358589,0.486260771973846
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RUVBL1,RuvB-like 1,41843,0.00736364315311168,0.0106066695828561,-0.0134254292292863,0.0281527155355097,0.487539818830303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00256920396284532,0.00371779767367229,-0.00471767947755236,0.00985608740324301,0.489542808913898
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL9,Interleukin-9,39757,-0.00415223991088662,0.00601206327823988,-0.0159358839362368,0.00763140411446354,0.489799006454393
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,39560,0.00245908099063117,0.00358033653782706,-0.00455837862350987,0.0094765406047722,0.492204667281288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00332072941703668,0.00483541268610504,-0.0061566794477292,0.0127981382818026,0.492253413281618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42070,0.00347569274450551,0.00506475356060302,-0.00645122423427641,0.0134026097232874,0.492566585976201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAEP,Glycodelin,42016,-0.00767976462999431,0.0112219838622977,-0.0296748530000978,0.0143153237401092,0.493766003500626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN2,Contactin-2,42262,0.00317229799945961,0.00471325258979735,-0.0060656770765432,0.0124102730754624,0.500921016019759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MN1,Transcriptional activator MN1,39649,-0.00423708736723886,0.00631068292279414,-0.0166060258959154,0.00813185116143765,0.501970208881562
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NENF,Neudesin,39919,0.00801714526839661,0.0120346101555015,-0.0155706906363864,0.0316049811731796,0.505313419201924
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.00836397278319065,0.0126215651180935,-0.0163742948482726,0.0331022404146539,0.50755336097555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00616333992102754,0.00935499013494383,-0.0244991205855174,0.0121724407434624,0.510019224338711
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00197854533664019,0.00300556731534724,-0.0039123666014404,0.00786945727472078,0.510362950143559
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESPL1,Separin,39560,-0.00371939454831457,0.00571684855763506,-0.0149244177212793,0.00748562862465014,0.515316914121842
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,39919,0.00268027543226526,0.00412577577416013,-0.00540624508508859,0.0107667959496191,0.515936960271673
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNXB,Tenascin-X,42137,-0.0018028513074082,0.00280076404361869,-0.00729234883290082,0.00368664621808442,0.519781012232352
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCL2,Phosducin-like protein 2,39560,-0.00358971789122614,0.00559340056751935,-0.0145527830035641,0.00737334722111178,0.521031168434026
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSND,Barttin,39560,0.00230430364363114,0.00359425810573404,-0.00474044224360758,0.00934904953086985,0.521466641872978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00628485333185675,0.00980420496033507,-0.0129313883904,0.0255010950541135,0.521512365838959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,39649,0.00348653534174078,0.00544324576306469,-0.00718222635386601,0.0141552970373476,0.521844582755267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNLZ,DNL-type zinc finger protein,39586,-0.00577019575703499,0.00904717374513377,-0.0235026562974972,0.0119622647834272,0.523623767796822
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00192847369331349,0.003031651195291,-0.00401356264945687,0.00787051003608384,0.524713315273605
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTN3,Myeloblastin,41800,-0.00327277136175559,0.00515715759884437,-0.0133808002554906,0.00683525753197937,0.525695374229706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,42181,0.00192597002739448,0.00305975867802874,-0.00407115698154185,0.00792309703633081,0.529064026971837
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00437649692454137,0.0069622942714455,-0.00926959984749181,0.0180225936965746,0.529624146703187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSMB,Beta-microseminoprotein,42103,-0.00468838239946009,0.00747741332643433,-0.0193441125192714,0.00996734772035119,0.530665957430062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00468287460228734,0.00748561985824164,-0.00998894031986628,0.019354689524441,0.531601581745723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSN,Gelsolin,39943,-0.00126521013734723,0.00202812147268356,-0.00524032822380701,0.00270990794911255,0.532749474693958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM2,Isthmin-2,39966,0.00284039814341147,0.00464868288129832,-0.00627102030393325,0.0119518165907562,0.541204265006702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",39919,-0.0027526512177732,0.00451533618975315,-0.0116027101496894,0.00609740771414297,0.542124040191809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP4,Caspase-4,39757,-0.0108331171324133,0.0177705568262481,-0.0456634085118596,0.0239971742470329,0.54213230212828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00371780261146334,0.00611351848908486,-0.0157002988500697,0.00826469362714298,0.543114982579009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMI,N-myc-interactor,39875,-0.00472461726757371,0.00780404130101996,-0.0200205382175728,0.0105713036824254,0.544921123662758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBQLN3,Ubiquilin-3,39575,0.00364065642544013,0.00602197839291198,-0.00816242122466735,0.0154437340755476,0.545482877134387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD10,Frizzled-10,39649,0.00384825421520252,0.00639093136593482,-0.00867797126202972,0.0163744796924348,0.547091348316563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR3,Folate receptor gamma,42132,-0.0123755639299351,0.0205624879352754,-0.0526780402830749,0.0279269124232046,0.54728308273495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAG,Myelin-associated glycoprotein,39649,0.00313454979961295,0.00521213502570427,-0.00708123485076743,0.0133503344499933,0.547589540117876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0020338383304445,0.00339547293241755,-0.00868896527798291,0.0046212886170939,0.549192768794002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,39586,-0.00532731537425433,0.00891645080146675,-0.0228035589451292,0.0121489281966205,0.550205681737703
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00206341814789633,0.00347292012662368,-0.00887034159607875,0.00474350530028608,0.552427365635472
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00402148868836974,0.00677998156002813,-0.0092672751692854,0.0173102525460249,0.553098456642332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00341520946045442,0.00577613269787561,-0.0147364295482906,0.00790601062738176,0.554356884217085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00229269702206309,0.00388019112757214,-0.00531247758797831,0.00989787163210449,0.554618148104305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASN,Vasorin,41975,0.00173350958897155,0.00293410881396137,-0.00401734368639272,0.00748436286433583,0.554655716220951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO6,Coronin-6,39586,-0.00246622284067761,0.00418213606439945,-0.0106632095269005,0.00573076384554531,0.555401164204253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00285845030374582,0.00486748771532619,-0.0123987262257851,0.0066818256182935,0.557045312946897
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42262,-0.00383956121512524,0.0065835920693534,-0.0167434016710579,0.00906427924080742,0.559767242503028
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00450571496137269,0.00773958958006904,-0.019675310538308,0.0106638806155626,0.560467588422578
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POF1B,Protein POF1B,39657,-0.00283043735370011,0.00486586311735882,-0.0123675290637234,0.00670665435632318,0.560785506592326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI16,Peptidase inhibitor 16,39990,0.00149652445132367,0.00258428160214381,-0.00356866748887819,0.00656171639152553,0.562541773852032
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00213965646567818,0.00369685258652144,-0.0093854875352602,0.00510617460390384,0.562750931657167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00358446579916388,0.00619949387699796,-0.0157354737980799,0.00856654219975212,0.563147568133514
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,39575,0.00261532547238897,0.00454444049355275,-0.00629177789497442,0.0115224288397524,0.564964994181211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0105566200332523,0.0184300620281884,-0.025566301541997,0.0466795416085017,0.566795876159519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHC1,SHC-transforming protein 1,39560,-0.00714833847901663,0.0125316735062424,-0.0317104185512516,0.0174137415932184,0.568403409938084
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,39649,-0.00243189620314594,0.00435450823845429,-0.0109667323505164,0.00610293994422447,0.576529473230322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00295105832351199,0.00529958246504079,-0.00743612330796796,0.0133382399549919,0.577643100589911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPO,Lactoperoxidase,41647,-0.00365093940463436,0.00659788665297236,-0.0165827972444602,0.00928091843519147,0.580033373037841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTTG1,Securin,39757,0.00245917433049534,0.0044558324933647,-0.00627425735649947,0.0111926060174902,0.581027864378443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,39649,0.00246929900923051,0.00450165148873464,-0.0063539379086894,0.0112925359271504,0.583337880889953
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSD1,Tryptase delta,39934,0.00214264189194036,0.00391449051051145,-0.00552975950866209,0.00981504329254281,0.584141090689459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00312594094318366,0.00574661413674083,-0.0143893046511957,0.00813742276482837,0.586478514691547
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN15,Tetraspanin-15,39575,-0.00292952903939104,0.00538557567579248,-0.0134852573639443,0.00762619928516223,0.586481160903309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00162564406418841,0.00299657512881819,-0.00424764318829524,0.00749893131667205,0.587484568412664
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRN1,Neuritin,39934,0.00201851539876667,0.00372285359584964,-0.00527827764909863,0.00931530844663196,0.587694322053636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLHL41,Kelch-like protein 41,39934,-0.00303552099175937,0.00561510608721373,-0.0140411289226983,0.00797008693917954,0.588794598938292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53BP1,TP53-binding protein 1,39657,-0.00486185096349505,0.00920690604199964,-0.0229073868058143,0.0131836848788242,0.597464357775984
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,39560,0.00483605365632969,0.00917842220129433,-0.0131536538582072,0.0228257611708666,0.598278010396859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00442773301802134,0.00845714785135296,-0.0210037428066731,0.0121482767706305,0.600602518651801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00149012482794713,0.00284822313352184,-0.00409239251375568,0.00707264216964993,0.600861682017654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00394171535853867,0.00759436659656947,-0.0188266738878148,0.0109432431707375,0.603749241764483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN7,Septin-7,39757,-0.00291160956550911,0.00569691055775581,-0.0140775542587105,0.00825433512769228,0.609301156289671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2BP,LRP2-binding protein,39649,-0.00421302746797934,0.00832504758338862,-0.020530120731421,0.0121040657954624,0.612820082350592
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00232056919793791,0.00459799769493621,-0.0113326446800129,0.00669150628413705,0.613783934671128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00143723731872005,0.00286139649291874,-0.00704557444484078,0.00417109980740069,0.615475071003007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL33,Interleukin-33,41913,0.00211674005644088,0.00422587439382459,-0.00616597375545532,0.0103994538683371,0.616449854848193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MELTF,Melanotransferrin,39958,0.00160487524473983,0.00322141376788127,-0.00470909574030746,0.00791884622978712,0.618359968855535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00194040464486905,0.00389849686674519,-0.00958145850368962,0.00570064921395153,0.618681532382406
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00327104256483845,0.00657803533879607,-0.00962190669920185,0.0161639918288788,0.619010152601245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00114328041455554,0.00230291124005232,-0.003370425615947,0.00565698644505808,0.619586547334821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,41839,-0.00178982252778579,0.00361670762728748,-0.00887856947726926,0.00529892442169767,0.620695723969717
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00137990602110742,0.00278890600310695,-0.00684616178719703,0.00408634974498219,0.620762175202396
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH22,Cadherin-22,39757,0.00145971959743023,0.00295145239540405,-0.0043251270975617,0.00724456629242216,0.62090868805885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX2,Transcription factor SOX-2,39915,0.00129618128175806,0.00262855185534858,-0.00385578035472515,0.00644814291824128,0.62194011378337
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXDNL,Peroxidasin-like protein,39919,-0.00301618053085845,0.00612656870754836,-0.0150242551976532,0.00899189413593633,0.622508665308814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF6,Fibroblast growth factor 6,39657,0.00204381609446504,0.00418342368112582,-0.00615569432054157,0.0102433265094716,0.625169253802859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31,Interleukin-31,39657,-0.00287130394206893,0.00595253942523353,-0.0145382812155267,0.0087956733313888,0.629555361925047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MBL2,Mannose-binding protein C,39826,-0.00557566807440796,0.0118118874238022,-0.0287269674250602,0.0175756312762443,0.636908335146666
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00137434109159042,0.00291661465549024,-0.00709090581635129,0.00434222363317046,0.637497568197848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL19,Interleukin-19,41756,-0.00367538889166178,0.00786042108992798,-0.0190818142279206,0.0117310364445971,0.640091513819299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00191294514820182,0.0040922839502049,-0.00993382169060342,0.00610793139419979,0.640186011460351
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESR1,Estrogen receptor,39657,0.00285077639521909,0.00611940652132895,-0.00914326038658565,0.0148448131770238,0.641326098559527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF75D,Zinc finger protein 75D,39757,-0.00304224727724141,0.00654899708670789,-0.0158782815671889,0.00979378701270605,0.64227257907104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,42310,0.00153802546868037,0.00331599965347741,-0.00496133385213536,0.0080373847894961,0.642784398738609
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBR1,T-box brain protein 1,39649,0.00238007585894503,0.00513998692329064,-0.00769429851070462,0.0124544502285947,0.643336962719741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB7,Integrin beta-7,42262,-0.00228425261010334,0.0049401737969351,-0.0119669932520961,0.00739848803188945,0.643814018343637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSCA,Prostate stem cell antigen,39930,0.0128212248297271,0.0278238474646526,-0.0417135162009921,0.0673559658604463,0.644951051472964
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00238692220706384,0.00518013390774317,-0.00776614025211277,0.0125399846662405,0.644962797484048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17F,Interleukin-17F,41913,-0.00360828142239446,0.00786229482260077,-0.019018379274692,0.0118018164299031,0.646288414209403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB2,Beta-crystallin B2,39929,0.00343568493927387,0.00748771582098265,-0.0112402380698521,0.0181116079483999,0.646355816829937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALLD,Palladin,39657,-0.00186182301770413,0.00408233204577398,-0.00986319382742114,0.00613954779201287,0.648349684099256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00227579362149529,0.00507371376829754,-0.0122202726073585,0.00766868536436789,0.653768107018364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDSN,Corneodesmosin,42246,0.00210119719565828,0.00468985109302522,-0.00709091094667114,0.0112933053379877,0.654138164378929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,39919,0.00170579706251881,0.00380917751332866,-0.00576019086360537,0.00917178498864299,0.654297137560667
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR1B,Cornifin-B,39757,0.00413939413932956,0.00925087350838351,-0.0139923179371021,0.0222711062157612,0.654551783832086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",41900,0.00208876020119469,0.00467079717497246,-0.00706600226175133,0.0112435226641407,0.654741080783366
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN1,Prorelaxin H1,39934,0.00207751622946017,0.00474425362156235,-0.00722122086880204,0.0113762533277224,0.661465963911338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GJA8,Gap junction alpha-8 protein,39560,-0.00292090196803598,0.00668459959801667,-0.0160227171801486,0.0101809132440767,0.662149038753714
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL21R,Interleukin-21 receptor,39657,-0.00249064320763904,0.00579685058516089,-0.0138524703545544,0.0088711839392763,0.667455324601786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLNL,Mesothelin-like protein,39649,-0.0017443398621394,0.00406280143266819,-0.00970743067016906,0.00621875094589026,0.667681192731478
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00187029576280338,0.00436729562487754,-0.0066896036619566,0.0104301951875634,0.668477223400902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2B,Alpha-amylase 2B,41300,-0.00227162892177352,0.00537089678795752,-0.0127985866261703,0.00825532878262321,0.672337799019381
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00283670991440676,0.00673151094549313,-0.0103570515387598,0.0160304713675733,0.673465718666824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD1,Glutamate decarboxylase 1,39560,0.00117997939839289,0.00282100138288607,-0.00434918331206381,0.0067091421088496,0.675747770904807
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM132A,Transmembrane protein 132A,39638,0.00280412694827191,0.00672408791081241,-0.0103750853569204,0.0159833392534642,0.676666688435702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSTN,Osteocrin,39649,0.00179816202415279,0.00433504421447715,-0.00669852463622243,0.010294848684528,0.678298790600676
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,39757,-0.0032302794370136,0.00784027586993167,-0.0185972201420797,0.0121366612680525,0.680339319421394
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA5,Annexin A5,41780,0.00133795365062915,0.00325855447081063,-0.00504881311215968,0.00772472041341798,0.681374522329758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF8,SLAM family member 8,41843,0.00236901994235654,0.00577280042241887,-0.00894566888558445,0.0136837087702975,0.681536635923653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLLT1,Protein ENL,39560,-0.00290588945419204,0.00710713743498062,-0.016835878826754,0.01102409991837,0.682643656695399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,39657,-0.00388030849612176,0.00949313393293403,-0.0224868510046725,0.0147262340124289,0.682731825644955
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00280304343643008,0.00690224361562169,-0.0163314409230486,0.0107253540501884,0.684672487143403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42123,0.00410674156015074,0.0101833784101411,-0.0158526801237258,0.0240661632440273,0.686749444053317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00173507848125985,0.00431462318606034,-0.00672158296341841,0.0101917399259381,0.68758951663586
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.00211371074064214,0.00526452419556328,-0.0124321781639462,0.00820475668266188,0.688059160530564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAND5,DAN domain family member 5,39657,-0.0023471418956722,0.00585532466497718,-0.0138235782390275,0.00912929444768306,0.688533907894626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00146805947022032,0.00366651719138987,-0.00865443316534446,0.00571831422490382,0.688871088637727
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_A,,39934,0.00138597971597079,0.0035134556287238,-0.00550039331632787,0.00827235274826944,0.693235848006194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00202822676230915,0.00516389311239645,-0.00809300373798789,0.0121494572626062,0.694496364095695
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAGE2A,G antigen 2A,39560,-0.00273866410323867,0.0070008731468063,-0.016460375470979,0.0109830472645017,0.6956651916436
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00249166558359022,0.00637020402992789,-0.0149772654822489,0.00999393431506844,0.695697057543742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00118693404286785,0.00305184570666569,-0.0071685516279326,0.00479468354219689,0.697340121871666
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP2,Dipeptidase 2,42070,-0.0012522838347898,0.00322177848946357,-0.0075669696741384,0.0050624020045588,0.697509154727207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00118167358526618,0.00307395821652315,-0.00720663168965157,0.0048432845191192,0.700677398919465
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEFL,Neurofilament light polypeptide,41797,0.00194303453542516,0.00507209048017765,-0.00799826280572304,0.0118843318765734,0.701663970519383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00164831791816186,0.0043066591851241,-0.00679273408468138,0.0100893699210051,0.701922051038239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00220342082052675,0.00576567739971427,-0.0135041485239667,0.00909730688291323,0.702348853712073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00137436400985197,0.00361352281822552,-0.00570814071387005,0.00845686873357398,0.703701034624966
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00143239043809198,0.0037886805038424,-0.00885820422562309,0.00599342334943912,0.705385121286464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00222656117446082,0.00589528032042649,-0.00932818825357509,0.0137813106024967,0.70567162782383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC9,Histone deacetylase 9,39586,0.00267150560178904,0.00714638280189144,-0.0113354046899182,0.0166784158934963,0.708540790008182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.00138480632765974,0.00371988652522337,-0.00590617126177807,0.00867578391709755,0.709696822359334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00219985324574202,0.00593280587488648,-0.0138281527605195,0.00942844626903547,0.710797571570832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLGAP5,Disks large-associated protein 5,39934,0.00195284691343563,0.00529008307255896,-0.00841571590877993,0.0123214097356512,0.712021021952818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTF,Ciliary neurotrophic factor,39586,-0.00135817226970376,0.0037011421429242,-0.00861241086983519,0.00589606633042767,0.713655691207833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00262630842279248,0.0073106098651632,-0.0169551037585124,0.0117024869129274,0.719417878298535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00113966893069192,0.0031983583232255,-0.00512911338283006,0.0074084512442139,0.721600733286015
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,41665,-0.00185749778443523,0.00524033966912891,-0.0121285635359279,0.00841356796705742,0.722998897857283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCLRE1C,Protein artemis,39560,-0.00115226294213525,0.00326106994924358,-0.00754396004265267,0.00523943415838218,0.723841164780754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00223759222427362,0.00634949132636575,-0.0102074107754032,0.0146825952239505,0.724541145391893
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.00565214751051512,0.0160699456360935,-0.0258449459362281,0.0371492409572583,0.725052517432552
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,39750,-0.00374025125744991,0.0107565033686055,-0.0248229978599166,0.0173424953450168,0.728057045252843
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3,Interleukin-3,39560,0.0022676696596831,0.00656019172970059,-0.0105903061305301,0.0151256454498963,0.729596429173788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,39575,-0.002754365283892,0.00800229377164237,-0.018438861076311,0.0129301305085271,0.730704753882164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENG,Endoglin,42310,0.000632848467491303,0.00185056707848729,-0.00299426300634378,0.00425995994132638,0.732374626444448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00232479008624193,0.00680203955505028,-0.0110072074416566,0.0156567876141405,0.732524230949125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00165679129169133,0.00485346646131027,-0.0111695855558595,0.0078560029724768,0.732837254416154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF1,Trefoil factor 1,42084,-0.0029229354539913,0.00862183928420886,-0.0198217404510407,0.0139758695430581,0.734603481467734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00152667472293855,0.00457087584569784,-0.0104855913805063,0.00743224193462922,0.738385531246919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00177539914950623,0.00532047841078029,-0.00865273853562314,0.0122035368346356,0.738618636173041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HK2,Hexokinase-2,41900,0.000972602309297223,0.00292327279041738,-0.00475701235992085,0.00670221697851529,0.739358387517186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRP15,RRP15-like protein,39586,0.00323902107717632,0.00976801906359485,-0.0159062962874696,0.0223843384418222,0.74020182310463
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00170258991059334,0.00513777792213831,-0.00836745481679775,0.0117726346379844,0.740358833697607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PITHD1,PITH domain-containing protein 1,39539,-0.0027008425804749,0.0082724838797998,-0.0189149109848825,0.0135132258239327,0.744063620101054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,41900,0.00209684590422663,0.00644945648275917,-0.0105440888019813,0.0147377806104346,0.745095529420825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2,Interleukin-2,41913,-0.00110384229112557,0.00342603556558391,-0.00781887199967004,0.0056111874174189,0.747312073732647
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPGN,Epigen,39919,-0.00155925415410011,0.00495847277612754,-0.0112778607953101,0.00815935248710988,0.753175526797774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00170075611417843,0.00540987991839122,-0.0123041207542252,0.00890260852586836,0.753238691727195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGN,Cingulin,39649,0.00124446556834581,0.00401016390483431,-0.00661545568512943,0.00910438682182105,0.756317502924613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,41839,0.0010778288279436,0.0034948789229677,-0.00577213386107309,0.00792779151696029,0.757781056041066
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00109935858769741,0.00368320450800837,-0.00831843942339381,0.006119722247999,0.765343378859775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN1,Cerebellin-1,39586,-0.00292240202326016,0.00992428534752702,-0.0223740013044131,0.0165291972578928,0.768404523654427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00213572727715269,0.00730738790314626,-0.0164582075673194,0.012186753013014,0.770085941266923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORN4,MORN repeat-containing protein 4,39560,0.00244400203700678,0.00838388837606409,-0.0139884191800788,0.0188764232540924,0.770665469635197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.000958662690687972,0.00333885212836869,-0.0075028128622906,0.00558548748091466,0.774022167991292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00199513037307252,0.00699357087112059,-0.0157025292804689,0.0117122685343238,0.775434439506618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6,Seizure protein 6 homolog,39649,0.00095509580482448,0.00335497603474225,-0.00562065722327033,0.00753084883291929,0.775894369556969
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,39554,0.00247414788000862,0.00883264931075857,-0.0148378447690782,0.0197861405290954,0.779395407166693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00239213635060462,0.0085725184490328,-0.0191942725107089,0.0144099998094997,0.780213856801416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,39586,-0.00138550851854793,0.00499007247243652,-0.0111660505645235,0.00839503352742765,0.781283978848339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000745839158742389,0.00272192974629366,-0.00608082146147797,0.00458914314399319,0.784081200247263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00134673997494024,0.00492084380759617,-0.00829811388794826,0.0109915938378287,0.784334998307317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00156651345203097,0.00575146440082949,-0.00970635677359482,0.0128393836776568,0.78534423099007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.000934413623539746,0.00350472876208195,-0.00593485475014088,0.00780368199722038,0.789769588466546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00218527375906293,0.00826512121408813,-0.0140143638205498,0.0183849113386757,0.791478947333011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCP11,T-complex protein 11 homolog,39757,-0.0016048220909761,0.00619277101858463,-0.013742653287402,0.0105330091054498,0.79552858920285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.000834614943988204,0.00322369250857559,-0.00548382237281995,0.00715305226079636,0.795716861625238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00101863505057258,0.00397817080642514,-0.00881584983116585,0.00677857973002068,0.79791221108798
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC5D,Netrin receptor UNC5D,39657,0.000706166602503099,0.00279580512331916,-0.00477361143920246,0.00618594464420866,0.800596888978932
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLN,Mesothelin,42048,0.00149687130733789,0.00622433763107847,-0.0107028304495759,0.0136965730642517,0.809956527509841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00164248775558154,0.00687655529936912,-0.0118355606311819,0.015120536142345,0.811223823733485
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42119,-0.00113919904560213,0.00477641604922399,-0.0105009745020812,0.0082225764108769,0.811493063187491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00192450734635417,0.00809428230551222,-0.0177893006651581,0.0139402859724498,0.812070514350629
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP9,Matrix metalloproteinase-9,42125,0.00150342992736794,0.00640976873493866,-0.0110597167931118,0.0140665766478477,0.814559310613918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF2,Trefoil factor 2,42166,0.00146247942153155,0.00625613042375147,-0.0107995362090213,0.0137244950520844,0.815169077055168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.000632682013930411,0.00274897482792509,-0.00475530864880276,0.00602067267666359,0.817977824144102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000992387161219498,0.00433441928785854,-0.00750307464298324,0.00948784896542224,0.818908094754114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00113890318444287,0.00499219781848285,-0.00864580453978352,0.0109236109086693,0.819544274649333
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCLN,Nicalin,41913,0.00124237513215694,0.00548624329726226,-0.00951066173047708,0.011995411994791,0.820852745886582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6,Interleukin-6,42070,-0.00178310076008944,0.00799819316893874,-0.0174595593712094,0.0138933578510305,0.8235871829152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAPPA,Pappalysin-1,41913,0.00113231341218643,0.00508198991678952,-0.00882838682472103,0.0110930136490939,0.823687532135272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL4,Early placenta insulin-like peptide,39919,-0.00113824680197434,0.00515394909243828,-0.0112399870231534,0.00896349341920468,0.825213645036672
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.000702317628499713,0.00318179318278258,-0.00553399700975415,0.00693863226675357,0.825305915467442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00160448058463417,0.00730710292330326,-0.0159264023143086,0.0127174411450402,0.826203746255751
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD70,CD70 antigen,42119,-0.00101667321180967,0.00473511440679576,-0.0102974974491294,0.00826415102551003,0.829997191376042
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.00157042554192777,0.00733251681694722,-0.0159421585031443,0.0128013074192888,0.830415523896612
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTN,Neuroplastin,41843,0.00177054334140673,0.00839277408719035,-0.0146792938694863,0.0182203805522998,0.832921384309997
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00120684600370515,0.00575770453103032,-0.0100782548771143,0.0124919468845246,0.833979485970852
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00136923419163231,0.00659208471551164,-0.0115512518507705,0.0142897202340351,0.835459476814254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00105219638329576,0.0051608276965932,-0.0111674186686184,0.00906302590202691,0.838449372664809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.000563953398313817,0.00281520487192962,-0.00608175494729586,0.00495384815066823,0.841230822750555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000900327639300369,0.00451625118263537,-0.00795152467866496,0.00975217995726569,0.841990356830416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF3,Fibroblast growth factor 3,39657,0.000624635832997873,0.00317143191863172,-0.0055913707275203,0.00684064239351605,0.843864778904998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00102434302015132,0.0052328988160046,-0.0092321386592177,0.0112808246995203,0.844809007131791
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVPL,Envoplakin,39757,0.000685231217952547,0.00357529767571069,-0.00632235222644041,0.0076928146623455,0.848014292499935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.000669595611208544,0.00351264847979483,-0.0075543866316064,0.00621519540918931,0.848823598328203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,39657,0.00253710583110364,0.0134229418404426,-0.0237718601761639,0.0288460718383712,0.850086369977033
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.000982866497363431,0.00521413381644886,-0.00923683578287633,0.0112025687776032,0.850487190705126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD2,Leiomodin-2,39586,0.00123620637316667,0.00658638413748389,-0.0116731065363018,0.0141455192826351,0.851122191693696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.00160768828869714,0.00860433720260067,-0.0184721892057944,0.0152568126284002,0.851783983559841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP15,Matrix metalloproteinase-15,39958,0.000973027398843548,0.00520924556589412,-0.00923709391030892,0.011183148707996,0.851829764876886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHDC3L,KH domain-containing protein 3,39560,-0.00131105742093767,0.0071880899058523,-0.0153997136364082,0.0127775987945328,0.855277677064361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00105356590355659,0.00580067094265517,-0.0124228809511607,0.0103157491440475,0.855877780696958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,39586,-0.00184607487746063,0.0103219935873922,-0.0220771823087494,0.0183850325538282,0.858059822197188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,39757,0.00162401685509948,0.00922613996823043,-0.0164592174826322,0.0197072511928311,0.860278725551418
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLNS1A,Methylosome subunit pICln,39649,-0.000620084326310416,0.00359882916305432,-0.00767378948589689,0.00643362083327606,0.863203516010079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,39560,-0.000732408390874934,0.00429074425312355,-0.00914226712699709,0.00767745034524722,0.864466781972183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.000695238878372294,0.00409919115990641,-0.00733917579504428,0.00872965355178887,0.8653246792671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.000528245518231033,0.00312203435392354,-0.0055909418154591,0.00664743285192117,0.865642536709413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF830,Zinc finger protein 830,39919,0.00139558867023696,0.00831035433792918,-0.0148927058321042,0.0176838831725782,0.866638426934175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171A2,Protein FAM171A2,39934,-0.00280350292165548,0.0167199724348356,-0.0355746488939332,0.0299676430506223,0.866842824803973
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL25,Interleukin-25,39510,0.000613767278779306,0.00368063891157164,-0.0066002849879011,0.00782781954545972,0.86756541829794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKZF2,Zinc finger protein Helios,41843,0.00156923810983494,0.00952675669947896,-0.0171032050211438,0.0202416812408137,0.869167652877824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,39930,0.000874275618171684,0.00538368936178996,-0.00967775553093664,0.01142630676728,0.870998964115602
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNB2,Ephrin-B2,39649,-0.000999569375809379,0.00619821659414143,-0.0131480739003266,0.0111489351487078,0.871885860910123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.000508506440400867,0.00317623696458134,-0.00571691801017857,0.0067339308909803,0.872807411439422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.000516731314081925,0.0032683336108947,-0.00692266519143553,0.00588920256327168,0.874378945106391
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00106125499944689,0.00682311459362838,-0.0123120496040647,0.0144345596029585,0.876399341282039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000550859918561456,0.00359404067531733,-0.00649345980506051,0.00759517964218342,0.878187893148453
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00059728673107761,0.00393085627452682,-0.00830176502915018,0.00710719156699496,0.879230526523855
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.00235848131980777,0.0157169464649799,-0.0331636963911685,0.0284467337515529,0.880720223290435
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHB,Lutropin subunit beta,41843,-0.00141906789759309,0.00948243554097891,-0.0200046415579117,0.0171665057627256,0.881041254762399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA10,Annexin A10,41839,-0.00129995526376957,0.00876535293508698,-0.0184800470165401,0.0158801364890009,0.882103464226593
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00120906750833508,0.008394710130057,-0.0176626993632468,0.0152445643465766,0.885481096665499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.00182517536049554,0.012726987999287,-0.023119721118107,0.0267700718390981,0.885968643695895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.000898925730668064,0.00630127058472697,-0.0132494160767329,0.0114515646153968,0.886563021012664
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00060317806503458,0.00448845053593345,-0.00940054111546414,0.00819418498539498,0.89310100400009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCIN,Adseverin,39586,-0.00105447076082547,0.00790373803623396,-0.016545797311844,0.0144368557901931,0.89386827208345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRX,Cone-rod homeobox protein,41900,0.00149348535341036,0.0115164625565629,-0.021078781257453,0.0240657519642737,0.896819473051786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3A,Uroplakin-3a,39586,-0.000670791818434709,0.00518881847369588,-0.0108408760268786,0.00949929239000922,0.897141304384106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHIT1,Chitotriosidase-1,42207,-0.00207779368314761,0.0167761892878734,-0.0349591246873795,0.0308035373210843,0.901432915213159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAGLN3,Transgelin-3,39560,0.000787716141878232,0.00642862598787969,-0.011812390794366,0.0133878230781224,0.90247949019982
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKIV2L,Helicase SKI2W,39575,-0.000518876748569396,0.00423805587378754,-0.00882546626119297,0.00778771276405418,0.902558560743676
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.000543953256340354,0.00449352429445052,-0.00935126087346337,0.00826335436078266,0.90365107413676
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00212430628746545,0.0177835959101118,-0.0369801542712846,0.0327315416963537,0.904918484626085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO1,Alpha-enolase,42119,-0.0010059481780504,0.00842626238428985,-0.0175214224512585,0.0155095260951577,0.904974107548462
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00063700089009215,0.00543837895936966,-0.0100222218702724,0.0112962236504567,0.906758660972479
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,39649,-0.000506216778695067,0.00437076874024759,-0.00907292350958035,0.00806048995219022,0.907798329997142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF12,Fibroblast growth factor 12,39657,0.000559586371835051,0.00485406025315928,-0.00895437172435714,0.0100735444680272,0.908223600929384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.000356053822720843,0.00324021177773612,-0.00599476126164196,0.00670686890708364,0.912501472421114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKAP12,A-kinase anchor protein 12,39736,-0.00024324544187072,0.00227786900360575,-0.00470786868893799,0.00422137780519655,0.914960356646535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB116,Beta-defensin 116,39586,0.00080414149384406,0.00804211068487827,-0.0149583954485174,0.0165666784362055,0.920353018268396
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL11,Interleukin-11,41913,-0.000616531690420688,0.00652658642094714,-0.0134086410754771,0.0121755776946357,0.924741485097516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20,Interleukin-20,41913,-0.000450310025597847,0.00499823620017086,-0.0102468529779327,0.00934623292673704,0.928214042040071
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JUN,Transcription factor AP-1,41913,0.000465338059586897,0.00517219439099468,-0.00967216294676267,0.0106028390659365,0.928313064098904
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPT1,Translationally-controlled tumor protein,41913,0.000569946339660469,0.00686363620917621,-0.0128827806303249,0.0140226733096458,0.933822142237857
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10,Interleukin-10,41913,-0.000673234805311367,0.00823909372744791,-0.0168218585111093,0.0154753889004865,0.934876773040567
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBZ,Hemoglobin subunit zeta,39958,-0.000925227012884705,0.0115008693680119,-0.0234669309741881,0.0216164769484187,0.935882018613847
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,39657,-0.000178908623028138,0.0023537494077502,-0.00479225746221853,0.00443444021616225,0.93941247341098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN1,Neuroligin-1,39649,-0.000544940600907472,0.00719711840520877,-0.0146512926751167,0.0135614114733017,0.939646021033779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,39638,-0.000328963473179811,0.00441913406539978,-0.00899046624136338,0.00833253929500375,0.940661066448632
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRNN,Cornulin,41749,0.000502095343094899,0.00721516955582982,-0.0136396369863316,0.0146438276725214,0.944521971016995
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.000432841411525882,0.00647390805820735,-0.0122560183825605,0.0131217012056123,0.946694668599817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,41614,-0.000230221690760841,0.00346272499198835,-0.007017162675058,0.00655671929353632,0.94699216452967
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.0003668370744057,0.00552766143914761,-0.0104673793463236,0.011201053495135,0.947089360063639
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.000432117638090539,0.00667917862026677,-0.0126590724576323,0.0135233077338134,0.94841685914065
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000298733643250285,0.00471280531846361,-0.00893836478093838,0.00953583206743895,0.949458979118405
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5A,Cytochrome b5,39560,0.000481612511040432,0.00762560229966088,-0.0144645679962949,0.0154277930183758,0.949642392102416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERVV_1,,39575,-0.000293450172905501,0.00466696825287241,-0.00944070794853543,0.00885380760272442,0.949864706013252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.000263005538497839,0.00432373351455378,-0.00873752322702325,0.00821151215002757,0.951497026491732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.000232572080901753,0.00408011338515695,-0.00776445015400588,0.00822959431580938,0.95454493959427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL4,Myosin light chain 4,39638,0.000313135511938755,0.00552378037106086,-0.0105134740153405,0.011139745039218,0.954794261750698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.000277556507655719,0.00518245552486015,-0.0104351693363816,0.00988005632107017,0.95728913287256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,39649,0.000579208705065406,0.0113078055990614,-0.0215840902690949,0.0227425076792257,0.959149527115233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,39649,0.000269348649464768,0.00548640924126527,-0.0104840134634152,0.0110227107623447,0.960845435842909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000156463476543469,0.00324063516143133,-0.00619518143986195,0.00650810839294888,0.961492562087008
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPACAM2,HEPACAM family member 2,39929,0.000190508180244142,0.00467765060764503,-0.00897768701074012,0.0093587033712284,0.967513997917039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL2,Interferon lambda-2,39586,-0.000253402589985668,0.00626987428767179,-0.0125423561938224,0.012035551013851,0.967762291482181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC1,Sialoadhesin,42185,-0.000153781732277905,0.00445265592577225,-0.00888098734679152,0.00857342388223571,0.972449382117091
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0001043488768267,0.00321294830561748,-0.00640172755583697,0.00619302980218357,0.974091744409433
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB5,Integrin beta-5,42181,-0.000126403731111346,0.00411533316325066,-0.00819245673108264,0.00793964926885995,0.975497033182317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAX,Integrin alpha-X,39757,-0.000166030095196742,0.00552961294283625,-0.0110040714631558,0.0106720112727623,0.976047152111258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,41839,0.000154169818458934,0.00579765798603237,-0.0112092398341645,0.0115175794710824,0.978785761605903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLINT1,Clathrin interactor 1,39560,0.00014229819232193,0.00535321688561688,-0.0103500069034872,0.010634603288131,0.978793765874044
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP73,Tumor protein p73,39649,-8.07384594150647e-05,0.00367165376101008,-0.00727717983099482,0.00711570291216469,0.982456591715766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAP1,Antigen peptide transporter 1,39757,0.000126046323920941,0.0062466924636179,-0.0121174709047701,0.012369563552612,0.983901666647708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK12,Kallikrein-12,41843,-0.000266697009476348,0.0142976659561831,-0.0282901222835951,0.0277567282646424,0.985118055640768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22,Interleukin-22,39919,-9.59402149407945e-05,0.00753851380964727,-0.0148714272818494,0.0146795468519679,0.989846080941362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,41913,-4.42715646166403e-05,0.0061085821004508,-0.0120170924815002,0.0119285493522669,0.994217541036387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP350,Centrosome-associated protein 350,39560,-2.38411958379187e-05,0.00391569771541977,-0.00769860871806067,0.00765092632638484,0.995142124849596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-1.3049577170297e-05,0.00258564436072724,-0.00508091252419569,0.0050548133698551,0.995973234973438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-1.63874750000336e-05,0.00442954999626578,-0.00869830546768096,0.00866553051768089,0.997048236065997
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,41913,1.91976613427177e-05,0.00639196778214515,-0.0125090591916618,0.0125474545143472,0.997603678954305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42181,2.20432022104299e-06,0.00295887396934817,-0.00579718865970137,0.00580159730014345,0.99940559802436
